
<!DOCTYPE html>
<html dir="ltr" lang="zh-CN">
<head>
 
<link rel="preconnect" href="https://cdn.cookielaw.org">
<link rel="preconnect" href="https://www.googletagmanager.com">
<link rel="dns-prefetch" href="https://www.google-analytics.com">
<link href="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" rel="preload" as="script">
 <link href="https://www.googletagmanager.com/gtm.js?id=GTM-5MKXR9" rel="preload" as="script">
<!-- Diagnostic info: Cookie Law information is not enabled for current language. -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta lang="zh-CN">
<meta http-equiv="content-type" content="text/html; charset=utf-8">
<meta http-equiv="content-language" content="zh-CN">
<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1, minimum-scale=1, maximum-scale=5, user-scalable=1">
 <!-- Title and Description -->
 <title>（TB） 结核 - 传染病 - MSD诊疗手册专业版</title>
 
 <!-- Schema.org/Additional markup -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 <!-- Twitter Card data -->
 
 
 
 
 
 <!-- Open Graph data -->
 
 
 
 
 
 
 
 
 
 
 
 
 
<!-- Google Tag Manager -->
<script></script>
<!-- End Google Tag Manager -->
 <script type="text/javascript">
 // Way froward settings. Strongly typed for Typescript code.
 // Typescript definition file is in \src\Foundation\Presentation\code\Scripts\typings\Settings.d.ts
 MManual = window.MManual || {};
 MManual.Foundation = MManual.Foundation || {};
 MManual.Feature = MManual.Feature || {};
 MManual.Foundation.Logging = {
 Level : "WARN"
 }
 MManual.Foundation.Context = {
 Language: {
 Name: "zh-CN",
 Code: "zh"
 },
 Edition: "Professional"
 }
 MManual.Foundation.Context.Item = {}
 
 MManual.Foundation.Context.Item.SitecoreId = "1768e837-2640-4ba1-82b4-00fecd3bc5a7";
 MManual.Foundation.Context.Item.MediaId = "";
 MManual.Foundation.Context.Item.VasontId = "v1010663_zh";
 MManual.Foundation.Context.Item.TemplateId = "9fe4ab09-1603-40e4-91f9-0ac01a474c58";
 
 
 MManual.Foundation.Context.Chapter = {
 SitecoreId : "6c5e30c9-7884-4a09-a8fc-af5ffc08c592",
 VasontId : "v1010641_zh"
 }
 MManual.Foundation.Context.Section = {
 SitecoreId : "d1935ecb-65d1-43de-b635-c774246b848b",
 VasontId : "v878841_zh"
 }
 
 MManual.Foundation.TemplateIds = {
 Topic : "9fe4ab09-1603-40e4-91f9-0ac01a474c58"
 }
 MManual.deferredScripts = [];
 // Below settings are obsolete. Please use MManual.Foundation.Context
 //////////////////
 // OBSOLETE START
 ///////////////////
 MManual.settings = MManual.settings || {};
 MManual.settings.edition = "Professional";
 MManual.settings.language = "zh-CN";
 MManual.settings.languageCode = "zh";
 MManual.settings.displayDateFormat = "yy-MM-dd";
 MManual.settings.dateFormat = "yy-MM-dd";
 MManual.settings.loadLocationsGlobal = true;
 MManual.settings.LexicompEnabled = false;
 MManual.settings.topic = MManual.settings.topic || {};
 MManual.settings.topic.getTopicsForResourceUrl = "/Redesign/Topic/GetTopicsForResource";
 MManual.settings.topic.getTopicHelpfulUrl = "/Redesign/Topic/GetTopicHelpful";
 MManual.settings.topic.wasThisTopicHelpfulUrl = "/Redesign/Topic/WasThisTopicHelpful";
 MManual.settings.topic.getTableBodyUrl = "/Redesign/Topic/GetTableBody";
 MManual.settings.socialMedia = MManual.settings.socialMedia || {};
 MManual.settings.socialMedia.enableMultimediaPopupShareButton = true;
 MManual.CommonLetters = ['Common.Letters.Alphabet'];
 MManual.CommonNumbers = ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9'];
 MManual.Context = MManual.settings;
 MManual.Context.Item = MManual.Foundation.Context.Item;
 /////////////////
 // OBSOLETE END
 /////////////////
 </script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-3.5.1.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-ui-1.13.1.custom/jquery-ui.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Foundation/Presentation/Library/Knockout/knockout-3.5.1.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/hammer.2.0.7.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es5-shim.4.5.13.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es6-shim.0.35.4.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/slick-1.8.0/slick.1.8.0.min.js" type="text/javascript"></script>
<!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsjsv4.1.2.2-13178e13ca.js?v=9oeWsccS0AXvU_mpLneFQpk81D2qyviYAadBAspEdRc1"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
 <script src="/bundles/redesign/ie8libsjsv4.1.2.2-13178e13ca.js?v=NYMKNIKPtdByxJkp3-a4OoxrVMsYmUh3Th334huO0BY1"></script>
<![endif]-->
<!-- Add custom class to categorize all cookies as functional. -->
<script src='./bundles/redesign/mmanualjsv4.1.2.2-13178e13ca.js?v=qZy1l8ugVchOqoSbrCHnQvB_O3jXnpspHrGZgwDHF0I1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicjsv4.1.2.2-13178e13ca.js?v=kSA_yN8XuMyhoVC1QLzYxWJE66uhmC-mSc_-tgT27II1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicResourceSearchjsv4.1.2.2-13178e13ca.js?v=iHsFLQRu7O1_jYYodP5cLz5m6_oggwQ97PNvPDyRMrw1' class='optanon-category-C0002'></script>
<!--Region information -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<link rel="preload" href="/Content/Fonts/Redesign/oldrambla/Rambla-Latin-webfont.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-300-Light.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-600-SemiBold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link href="./bundles/redesign/mmanualcssv4.1.2.2-13178e13ca.css?v=RUczVKOp43QqHlIomZoV4XMWus4DZWBAeuESVt-1iCc1" rel="stylesheet" type="text/css" media="screen">
<link href="./bundles/redesign/jqueryuicssv4.1.2.2-13178e13ca.css?v=3k6hV5TZDiil7_Jv0lADrVVLB9hJfoX2PenhijDq_d81" rel="stylesheet" type="text/css" media="screen">
 <link href="./bundles/redesign/mmanualprofessionalcssv4.1.2.2-13178e13ca.css?v=Lf2mEc1mNu26ayS3cHvJyIfMnm0MoeX0377nXTzTN181" rel="stylesheet" type="text/css">
<!--[if lt IE 9]><link href="/bundles/redesign/ie8cssv4.1.2.2-13178e13ca.css?v=" rel="stylesheet"/>
<![endif]-->
<link href="./bundles/redesign/mmanualcssprintv4.1.2.2-13178e13ca.css?v=2xJ7o27xwBLBtbGx65XzwLYcjgNEMec7qcBRi3GYAM01" rel="stylesheet" type="text/css" media="print">
<link href="./bundles/redesign/mmanualcsshybridv4.1.2.2-13178e13ca.css?v=LCUeOfwqiGi437ffhbWXxV6YW74rb9NUl93CESRStCs1" rel="stylesheet" type="text/css" media="hybrid">
<!--[if lt IE 9]>
 <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<script type="text/javascript">
 function msieversion() {
 var ua = window.navigator.userAgent;
 var msie = ua.indexOf("MSIE ");
 if (msie > 0 || !!navigator.userAgent.match(/Trident.*rv\:11\./) || msie == NaN)
 var test = $('li.no-children');
 test.addClass("noSpace");
 return false;
 };
 //msieversion();
</script>
<div style="display: none">
 <div class="confirmationpopup__container" id="access-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">默沙东 诊疗手册 </span>
 </div>
 <div class="confirmationpopup__description">
 <p>欢迎来到默沙东诊疗手册专业版医讯网站 本网站旨在为医药专业人员提供在线服务，如果您不是医药专业人员，建议您退出网站，登录默沙东中国官方网站了解相关信息。如您并非医药专业人员，不论您基于任何原因访问或浏览本网站，您同意均不应参考本网站内容作为诊断、治疗、预防、康复、使用医疗产品或其他任何产品的建议或意见，对此您应寻求执业医师及其他具备相应资质的专业人士意见并遵照医嘱。本网站所载信息绝无意代替您自己的医学判断并且本网站刊载的任何观点、评论和其他内容亦无意作为可以信赖的建议，因此，我们郑重声明因任何本网站访问者或任何获知本网站内容者基于对本网站材料的信赖所引起的任何责任与义务都与本网站无关。您同意默沙东将不对您使用和/或依赖本网站内容、产品、信息或者资讯导致的直接或间接损失承担任何责任，并不对网站内容及其引述的产品、方法、资讯或其他材料的准确性、时效性、可适用性承担任何明示或暗示的保证责任。默沙东诊疗手册网站将对所有注册用户信息进行验证，您必须接受并遵守用户协议条款才能使用本网站。如注册人员信息没能通过验证，默沙东诊疗手册网站有权终止该用户使用本网站的权利，在本网站下方均有链接功能，您可随时通过链接浏览用户使用协议条款与网站保护政策。</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">我是专业医学人士</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">我不是专业医学人士</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script></script>
<div style="display: none">
 <div class="confirmationpopup__container" id="external-link-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">要离开本网站吗？</span>
 </div>
 <div class="confirmationpopup__description">
 <p>您选择的链接将带您前往第三方网站。我们无法控制任何第三方网站的内容或对其负责。</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">继续</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">取消 </a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script> 
 var externalUrls = JSON.parse(atob('["www.cdc.gov/mmwr/preview/mmwrhtml/rr58e324a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm","www.cdc.gov/vaccines/vpd/hepb/hcp/faqs-hcp-pediarix.html","cid.oxfordjournals.org/content/53/7/e25.full.pdf html?sid=67183860-0d8a-4d54-9d57-fd12d5682421","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.drugs-porphyria.org","porphyriafoundation.org/drugdatabase","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060","academic.oup.com/cid/article/58/1/e1/374007","www.cdc.gov/hepatitis/hav/havfaq.htm","journals.lww.com/ajg/Fulltext/2018/02000/ACG_Clinical_Guideline__Alcoholic_Liver_Disease.9.aspx","www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm","jama.jamanetwork.com/article.aspx?articleid=2492881","www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines","gi.org/guideline/genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes","rheumatology.oxfordjournals.org/content/42/2/235.full.pdf","onlinelibrary.wiley.com/doi/10.1002/14651858.CD003448.pub4/abstract?systemMessage=Wiley Online Library will be unavailable on Saturday 17th December 2016 at 09:00 GMT/ 04:00 EST/ 17:00 SGT for 4hrs due to essential maintenance.Apologies for the inconvenience","cid.oxfordjournals.org/content/early/2016/11/03/cid.ciw670.full","www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm","onlinelibrary.wiley.com/doi/10.1111/apt.13148/abstract","onlinelibrary.wiley.com/doi/10.1359/jbmr.06s204/abstract","onlinelibrary.wiley.com/doi/10.1002/jbmr.438/abstract","journals.lww.com/infectdis/Fulltext/2013/05000/New_Guidelines_for_Antimicrobial_Prophylaxis_in.10.aspx","jama.jamanetwork.com/article.aspx?articleid=1487498","cid.oxfordjournals.org/content/46/12/1801.full","www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.onlinejacc.org/content/64/22/e77","jamanetwork.com/journals/jamasurgery/fullarticle/2623725","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01","www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html","www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm","www.onlinejacc.org/content/56/22/1864","www.idsociety.org/practice-guideline/hap_vap","academic.oup.com/cid/article-lookup/doi/10.1086/649858","acp.silverchair-cdn.com/acp/content_public/journal/aim/937814/m183600ff3_panel_2.jpeg?Expires=1556744998&amp;Signature=Oc7aO8PzGrh4tsbJzhWwSTvws~WHIkN~BaNqycHCh1TDufduqpbjgojduPU-8q5Owv2tym0x3HekrEXjegtUiZ2C15Qag5cNuhdxGu84JMb5nLmefg~ofSQfhTAdRWr9ECrJt4a1nu0Rl2crQwlTdDcL4Q8k9MGLgeg6yqGHzJGmlul2E8fEWxiP1ivlR9GypBYLjQ-B3eUH4hi-SYVCDfitv2zjW01hFzUlZM6OSXb5yEGThsimV8yQSCxcSLwaaY~CnZZ96lrcrr87nkPmtyvM9iPUUs-ix3Be5lXTIDWuIRrY3xmWXTnpNu7fxROSemZYm5ESTXbpGdJH6gMyuA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","www.cdc.gov/mmwr/preview/mmwrhtml/mm6203a3.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.ncbi.nlm.nih.gov/pubmed?term=Crit Care Med[Jour] AND 42[volume] AND 1157[page] AND 2014[pdat] AND Karvellas CJ[first author] AND Outcomes and complications of intracranial pressure monitoring in acute liver failure&amp;TransSchema=title&amp;cmd=detailssearch","www.ncbi.nlm.nih.gov/pubmed?term=\"Hepatology (Baltimore, Md.)\"[Jour] AND 66[volume] AND 1219[page] AND 2017[pdat] AND Albillos A[author] AND Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. &amp;TransSchema=title&amp;cmd=detailssearch","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/the-american-society-of-colon-practical-guideline-sinus-pilonidalis.pdf","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/practice_parameters_for_the_management_of_hemorrhoids.pdf\"","www.cdc.gov/mmwr/preview/mmwrhtml/mm5803a4.htm","www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm","pubmed.ncbi.nlm.nih.gov/21956720-evidence-report-genetic-and-metabolic-testing-on-children-with-global-developmental-delay-report-of-the-quality-standards-subcommittee-of-the-american-academy-of-neurology-and-the-practice-committee-of-the-child-neurology-society?from_term=\"Neurology\"[Jour] AND 2011[pdat]&amp;from_pos=7","www.nal.usda.gov/fnic/vitamins-and-minerals","www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management","www.willseye.org/doctor/melvin-roat-md-facs","faculty.mdanderson.org/profiles/pedro_ramirez.html","pharmacy.ucsf.edu/shalini-lynch","weillcornell.org/jwbarnhill","profiles.stanford.edu/david-spiegel","www.umc.edu/doctors/Huang_Juebin","www.chop.edu/doctors/moldenhauer-julie-s","www.urmc.rochester.edu/people/20996734-stephen-brian-sulkes","podiatry.temple.edu/kendrick-whitney","www.med.upenn.edu/apps/faculty/index.php/g275/p8178541","www.urmc.rochester.edu/people/21136627-ronald-rabinowitz","psychiatry.ubc.ca/person/rosemary-basson","profiles.utsouthwestern.edu/profile/48082/ravindra-sarode.html","sop.washington.edu/people/brian-werth","pharmacy.ucsd.edu/faculty/le","www.chop.edu/doctors/calabria-andrew-c","medicine.uiowa.edu/psychiatry/profile/william-coryell","www.chop.edu/doctors/mehta-jay","www.adelphi.edu/faculty/profiles/profile.php?PID=0649","www.ot.wustl.edu/about/our-people/peggy-barco-8","www.urmc.rochester.edu/people/21411717-jimena-cubillos","www.mlanet.org/resources/userguide.html","www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#how-effective-are-hpv-vaccines","www.ncbi.nlm.nih.gov/books/NBK25349","www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf","academic.oup.com/cid/article/45/7/941/544359","academic.oup.com/cid/article/55/10/e86/321183","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","www.ncbi.nlm.nih.gov/pmc/articles/PMC5848239","pubmed.ncbi.nlm.nih.gov/29260225","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","jamanetwork.com/article.aspx?articleid=1487498","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","circ.ahajournals.org/content/132/15/1435.long","www.porphyriafoundation.com","porphyriafoundation.org/for-healthcare-professionals/drug-safety","www.porphyria-europe.com","www.drugs-porphyria.org","profiles.stanford.edu/judith-prochaska","circ.ahajournals.org/content/132/15/1435.long","aasld.org/publications/practice-guidelines","www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31065","www.ncbi.nlm.nih.gov/pubmed/22972059","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","academic.oup.com/cid/article/53/7/e25/424286","www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults","www.idsociety.org/practice-guideline/hap_vap","www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html","porphyriafoundation.org","www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986","www.lajh.org/about/the-jewish-home-team/meet-our-clinicians","www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html","www.ncbi.nlm.nih.gov/pmc/articles/PMC7431966","www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext","www.med.upenn.edu/apps/faculty/index.php/g275/p8841440","www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm","www.essentialaccessibility.com/merck","www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","ascopubs.org/doi/full/10.1200/JCO.21.00006","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext","ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","jamanetwork.com/journals/jamaoncology/fullarticle/2773114","ascopubs.org/doi/full/10.1200/JCO.21.00006","pubmed.ncbi.nlm.nih.gov/36107786","pubmed.ncbi.nlm.nih.gov/30304427","www.ncbi.nlm.nih.gov/pmc/articles/PMC5958910","www.ahajournals.org/doi/10.1161/HYP.0000000000000084","pubmed.ncbi.nlm.nih.gov/27195814","pubmed.ncbi.nlm.nih.gov/36130612","www.ncbi.nlm.nih.gov/pmc/articles/PMC9940918"]'));
 $(document).ready(function () {
 $("a").click(function() {
 var href = $(this).attr('href');
 if (MManual.Foundation.Url.IsAbsoluteUrl(href)) {
 var hrefWithoutProtocol = MManual.Foundation.Url.RemoveProtocol(href);
 var match = externalUrls.some(function(url) {
 return url.length > 0 && hrefWithoutProtocol.startsWith(url);
 });
 if (match) {
 externalLinkConfirmation.showConfirmationModal(href);
 } else {
 return true;
 }
 } else {
 return true;
 }
 return false;
 });
 });
 </script>
 <!-- AddToAny script remove-->
<script></script>
 
<script type="text/html" id="audio-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-audio-template">
 <!-- ko if: isSideline-->
 <div class="inlinebox inlinebox--right inlinebox--clickable" data-bind="attr: {id: ItemId}, css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">音频</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl}">
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses(), attr: {id: ItemId}">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 <!-- ko if: detailsAvailable -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 展示详情
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 隐藏详情
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="biodigital-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback, swipe: {next: parentContext.showNext, prev: parentContext.showPrev}" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-biodigital-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title, width:ImageWidth, height:ImageHeight}" />
 <div class="box__action"></div>
 <div class="box__label">3D 模型</div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: isInline -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
 
<script type="text/html" id="image-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Alt}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/javascript">
 (function (MManual) {
 var deferredScripts = [];
 
 deferredScripts.push("./bundles/redesign/imageplayerv4.1.2.2-13178e13ca.js?v=sWgoLvG7zFKbYfkOiaTYY5tBk5gefAsRS0qs0ENFdUc1");
 
 MManual.ImagePlayerScripts = deferredScripts;
 }(window.MManual = window.MManual || {}));
</script>
<script type="text/html" id="inlinemedia-photo-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__innerwrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 </div>
 <div class="inlinemedia__content">
 <div class="inlinemedia__image--container">
 <img class="h-nocopy" loading="lazy" oncontextmenu="return false;" data-bind="attr: { src: ThumbnailUrl, alt: Alt, width:ImageWidth, height:ImageHeight }" />
 </div>
 <!-- ko if: isSideline -->
 <div class="inlinemedia__subtitle" data-bind="html: Credits"></div>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isInline() && detailsAvailable() -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 展示详情
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 隐藏详情
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="infographic-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper h-nocopy">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Title}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 <div class="multimedia__image--actions hide-on-print">
 <div class="multimedia__image--actionzoom" data-bind="click: toggleZoom"></div>
 </div>
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: CitationLink -->
 <div class="multimedia__description--source">
 <span class="multimedia__description--sourcetitle">资料来源：</span>
 <!-- ko if: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationText, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 <!-- ko ifnot: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationLink, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-labtest-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">实验室检测</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="55" height="55" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script><script type="text/html" id="labtest-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="mediawidget-labtest-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labest',
 MediaNameTranslated: '实验室检测' ,
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="mediawidget-labtest-list-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labtest',
 MediaNameTranslated: '实验室检测',
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="inlinemedia-featuredlink-template">
 <!-- ko ifnot: isText-->
 <!-- ko ifnot: isModal -->
 <a data-bind="attr: {href: IframeSrcComputed, target: Target}">
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 </div>
 </div>
 </a>
 <!-- /ko -->
 <!-- /ko -->
 <!-- ko if: isModal -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }">
 </div>
 <!-- /ko -->
</script><script type="text/html" id="featuredlink-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="iframe-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="multimedia-thumbnail-template">
 <div class="modalcarousel__item" data-bind="event:{click: $parentContext.$parent.navToClick.bind($index()), keypress: $parentContext.$parent.navToClickKeyPress.bind($index())}, css: {'modalcarousel__item--active' : $parentContext.$parent.activeIndex() == $index()}, attr: { title: item.Title}, modalCarousel, css-static: 'modalcarousel__item--' + item.MediaType()" tabindex="0" role="button">
 <div class="modalcarousel__item--wrapper">
 <div class="modalcarousel__item--imagewrapper h-nocopy">
 <img oncontextmenu="return false;" data-bind="lazyload: {src: item.ThumbnailUrl, options: {loadOnlyInViewport: true} , updateTick: $parentContext.$parent.carouselScrollTick}, attr: {alt: item.Title }, scrollIntoView:$parentContext.$parent.activeIndex() == $index()" />
 </div>
 <div class="modalcarousel__item--text" data-bind="html: item.Title"> </div>
 </div>
 <div class="modalcarousel__item--number" data-bind="text: ($index() + 1)"></div>
 </div>
</script>
<script type="text/html" id="text-player-template">
 <div class="multimedia">
 <div class="multimedia__text" data-bind="html: Text"> </div>
 </div>
</script>
<script type="text/html" id="multimedia-link-block-template">
 <i class="inlinemedia__icon--open"
 data-bind="hoverVisible: enableHover, hoverTargetId: '.multimedia__link'"></i>
 <button class="multimedia__link--block" aria-expanded="false" data-bind="shortClick: showPlayer, attr : {'aria-label':'Common.AriaLabels.ExpandPopup'+' '+ item.MediaNameTranslated()}"></button>
</script>
<script type="text/html" id="multimedia-link-text-template">
 <a class="multimedia__link--text" role="button" tabindex="0" aria-expanded="false" data-bind="shortClick: showPlayer, html: linkText, css: cssClass"></a>
</script><div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
<script type="text/html" id="multimedia-popup-template">
 <!-- ko if: playerVisible -->
 <div class="modal" role="dialog" tabindex="-1" aria-labelledby="exampleModalLabel">
 <div class="modal--shade" data-bind="click: hidePopup"></div>
 <div class="modaldialog" data-bind=" arrowKeys: {left: showPrev, right: showNext}, css : {'h-expanded' : expanded }">
 <div class="modaldialog__header hide-on-print">
 <div class="modaldialog__header--wrapper">
 <div class="modaldialog__header--title modaldialog__header--element" data-bind="html: popupTitle(), scaleText: popupTitle"></div>
 <div tabindex="0" role="button" class="modaldialog__header--close modaldialog__header--element" data-bind="event: { click: hidePopup, keypress: hidePopupKeyPress }">
 关闭
 </div>
 </div>
 </div>
 <div class="modaldialog__content">
 <div class="modaldialog__content--wrapper" data-bind="swipe: {next: showNext, prev: showPrev, canSwipe: canSwipe}">
 <div class="modaldialog__media" data-bind="css :{ 'modaldialog__media--withcarousel': !(displaySingle() || hideCarousel()), 'modaldialog__media--single': displaySingle }">
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--prev" tabindex="0" role="button" aria-label="上一个" data-bind="event: { click: showPrev, keypress: showPrevKeyPress }">
 <div class="mm-icon" data-bind="css : showPrevClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__media--wrapper">
 
 <!-- ko component: {name: activeEntry().item.MediaType() + '-player', params: activeEntry} -->
 <!-- /ko -->
 
 </div>
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--next" tabindex="0" role="button" aria-label="下一个" data-bind="event: { click: showNext, keypress: showNextKeyPress }">
 <div class="mm-icon" data-bind="css: showNextClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: (displaySingle() || hideCarousel()) -->
 <div class="modaldialog__carousel hide-on-print">
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--prev" tabindex="0" role="button" data-bind="event:{click: carouselShowPrev, keypress:carouselShowPrevKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowPrevDisabled() } "></div>
 <div class="modaldialog__carousel--wrapper">
 <div class="modalcarousel" data-bind="scrollTick : carouselScrollTick, scroll : carouselIsScrolled ">
 <!-- ko foreach: {data: activeList, as: 'entry'} -->
 <!-- ko template: {name: 'multimedia-thumbnail-template', data: entry} -->
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--next" tabindex="0" role="button" data-bind="event:{click: carouselShowNext, keypress:carouselShowNextKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowNextDisabled() }"></div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__toolbar hide-on-print">
 <!-- ko ifnot: displaySingle -->
 <div class="modaldialog__pager">
 <a class="modaldialog__pager--nav modaldialog__pager--navfirst" data-bind="click: showFirst">«</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navleft" data-bind="click: showPrev">‹</a>
 <span class="modaldialog__pager--number" data-bind="text: activeEntry().index + 1"></span>/<span class="modaldialog__pager--number" data-bind="text: activeList().length"></span>
 <a class="modaldialog__pager--nav modaldialog__pager--navright" data-bind="click: showNext">›</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navlast" data-bind="click: showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__actions">
 <!-- ko if: detailsAvailable -->
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-show" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--show"></i>
 <span class="modaldialog__action--text">
 展示详情
 </span>
 </div>
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-hide" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--hide"></i>
 <span class="modaldialog__action--text">
 隐藏详情
 </span>
 </div>
 <!-- /ko -->
 <!-- ko if: MManual.settings.socialMedia.enableMultimediaPopupShareButton -->
 <div class="modaldialog__action modaldialog__action--share a2a_kit" data-a2a-icon-color="transparent,transparent" data-bind="attr:{'data-a2a-url': shareUrl}">
 <a class="modaldialog__icon--share a2a_dd" href="https://www.addtoany.com/share" data-a2a-icon-color="transparent,transparent" role="button"></a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__action modaldialog__action--print" data-bind="event:{click: printPopupContent, keypress:printPopupContentKeyPress}" tabindex="0" role="button" aria-label="打印">
 <div class="modaldialog__icon--print"></div>
 </div>
 </div>
 </div>
 <div class="modaldialog__copyright-print">
 <div class="modaldialog__copyright-print--logo">
<img src="/Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71" />
 </div>
 <div class="modaldialog__copyright-print--text">
 © 2023 Merck & Co., Inc., Rahway, NJ, USA 及其附属公司。保留所有权利。
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
</script>
<script type="text/html" id="podcast-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
 <script type="text/html" id="quiz-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <h3 class="multimedia__title" data-bind="html: Title"> </h3>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe frameBorder="0" scrolling="auto" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation, swipe: {left: parentContext.showNext, right: parentContext.showPrev}"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 </div>
</script>
<script type="text/html" id="table-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__table">
 <div class="multimedia__table--wrapper">
 <div data-bind="html: tableBody, stickyHeaderTable: tableBody" class="modaltable"> </div>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="m-link-text-template">
 <!-- ko if: isModal -->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="shortClick: showPlayer, html: linkText, css: cssClass, attr: { title: item.Title }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target }"></a>
 <!-- /ko -->
 <!-- ko ifnot: isModal -->
 <!--ko if: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: target=='_blank'? url :'https://www.msdmanuals.cn/'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:url}"></a>
 <!-- /ko -->
 <!--ko ifnot: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: 'https://www.msdmanuals.cn/'+'/professional/multimedia'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:'/professional/multimedia'+ url}"></a>
 <!-- /ko -->
 <!-- /ko -->
</script>
<script type="text/html" id="clinicalcalculator-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-calculator-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">临床计算器：</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="48" height="48" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="video-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__video">
 <div class="multimedia__video--spacer"></div>
 <div class="multimedia__video--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <div class="multimedia__video--print" onclick="$(this).hide(); return true;">
 <img loading="lazy" data-bind="attr: { src: ThumbnailUrl, alt: Title }">
 </div>
 </div>
 <div class="multimedia__video--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<link rel="stylesheet" href="./Content/Styles/fa/fonts/font-awesome.css" type="text/css" media="screen"><link rel="stylesheet" href="./CustomCss/custom_mobile_styles.css"><script type="text/javascript" src="./customscript/videodetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/VideoPath.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/Appdetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/customscript.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script></head>
<body class="professional msd zh ">
 <a href="/n3wbr@nds" rel="nofollow" style="display:none" arial-hidden="true">honeypot link</a>
 <!-- Google Tag Manager (noscript) -->
<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5MKXR9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<!-- End Google Tag Manager (noscript) -->
 <div id="testone"> <div class="l-viewport">
 
<input type="hidden" id="currentSitecoreItemId" value="1768e837-2640-4ba1-82b4-00fecd3bc5a7">
<input type="hidden" id="wasThisTopicHelpfulUrl" value="/Custom/Topic/WasThisTopicHelpful">
<input type="hidden" id="getTopicHelpfulUrl" value="/Custom/Topic/GetTopicHelpful">
<input type="hidden" id="languageSwitchUrl" value="/professional/LanguageSwitch">
<input type="hidden" id="resourceServiceUrl" value="/custom/Topic/GetTopicsForResource">
<input type="hidden" id="tableBodyServiceUrl" value="/custom/Topic/GetTableBody">
<input type="hidden" id="getAlphabetUrl" value="/Redesign/Widgets/GetAlphabet">
<input type="hidden" id="landingPageUrl" value="https://www.msdmanuals.cn/">
<input type="hidden" id="standaloneMultimediaBaseUrl" value="/professional/multimedia">
<input type="hidden" id="currentEdition" value="Professional">
<input type="hidden" id="currentLanguage" value="zh-CN">
<input type="hidden" id="currentLanguage2LetterISO" value="zh">
<input type="hidden" id="oldRestrictedBrightcovePlayer" value="3851244774001">
<input type="hidden" id="restrictedBrightcovePlayer" value="5qrY5f1MK_default">
<input type="hidden" id="shareableBrightcovePlayer" value="6CaKiGXJD_default">
<input type="hidden" id="selectLanguageLabel" value="
选择语言">
<input type="hidden" id="commonCloseText" value="关闭">
<input type="hidden" id="readAllText" value="全部读取">
 
 
 <!-- New div groups for LetterSpine and Header has been created
 due to problems with existing styling
 ToDo rewrite whole header and letter spine as one component -->
 <div id="l-group--header-letterpine" class="main-header sticky-header">
 <div class="l-group l-group--header">
 <div id="l-layer--header" class="l-layer l-layer--header" data-header-element-position="static" data-header-element-order="0">
 
 
 
 </div>
 </div>
 </div>
 
 
 <!-- <div id="l-group--header-letterpine--fixed" class="main-header l-group--header-letterpine-fixed l-group--header-letterpine-fixed--hidden l-group--header-letterpine-fixed--animate">
 <div class="l-group l-group--headerfixed hide-on-print">
 <div class="l-layer l-layer--header l-layer--fixed" data-header-element-position="fixed" data-header-element-order="0">
 
 
 </div>
 </div>
 <div class="l-group l-group--letterspinefixed"></div>
 </div>
 <div class="l-layer l-layer--underskirt">
 </div>-->
 
 
 
 <div class="l-layer l-layer--actiontoolbar">
 
 <div class="l-layer__content">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Common.AriaLabels.SocialMediaShare"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="打印"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="邮件"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </div>
 
 </div>
 <main id="maincontent" class="l-layer l-layer--main">
 
 <section class="l-layer__content main">
 
 <div class="orderize"></div>
<div class="main__content">
 <div class="topic__wrapper">
 
<script type="text/javascript">
 var resources = [];
 var resourcesIdList = [];
 $.each(resources, function() {
 if (this.MultimediaItem != null) {
 resourcesIdList.push({"itemId": this.MultimediaItem.ItemId, "uniqueId": this.MultimediaItem.UniqueId});
 }
 });
 $('a[href="#also-of-interest-news"],a[href="#also-of-interest-video"],a[href="#also-of-interest-biodigital"],a[href="#also-of-interest-student-stories"]').click(function ()
 {
 window.scrollTo(0, $("#Ph-Item-Lazyloading").offset().top - 230);
 });
</script>
<div class="orderize__candidate" data-orderize="100" itemscope="" itemtype="http://schema.org/MedicalCondition" data-preview-container='.topic__article'>
 <input type="hidden" value="" id="hdnTopicTopTile">
 <div class="autoload-placeholder-top hide-on-print" style="display:none">
 <a class="pre-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
 <div class="autoloadSettings" name="下一个:">
 <a id="autoloadEnable" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadChapter" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadSection" class="false" role="button" tabindex="-1"></a>
 <a id="stopAutoloadChapterCircular" class="false" role="button" tabindex="-1"></a>
 </div>
 <article class="topic__article">
 
<div class="tablebox tablebox--headings">
 <div class="tablebox__cell tablebox__cell--headings">
 <div class="topic__headings">
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <div class="topic__header--container">
 <div class="topic__authors topic__authors--container">
 <a id="top" role="button" tabindex="-1"></a>
 <h1 class="topic__header__headermodify--title topic__header__headermodify--title--animate" itemprop="name">
 （TB） 结核
 </h1>
 <div class="topic__authors-main-cont">
 <p class="topic__authors--description">作者： </p>
 
 <strong class="topic__label topic__label--author"><a href="./Contributors/nardell-edward.html">Edward A. Nardell</a></strong>
 <p class="topic__authors--description">, MD, Harvard Medical School</p>
 <div class="topic__revision">
 <div class="topic__authors">
 医学审查 7月 2022 
 </div>
 </div>
 </div>
 </div>
 <div class="topic__buttons hide-on-print">
 <div class="topicswitch topic__patient-education topic__patient-education--top" data-icd9="010;011;012;013;014;015;016;017;018;771.2;137" tabindex="0" role="link">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 看法 进行患者培训
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <div class="box topicmenu hide-on-print">
 <div class="topic-section-heading-list">
 <ul>
 <li>
 <a href="#v1010685_zh" class="topicmenu_mobile__paragraph">病因</a>
 </li>
 <li>
 <a href="#v1010704_zh" class="topicmenu_mobile__paragraph">流行病学</a>
 </li>
 <li>
 <a href="#v1010710_zh" class="topicmenu_mobile__paragraph">病理生理</a>
 </li>
 <li>
 <a href="#v1010739_zh" class="topicmenu_mobile__paragraph">症状和体征</a>
 </li>
 <li>
 <a href="#v1010743_zh" class="topicmenu_mobile__paragraph">诊断</a>
 </li>
 <li>
 <a href="#v1010794_zh" class="topicmenu_mobile__paragraph">预后</a>
 </li>
 <li>
 <a href="#v1010798_zh" class="topicmenu_mobile__paragraph">治疗</a>
 </li>
 <li>
 <a href="#v1011185_zh" class="topicmenu_mobile__paragraph">结核病筛查</a>
 </li>
 <li>
 <a href="#v1011229_zh" class="topicmenu_mobile__paragraph">预防</a>
 </li>
 <li>
 <a href="#v1011242_zh" class="topicmenu_mobile__paragraph">特殊人群</a>
 </li>
 <li>
 <a href="#v11555492_zh" class="topicmenu_mobile__paragraph">关键点</a>
 </li>
 <li>
 <a href="#v13952583_zh" class="topicmenu_mobile__paragraph">更多信息</a>
 </li>
 </ul>
 </div>
 </div>
<div class="topic__resources--title hide-on-print">
 主题资源
</div>
<div id="topicResources" class="hero hide-on-print">
 <div class="hero__tabs">
 <ul class="hero__header">
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Biodigitals'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 3D 模型 (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Biodigitals" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Biodigitals'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Calculators'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 临床计算器 (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Calculators" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Calculators'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Images'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Images'); }, keypress: function() { $data.activateGroup('Images'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 图片 (1)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Images" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Images'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="结核病（胸部 X 光检查）">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?mw=350&amp;thn=0&amp;sc_lang=zh" width="3969" height="3402" loading="lazy">
 </div>
 <span class="hero__description">
 结核病（胸部 X 光检查）
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"结核病（胸部 X 光检查）","Credits":"\u003cspan id=\u0022v27304825_zh\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eZEPHYR/科学图片库\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"cb3fcc38-3d3b-4984-8ad6-6370e6d3c7ad","Title":"%E7%BB%93%E6%A0%B8%E7%97%85%EF%BC%88%E8%83%B8%E9%83%A8%20X%20%E5%85%89%E6%A3%80%E6%9F%A5%EF%BC%89","ShareUrlTitle":"结核病胸部-x-光检查","Description":"%3Cp%3E%E8%82%BA%E7%BB%93%E6%A0%B8%E6%82%A3%E8%80%85%E8%83%B8%E9%83%A8%20X%20%E5%85%89%E7%89%87%E4%B8%8A%E7%9A%84%E5%8F%B3%E4%B8%8A%E5%8F%B6%E7%A9%BA%E6%B4%9E%E7%97%85%E5%8F%98%E3%80%82%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0\u0026sc_lang=zh","ThumbnailUrl":"./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=zh","MediaType":"image","MediaNameTranslated":"%E5%9B%BE%E7%89%87","UniqueId":"v27304822_zh","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"3969","ImageHeight":"3402","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"%E7%BB%93%E6%A0%B8%E7%97%85%EF%BC%88%E8%83%B8%E9%83%A8%20X%20%E5%85%89%E6%A3%80%E6%9F%A5%EF%BC%89","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"%E4%B8%BB%E9%A2%98%E8%B5%84%E6%BA%90%20%3A%20%E5%9B%BE%E7%89%87","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Tables'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Tables'); }, keypress: function() { $data.activateGroup('Tables'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 表格 (1)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Tables" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Tables'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="一线抗结核药物*">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 一线抗结核药物*
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"b9ae3000-0eeb-45ea-aa72-3cda78f44d1e","Title":"%E4%B8%80%E7%BA%BF%E6%8A%97%E7%BB%93%E6%A0%B8%E8%8D%AF%E7%89%A9%2A","ShareUrlTitle":"一线抗结核药物","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"%E8%A1%A8%E6%A0%BC","UniqueId":"v1010853_zh","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"%E4%B8%80%E7%BA%BF%E6%8A%97%E7%BB%93%E6%A0%B8%E8%8D%AF%E7%89%A9%2A","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"%E4%B8%BB%E9%A2%98%E8%B5%84%E6%BA%90%20%3A%20%E8%A1%A8%E6%A0%BC","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Videos'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 视频 (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Videos" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Videos'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Audios'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 音频 (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Audios" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Audios'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 </ul>
 </div>
</div>
<div class="topic__accordion">
 <span id="v1010682_zh" class="anchor"></span><div class="para"> <p><div class='topic__explanation'>结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。</div></p></div><span id="v1010680_zh" class="anchor"></span><div class="para"> <p>（另请参阅 <a href="./{FF140D85-944A-48FB-A5BB-DAD14D91CD49}.html" data-toggle="tooltip" title="围产期结核病(TB）" data-id="165d5222-840d-4e81-bc28-a41458d748a7" data-itemid="ff140d85-944a-48fb-a5bb-dad14d91cd49">围产期结核病</a><span id="165d5222-840d-4e81-bc28-a41458d748a7" class="d-none xref"> <span class="tooltip-container"> <a href="./{FF140D85-944A-48FB-A5BB-DAD14D91CD49}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 围产期结核病(TB） </span> 围产期结核病是指围产期获得的结核菌感染。症状和体征不具特异性。诊断根据培养结果、X线检查和活检。治疗使用抗结核药物。 （ （TB） 结核 成人 和新生儿感染概述。） 婴儿通过以下途径感染结核： 通过胎盘经脐静脉到达胎儿肝脏 通过吸入被感染的羊水 <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span> 和 <a href="./{41EBCC40-5B7B-404D-B6F0-50D8151C4612}.html" data-toggle="tooltip" title="肺外结核（TB）感染" data-id="b5f838f4-cc1f-4c3a-ac0c-4121eafc1fec" data-itemid="41ebcc40-5b7b-404d-b6f0-50d8151c4612">肺外结核</a><span id="b5f838f4-cc1f-4c3a-ac0c-4121eafc1fec" class="d-none xref"> <span class="tooltip-container"> <a href="./{41EBCC40-5B7B-404D-B6F0-50D8151C4612}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 肺外结核（TB）感染 </span> 肺外结核通常由血行播散引起。有时感染直接从邻近器官延伸而来的。症状因不同感染部位而异，主要有发热、乏力及消瘦。诊断通常依赖痰涂片和培养，快速分子诊断测试越来越受重视。治疗是联合用药至少6个月给。 结核病 (TB) 仅指由 <i>结合分枝杆菌</i>... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/8/4/484-cutaneous-tuberculosis-scrofuloderma-slide-20-springer-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="肺外结核（TB）感染" loading="lazy"> </span> </a> </span> </span>。）</p></div><span id="v38408720_zh" class="anchor"></span><div class="para"> <p>它是一类生长缓慢的微需氧杆菌。它们因细胞膜富含脂质而具有抗酸特点（即，在用卡福菌素染色后，对酸的脱色具有抗性），并对革兰氏染色具有相对抗性。最常见的分枝杆菌感染是结核；其他包括 <a href="./{37E0A49A-17EF-4C61-BB00-3BDEAC204775}.html" data-toggle="tooltip" title="麻风" data-id="a4055992-04a0-492e-b962-389c866dc0db" data-itemid="37e0a49a-17ef-4c61-bb00-3bdeac204775">麻风病</a><span id="a4055992-04a0-492e-b962-389c866dc0db" class="d-none xref"> <span class="tooltip-container"> <a href="./{37E0A49A-17EF-4C61-BB00-3BDEAC204775}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 麻风 </span> 麻风病是一种慢性感染，通常由耐酸杆菌<i>麻风分枝杆菌</i>或密切相关的<i>弥散型麻风分枝杆菌</i>引起。这些生物体对周围神经、皮肤和上呼吸道粘膜具有独特的嗜性。表现多种，主要有皮肤多形性麻木和外周神经疾病。诊断有赖于临床，确诊需活检。治疗用氨苯砜联用其他抗分枝杆菌药物。患者接受治疗后很快就无... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/0/m2000171_tuberculoid_leprosy_science_photo_library_high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="麻风" loading="lazy"> </span> </a> </span> </span>以及各种环境 <a href="./{8CF4C69D-B9A4-4212-9A25-F307B195ECF2}.html" data-toggle="tooltip" title="非结核分枝杆菌感染" data-id="152e1ded-82ff-4b27-ab90-87d350b605c9" data-itemid="8cf4c69d-b9a4-4212-9a25-f307b195ecf2">非结核分枝杆菌感染</a><span id="152e1ded-82ff-4b27-ab90-87d350b605c9" class="d-none xref"> <span class="tooltip-container"> <a href="./{8CF4C69D-B9A4-4212-9A25-F307B195ECF2}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 非结核分枝杆菌感染 </span> 有超过 170 种公认的分枝杆菌，主要是环境的。环境暴露于许多这些生物是常见的，但大多数暴露不会导致感染，许多感染不会导致疾病。疾病通常需要局部或全身宿主防御缺陷。患有慢性肺病的人（尤其是 囊性纤维化)、体弱的老年人和免疫功能低下的人面临的风险最高，但其他缺陷不太明显的人可能会出现进展性疾病。定期报... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>，如由<i>鸟分支杆菌</i>复合物引起的感染。</p></div><span id="v1010684_zh" class="anchor"></span><div class="para"> <p>结核病（TB）是全球成年人死亡的主要传染原因，2020年约有150万人死亡，其中大多数在中低收入国家（<a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v68425434_zh" data-toggle="tooltip" title="参考文献" data-id="ba92b672-0cd7-4105-a2d3-911795c70a37" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">1</a><span id="ba92b672-0cd7-4105-a2d3-911795c70a37" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v68425434_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 参考文献 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="参考文献" loading="lazy"> </span> </a> </span> </span>）。在HIV和结核都流行的国家和地区，HIV/AIDS是导致结核发病率和病死率增加的一个重要因素。</p></div> <section id="v68425433_zh" class="topic__section GHead"> <span></span> <h2 id="" class="topic__header--section"> <span id="v68425434_zh" class="anchor"></span> 参考文献 </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v68425437_zh" class="anchor"></span><div class="para"> <p>1.<a rel="nofollow" target="_blank" href="https://www.who.int/publications/i/item/9789240037021">World Health Organization (WHO)</a>: Global Tuberculosis Report 2021.Accessed on 5/9/2022.</p></div></li></ul></div> </div> </section> <section id="v1010685_zh" class="topic__section FHead" itemprop="cause" itemscope="" itemtype="http://schema.org/MedicalCause"> <h2 id="Etiology_v1010686_zh" class="topic__header--section" data-originaltitle="病因"> <span id="v1010686_zh" class="anchor"></span> 结核病的病因 </h2> <div class="topic__content"> <span id="v1010687_zh" class="anchor"></span><div class="para"> <p>结核通常指由结核分枝杆菌 <i>Mycobacterium tuberculosis</i>（人是主要宿主）所引起的疾病。其他还有牛型结核杆菌、非洲结核杆菌和田鼠分枝杆菌等，也可引起类似感染，<i>M. bovis</i>, <i>M. africanum</i>, 和<i>M. microti</i>他们和 。这三种细菌，连同<i>结核分枝杆菌</i>和其他不太常见的分枝杆菌，被称为<i>结核分枝杆菌复合体。</i></p></div><span id="v1010692_zh" class="anchor"></span><div class="para"> <p>结核感染途径主要是吸入带结核分枝杆菌 <i>M. tuberculosis</i>的空气颗粒（飞沫）。它们主要通过咳嗽、唱歌和其他活动性肺结核或喉结核患者的强制呼吸动作传播，这些患者的痰中含有大量有机体（约10000个有机体/mL，荧光显微镜检测极限）。尤其是有肺空洞者传染性最强，因为空洞中带有大量结核菌。</p></div><span id="v38408726_zh" class="anchor"></span><div class="para"> <p>带结核杆菌的飞沫 (特别是直径 < 5微米的颗粒)可在室内空气中漂浮数小时，增加了传染机会。=""></p></div><span id="v1010694_zh" class="anchor"></span><div class="para"> <p>未经治疗的活动性肺结核的传染性差异很大。某些 结核分枝杆菌<i>结核分歧杆菌</i>菌株传染性更高，而 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010762_zh" data-toggle="tooltip" title="痰液检查、培养和化验" data-id="60b7b85c-ab91-42d0-b593-8b5a85ddc050" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">痰涂片阳性</a><span id="60b7b85c-ab91-42d0-b593-8b5a85ddc050" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010762_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 痰液检查、培养和化验 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt=" 痰液检查、培养和化验" loading="lazy"> </span> </a> </span> </span>患者的传染性比仅培养阳性患者的传染性更高。肺空洞患者（这与痰结核菌量密切相关）比那些无空洞者的传染性更高。粘度较低的呼吸道分泌物更容易雾化，咳嗽和其他呼吸动作在产生气溶胶方面的效果差异很大。</p></div><span id="v38408727_zh" class="anchor"></span><div class="para"> <p>环境因素也有重要影响。频繁或长时间暴露于未经治疗的患者（这些患者在拥挤、通风不良、封闭的空间内产生大量结核杆菌）会加重传播;因此，贫困人群或生活在福利机构的人群面临较大的风险。与活动性病例密切接触的医疗保健人员的风险也增加。</p></div><span id="v38408728_zh" class="anchor"></span><div class="para"> <p>因此，对传染性的估计差异很大。一些研究表明，只有三分之一的未经治疗的肺结核患者会感染任何密切接触者，但世界卫生组织 (WHO) 估计每位未经治疗的患者每年可能感染 10 至 15 人。然而，大多数那些感染者不发展为活动性结核。</p></div><span id="v38408729_zh" class="anchor"></span><div class="para"> <p>一旦开始有效的治疗，传染性就会迅速下降；咳嗽减少，即使存在于痰液中，微生物也没有传染性。对家庭接触者的流行病学研究表明，在患者开始有效治疗的2周内，传播结束，但更精确的人与动物研究表明，传播在开始治疗的几天内结束。</p></div><span id="v1010695_zh" class="anchor"></span><div class="para"> <p>更少见的是由感染伤口冲洗后产生的气溶胶、分支杆菌实验室、气溶胶或在尸检室直接穿刺导致的传播。</p></div><span id="v38408730_zh" class="anchor"></span><div class="para"> <p>扁桃体、淋巴结、腹部器官、骨骼和关节的结核病曾经通常由摄入受<i>牛分枝杆菌</i>污染的牛奶或奶制品（例如奶酪）引起的，但在牛奶经过巴氏杀菌并且结核菌素皮肤试验结果呈阳性的奶牛被屠宰的国家，这种传播途径已基本根除。由于<i>牛分枝杆菌</i>引起的结核病仍发生在牛结核病流行的国家（如一些拉丁美洲国家）和来自这些国家的移民中。 将未经高温消毒的牛奶制成奶酪的日益普及引发新的问题，特别是如果奶酪来自由牛结核病的国家（例如，墨西哥，英国）。牛和人类结核病可以传播给其他物种，例如獾、鹿、灵长类动物和动物园动物。屠宰场与人畜共患结核病传播有关。</p></div> </div> </section> <section id="v1010704_zh" class="topic__section FHead"> <h2 id="Epidemiology_v1010705_zh" class="topic__header--section" data-originaltitle="流行病学"> <span id="v1010705_zh" class="anchor"></span> TB的流行病学 </h2> <div class="topic__content"> <span id="v1010706_zh" class="anchor"></span><div class="para"> <p>根据结核菌素皮肤试验调查，估计世界上约有四分之一的人口受到感染。对于感染者，任一时间可能有1500万人患活动性结核。</p></div><span id="v68425442_zh" class="anchor"></span><div class="para"> <p>2020年，全球估计新增990万（127/10万）肺结核病例。大多数新发病例发生在东南亚（43％）、非洲（25％）和西太平洋（18％) (<a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v38408741_zh" data-toggle="tooltip" title="流行病学参考" data-id="61e41aa8-a89b-424c-a7ef-5f98ab92e19c" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">1</a><span id="61e41aa8-a89b-424c-a7ef-5f98ab92e19c" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v38408741_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 流行病学参考 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt=" 流行病学参考" loading="lazy"> </span> </a> </span> </span>）。</p></div><span id="v68425444_zh" class="anchor"></span><div class="para"> <p>发病率因国家、年龄、种族、性别以及社会经济地位不同而异。2020年，三分之二的新增病例发生在8个国家；大多数发生在印度（26%），其次是印度尼西亚（8.4%）、中国（8.5%）、菲律宾（6.0%）、巴基斯坦（5.8%）、尼日利亚（4.6%）、孟加拉国（3.6%）和南非（3.3%） (<a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v38408741_zh" data-toggle="tooltip" title="流行病学参考" data-id="3db6eb5a-3bc3-4cbd-a4b5-467ae93120ea" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">1</a><span id="3db6eb5a-3bc3-4cbd-a4b5-467ae93120ea" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v38408741_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 流行病学参考 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt=" 流行病学参考" loading="lazy"> </span> </a> </span> </span>）。 包括朝鲜、莱索托、莫桑比克、菲律宾和南非在内的少数国家的发病率高于500/100,000（<a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v38408741_zh" data-toggle="tooltip" title="流行病学参考" data-id="94c54837-631c-4e69-855f-a274110c1c7a" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">1</a><span id="94c54837-631c-4e69-855f-a274110c1c7a" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v38408741_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 流行病学参考 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt=" 流行病学参考" loading="lazy"> </span> </a> </span> </span>）。</p></div><span id="v1010707_zh" class="anchor"></span><div class="para"> <p>在全球范围内，药物敏感结核病的发病率和死亡率正在缓慢下降。2015 年至 2019 年累计减少 9%（从每 100,000 人的 142 至 130 例新病例），其中 2018 年至 2019 年期间减少了 2.3%。这部分归因于全球结核防控工作，使得患者可以获得更多的抗结核和抗HIV药物。然而，2020 年至 2021 年的全球 COVID-19 大流行扰乱了包括结核病控制在内的其他公共卫生计划，尽管现在量化还为时过早，但世卫组织预测这些全球下降趋势将停滞或逆转。 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v38408741_zh" data-toggle="tooltip" title="流行病学参考" data-id="0fa20303-defd-4353-9cef-cf3334ee6b43" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">1</a><span id="0fa20303-defd-4353-9cef-cf3334ee6b43" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v38408741_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 流行病学参考 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt=" 流行病学参考" loading="lazy"> </span> </a> </span> </span>）。</p></div><span id="v11555445_zh" class="anchor"></span><div class="para"> <p>2021 年，美国向 CDC 报告了 7860 例新的结核病病例，发病率为 2.4/100,000（<a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v38408741_zh" data-toggle="tooltip" title="流行病学参考" data-id="632f999d-c816-424a-b2c5-c699372bc29c" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">2</a><span id="632f999d-c816-424a-b2c5-c699372bc29c" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v38408741_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 流行病学参考 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt=" 流行病学参考" loading="lazy"> </span> </a> </span> </span>）。在 2020 年 COVID-19 大流行期间，发病率比 2019 年下降了 20%（<a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v38408741_zh" data-toggle="tooltip" title="流行病学参考" data-id="b17828b8-5442-4550-99ff-86af763f5fe1" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">3</a><span id="b17828b8-5442-4550-99ff-86af763f5fe1" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v38408741_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 流行病学参考 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt=" 流行病学参考" loading="lazy"> </span> </a> </span> </span>）。与通常每年 2% 至 3% 的下降相比，这 20% 的下降幅度和幅度表明，在 COVID-19 大流行期间存在结核病报告不足和/或大量病例诊断延迟的情况。2020年，71%的美国结核病病例发生在美国以外高流行地区出生的患者中。非美国出生人群的结核病发病率（11.5/10万）远高于美国出生人群（0.7/10万[ <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v38408741_zh" data-toggle="tooltip" title="流行病学参考" data-id="c84a695f-5312-4439-85dd-cc56e5175671" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">3</a><span id="c84a695f-5312-4439-85dd-cc56e5175671" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v38408741_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 流行病学参考 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt=" 流行病学参考" loading="lazy"> </span> </a> </span> </span>]）。居住在集体设施（如庇护所、长期护理设施或教养设施）中的人以及过去一年无家可归的人患结核病的风险增加。该人群中的患病率与世界上其他高患病率国家接近。</p></div><span id="v1010708_zh" class="anchor"></span><div class="para"> <p>1985年至1992年间，结核病在美国部分地区和其他经济发达国家再次流行；它与几个因素有关，包括HIV感染、无家可归、公共卫生基础设施恶化以及出现耐多药结核病（MDR-TB，定义为至少对异烟肼和利福平的耐药性）。在美国，通过有效的公共卫生和机构感染控制措施，耐多药结核病和耐利福平结核病（MDR/RR-TB）已基本得到控制，但直到最近，由这些微生物引起的感染在世界范围内一直在增加。然而，全世界的发病率似乎正在缓慢下降。结核病发病率的降低和对药物敏感和耐药结核病的（分子）诊断、治疗和病例管理的改进是可能的解释。尽管 MDR/RR-TB 病例占事件病例的不到 4%，但这些病例的诊断和治疗消耗了不成比例的结核病控制资源。MDR/RR-TB 给受影响的人及其家人带来了不成比例的人类痛苦、死亡和经济后果。</p></div><span id="v38408739_zh" class="anchor"></span><div class="para"> <p>尽管如此，在世界许多地区，MDR/RR-TB仍无法快速诊断并及时采用有效的治疗方案，包括有效管理二线药物的不良反应。这导致持续的疫情扩散，低治愈率，以及耐药结核传播。高抗药性结核病患者的治疗效果更差，包括高死亡率，尤其是在同时感染艾滋病毒的患者中，即使他们正在接受抗逆转录病毒药物治疗。更新、更短、更有效（非注射）的治疗方案，加上不良反应管理、社区推广和社会支持，会使全球耐药结核病的流行病学趋势更为有利，特别是在少数地区（如秘鲁、俄罗斯托木斯克地区）。印度和中国正在实施全国范围的耐多药结核病项目，这些项目的成败可能会极大地影响耐多药结核的未来。</p></div> <section id="v38408740_zh" class="topic__section GHead"> <span></span> <h3 id="Epidemiology_v1010705_zh_v38408741_zh" class="topic__header--subsection"> <span id="v38408741_zh" class="anchor"></span> 流行病学参考 </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v38408744_zh" class="anchor"></span><div class="para"> <p>1.<a rel="nofollow" target="_blank" href="https://www.who.int/publications/i/item/9789240037021">World Health Organization (WHO)</a>: Global Tuberculosis Report 2021.Accessed on 4/17/2022.</p></div></li><li class="topic__listitem"><span id="v68425451_zh" class="anchor"></span><div class="para"> <p>2.<a rel="nofollow" target="_blank" href="https://www.cdc.gov/tb/statistics/default.htm">Centers for Disease Control and Prevention (CDC)</a>: Tuberculosis—Data and Statistics.Accessed on 4/19/2022.</p></div></li><li class="topic__listitem"><span id="v38408750_zh" class="anchor"></span><div class="para"> <p>3.<a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993554/">Deutsch-Feldman M, Pratt RH, Price SF, et al</a>: Tuberculosis—United States, 2020.<span data-mmanualobjecttype="pubtitle">MMWR Morb Mortal Wkly Rep</span> 70:409–414, 2021.doi: 10.15585/mmwr.mm7012a1</p></div></li></ul></div> </div> </section> </div> </section> <section id="v1010710_zh" class="topic__section FHead"> <h2 id="Pathophysiology_v1010711_zh" class="topic__header--section" data-originaltitle="病理生理"> <span id="v1010711_zh" class="anchor"></span> TB的病理生理学 </h2> <div class="topic__content"> <span id="v38408752_zh" class="anchor"></span><div class="para"> <p> 结核病的发生分三个阶段：</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v38408755_zh" class="anchor"></span><div class="para"> <p>原发感染</p></div></li><li class="topic__listitem"><span id="v38408757_zh" class="anchor"></span><div class="para"> <p> 潜伏感染</p></div></li><li class="topic__listitem"><span id="v38408759_zh" class="anchor"></span><div class="para"> <p>活动性感染</p></div></li></ul></div><span id="v1010712_zh" class="anchor"></span><div class="para"> <p><i>结核杆菌</i>最初会引起原发性感染，其中一小部分最终会发展为严重程度不同的临床疾病。然而，大多数（约95%）原发感染是无症状的。未知比例的原发感染会自发消退，但大多数感染后会进入潜伏期（休眠期）。部分（5-10%）潜伏感染随后会发展为重新激活，伴有疾病症状和体征。</p></div><span id="v38408760_zh" class="anchor"></span><div class="para"> <p>但原发性感染和潜伏期通常没有传染性。</p></div> <section id="v1010713_zh" class="topic__section GHead"> <span></span> <h3 id="Pathophysiology_v1010711_zh_v1010714_zh" class="topic__header--subsection"> <span id="v1010714_zh" class="anchor"></span> 原发TB感染 </h3> <div class="topic__content"> <span id="v1010715_zh" class="anchor"></span><div class="para"> <p>小的带菌颗粒经吸入后到达中肺或下肺肺泡内才可致人体感染。大颗粒带菌飞沫通常局限于气道近段而不能感染。感染通常起始于单一颗粒，其上含有少量结核菌。也许只有易感者可由一次接触结核菌而感染，其余人群多需反复接触结核菌才发展为活动结核。</p></div><span id="v1010716_zh" class="anchor"></span><div class="para"> <p>肺泡巨噬细胞吞噬<i>M. tuberculosis</i> 结核分枝杆菌后开始出现感染。未被肺泡巨噬细胞杀灭的菌体，可在其中复制，并最终杀死细胞（经CD8淋巴细胞辅助）；引起炎症细胞聚集，形成特征性结核结节或肺炎。</p></div><span id="v38408761_zh" class="anchor"></span><div class="para"> <p> 在感染的最初几周，一些感染的巨噬细胞迁移到区域淋巴结（例如，肺门，纵隔），并进入血液。然后，病原体可以血液传播到身体的任何部位，特别是肺的顶后部，长骨，肾，椎体和脑膜的骨骺。如患者对结核具有部分免疫力，例如接种疫苗或与先前自然感染的 结核分枝杆菌 或环境中分枝杆菌 <i>M. tuberculosis</i> ，则较少出现血行播散结核。</p></div><span id="v1010717_zh" class="anchor"></span><div class="para"> <p><b>潜伏TB感染</b>在大多数原发感染后发生。 大约有95％的感染者，结核菌在不受抑制的生长约3周后，通常在出现症状或体征前，机体免疫系统抑制了杆菌的复制。肺部或其他部位杆菌病灶可形成上皮样肉芽肿，中心有干酪样坏死；结核杆菌可在坏死组织中存活数年，是否发病主要取决于机体的免疫状态。病灶还可形成结核瘢痕（西蒙病灶，多来源于其他病灶经血行播散而来），或钙化病灶（Ghon病灶）。Ghon病灶累及淋巴结则是成为Ghon综合征（原发综合征），如果出现钙化，则称为Ranke综合征。 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010775_zh" data-toggle="tooltip" title="皮肤菌素实验" data-id="cae1f399-6a9e-4122-aecd-d759b677cb11" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">结核菌素试验</a><span id="cae1f399-6a9e-4122-aecd-d759b677cb11" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010775_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 皮肤菌素实验 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="皮肤菌素实验" loading="lazy"> </span> </a> </span> </span>和gamma 干扰素分泌试验（<a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010792_zh" data-toggle="tooltip" title="IGRA（干扰素-γ释放试验）" data-id="67b3d6c1-796e-4c20-8ceb-8250c523bb7b" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">IGRA</a><span id="67b3d6c1-796e-4c20-8ceb-8250c523bb7b" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010792_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> IGRA（干扰素-γ释放试验） </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="IGRA（干扰素-γ释放试验）" loading="lazy"> </span> </a> </span> </span>）在感染的潜伏阶段变为阳性。潜伏感染的部位是动态过程，并不像人们曾经认为的那样完全处于休眠状态。</p></div><span id="v1010722_zh" class="anchor"></span><div class="para"> <p>少数情况下，原发病灶也可快速发展，造成肺部急性感染，并可伴发空洞、胸膜浸润以及肺门或纵隔淋巴结肿大（若发生于儿童，可能导致挤压气管）。少量胸腔积液多为淋巴细胞性的，菌体量较少并可在几周内清除。多见于儿童和免疫抑制患者。</p></div><span id="v38408765_zh" class="anchor"></span><div class="para"> <p> <a href="./{41EBCC40-5B7B-404D-B6F0-50D8151C4612}.html" data-toggle="tooltip" title="肺外结核（TB）感染" data-id="8c0e0539-b95c-4d87-8b49-bc80a2f96653" data-itemid="41ebcc40-5b7b-404d-b6f0-50d8151c4612">肺外结核</a><span id="8c0e0539-b95c-4d87-8b49-bc80a2f96653" class="d-none xref"> <span class="tooltip-container"> <a href="./{41EBCC40-5B7B-404D-B6F0-50D8151C4612}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 肺外结核（TB）感染 </span> 肺外结核通常由血行播散引起。有时感染直接从邻近器官延伸而来的。症状因不同感染部位而异，主要有发热、乏力及消瘦。诊断通常依赖痰涂片和培养，快速分子诊断测试越来越受重视。治疗是联合用药至少6个月给。 结核病 (TB) 仅指由 <i>结合分枝杆菌</i>... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/8/4/484-cutaneous-tuberculosis-scrofuloderma-slide-20-springer-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="肺外结核（TB）感染" loading="lazy"> </span> </a> </span> </span> 在任何部位有时可以没有肺部累计证据。结核淋巴结病是最常见的肺外表现；然而，脑膜炎是最令人担忧的，因为它在年轻人和老年人中的死亡率很高。</p></div> </div> </section> <section id="v1010726_zh" class="topic__section GHead"> <span></span> <h3 id="Pathophysiology_v1010711_zh_v1010727_zh" class="topic__header--subsection"> <span id="v1010727_zh" class="anchor"></span> 活动性TB病 </h3> <div class="topic__content"> <span id="v1010728_zh" class="anchor"></span><div class="para"> <p> 感染结核病的健康人一生中有约5-10％会发展为活动性结核，尽管这一比例因年龄和其他危险因素而存在显著差异。</p></div><span id="v38408767_zh" class="anchor"></span><div class="para"> <p>在50%至80%的活动性疾病患者中，结核病在最初的2年内复发，但也可能在几十年后复发。</p></div><span id="v38408768_zh" class="anchor"></span><div class="para"> <p>再激活可以出现于任何一个器官，但最常见的还是肺部，可能与局部高O2浓度等因素相关。钙化灶和淋巴结钙化很少复发。</p></div><span id="v1010729_zh" class="anchor"></span><div class="para"> <p>导致细胞免疫下降的疾病和状态（这是控制结核的关键）显著利于再激活。因此，合并 <a href="./{58E097FD-A3ED-437F-85A6-10AC1181C94B}.html" data-toggle="tooltip" title="人类免疫缺陷病毒感染" data-id="aa7875b7-93ba-4355-a96f-be8c2be426e7" data-itemid="58e097fd-a3ed-437f-85a6-10ac1181c94b">HIV</a><span id="aa7875b7-93ba-4355-a96f-be8c2be426e7" class="d-none xref"> <span class="tooltip-container"> <a href="./{58E097FD-A3ED-437F-85A6-10AC1181C94B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 人类免疫缺陷病毒感染 </span> 由人免疫缺陷病毒（HIV）的两类相似的反转录病毒（HIV-1和HIV-2）感染引起CD4+T细胞损伤和细胞免疫功能破坏，进而导致发生某些感染和肿瘤的危险性增加。最初的感染可能导致不典型的发热性疾病。之后，由HIV感染所带来的疾病风险取决于免疫缺陷的程度，也即CD4+T淋巴细胞的减低程度。病毒可直接损... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/3/1/3/313_hiv_slide_3_springer_high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="人类免疫缺陷病毒感染" loading="lazy"> </span> </a> </span> </span>感染且未接受适当的抗逆转录病毒治疗（ART）的患者每年患活动性疾病的风险约为10%。</p></div><span id="v38408770_zh" class="anchor"></span><div class="para"> <p>其他程度比HIV感染小但有助于重新激活的风险因素，包括</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v38408773_zh" class="anchor"></span><div class="para"> <p> <a href="./{2896CB80-11AC-462A-BDE8-3A98AA056BBC}.html" data-toggle="tooltip" title="糖尿病（DM）" data-id="678bc4f0-b22e-4598-b3c8-94670c8bd2f4" data-itemid="2896cb80-11ac-462a-bde8-3a98aa056bbc">糖尿病</a><span id="678bc4f0-b22e-4598-b3c8-94670c8bd2f4" class="d-none xref"> <span class="tooltip-container"> <a href="./{2896CB80-11AC-462A-BDE8-3A98AA056BBC}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 糖尿病（DM） </span> 糖尿病是由胰岛素分泌受损以及各种不同程度的外周胰岛素抵抗所致的高糖血症。早期症状与高糖血症有关，包括多饮、多尿、多食、视力模糊。后期并发症包括血管病变，周围神经病变、肾病及易发感染。诊断有赖于血糖检测。 治疗是饮食、运动和降低血糖水平的药物，包括胰岛素、口服降糖药和非胰岛素注射药物。... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v38408776_zh" class="anchor"></span><div class="para"> <p> <a href="./{D5F40AC5-5B99-46DC-B97E-9038B2B2CF72}.html" data-toggle="tooltip" title="头颈部肿瘤概述" data-id="f15959e6-d2e1-4652-83f4-b247cf000cf9" data-itemid="d5f40ac5-5b99-46dc-b97e-9038b2b2cf72">头颈部恶性肿瘤</a><span id="f15959e6-d2e1-4652-83f4-b247cf000cf9" class="d-none xref"> <span class="tooltip-container"> <a href="./{D5F40AC5-5B99-46DC-B97E-9038B2B2CF72}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 头颈部肿瘤概述 </span> 美国每年有近65,000例头颈部肿瘤新发病例。排除皮肤和甲状腺，>90％的头颈部恶性肿瘤属于鳞状细胞（表皮样）癌，其他类型大多为腺癌、肉瘤和淋巴瘤。 头颈部肿瘤 最常见的部位 是 喉（包括声门上，声门和声门下） 口腔（舌，口底，硬腭，颊粘膜和牙槽嵴）... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v38408779_zh" class="anchor"></span><div class="para"> <p> 胃切除术</p></div></li><li class="topic__listitem"><span id="v38408781_zh" class="anchor"></span><div class="para"> <p> 空回肠旁路术</p></div></li><li class="topic__listitem"><span id="v38408783_zh" class="anchor"></span><div class="para"> <p> <a href="./{E257332E-7351-4E21-A432-820B08BFB4EC}.html" data-toggle="tooltip" title="慢性肾脏病" data-id="9a3bddc7-ce79-4877-b0ca-ee9ed53ecb1d" data-itemid="e257332e-7351-4e21-a432-820b08bfb4ec">慢性肾病</a><span id="9a3bddc7-ce79-4877-b0ca-ee9ed53ecb1d" class="d-none xref"> <span class="tooltip-container"> <a href="./{E257332E-7351-4E21-A432-820B08BFB4EC}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 慢性肾脏病 </span> 慢性肾脏病（CKD）是肾功能长期、进展性的减退。其征象进展缓慢，晚期表现包括厌食、恶心、呕吐、口腔炎、味觉障碍、夜尿、疲乏、易倦、瘙痒、思维敏锐性下降、肌肉抽搐和痉挛、水潴留、营养不良、周围神经病、抽搐。诊断依据肾功能的实验室检查，有时需行肾活检。治疗主要为针对原发因素的处理，但也包括对水、电解质的... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/3/3/633-uremic-frost-springer-high-with-arrow-cropped_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="慢性肾脏病" loading="lazy"> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v38408786_zh" class="anchor"></span><div class="para"> <p>显着体重减轻</p></div></li><li class="topic__listitem"><span id="v38408788_zh" class="anchor"></span><div class="para"> <p>使用抑制免疫系统的药物</p></div></li></ul></div><span id="v38408789_zh" class="anchor"></span><div class="para"> <p>实体器官移植后需要免疫抑制的患者风险最高，但皮质类固醇和肿瘤坏死因子（TNF）抑制剂等其他免疫抑制剂也通常会导致再激活。吸烟也是危险因素之一。</p></div><span id="v11555449_zh" class="anchor"></span><div class="para"> <p>部分患者中，活动性结核是由于再感染而非潜伏结核再激活。再感染常见于结核流行区域。潜伏感染的再激活多见于低流行地区。在特定患者，很难确定患者是再感染还是潜伏感染再激。</p></div><span id="v1010730_zh" class="anchor"></span><div class="para"> <p>结核主要引起的是 <a href="./{D1880A62-D774-40DA-9249-9C99B7C4C1B6}.html#v994907_zh" data-toggle="tooltip" title="Ⅳ型" data-id="3fb02f54-132a-48c4-b164-181277d39232" data-itemid="d1880a62-d774-40da-9249-9c99b7c4c1b6">迟发性超敏反应</a><span id="3fb02f54-132a-48c4-b164-181277d39232" class="d-none xref"> <span class="tooltip-container"> <a href="./{D1880A62-D774-40DA-9249-9C99B7C4C1B6}.html#v994907_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> Ⅳ型 </span> <span class="tooltip-readmore"> </span> </span> </a> </span> </span>（DTH），形成肉芽肿伴干酪样坏死。肺部病变是具有特征性，但并不总是伴有空洞，尤其是DTH受损的免疫抑制患者。原发感染中胸腔积液比较少见，主要是直接扩散或血型播散导致。大的结节病灶破溃后还可引起脓胸或支气管胸膜瘘，偶还可伴气胸。在抗结核药物治疗出现之前，结核性脓胸通常伴随气胸，由于空洞增大累及肺动脉导致的大量咯血，患者通常迅速病死。</p></div><span id="v1010736_zh" class="anchor"></span><div class="para"> <p> TB的病程差异很大，取决于细菌的毒力和宿主的免疫状态。 与许多欧洲人和他们的美国后裔不同，这些与世隔绝的人群（如美洲原住民）没有经历过几个世纪的自然选择压力，没有形成对本病的先天性或自然免疫力，他们的病程可能进展很快。在欧洲人和美国人中，结核病通常呈惰性。</p></div><span id="v1010737_zh" class="anchor"></span><div class="para"> <p>结核杆菌的超敏反应还可导致 <a href="./{988BC99A-E3AA-477D-8044-DEF67E8F02CA}.html" data-toggle="tooltip" title="急性低氧性呼吸衰竭 (AHRF, ARDS)" data-id="2dc8aa85-d2fa-422b-bb09-ffc3162fe799" data-itemid="988bc99a-e3aa-477d-8044-def67e8f02ca">急性呼吸窘迫综合征</a><span id="2dc8aa85-d2fa-422b-bb09-ffc3162fe799" class="d-none xref"> <span class="tooltip-container"> <a href="./{988BC99A-E3AA-477D-8044-DEF67E8F02CA}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 急性低氧性呼吸衰竭 (AHRF, ARDS) </span> 急性低氧性呼吸衰竭定义为无高碳酸血症的严重低氧血症（PaO2 另见 机械通气概述 急性低氧性呼吸衰竭（AHRF）时肺泡实变可能源于： 肺泡毛细血管静水压升高，如 左心衰竭（导致 肺水肿）或高血容量状态 肺泡毛细管通透性增加，如任何原因所致的急性呼吸窘迫综合征（ARDS） <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/p/u/l/pulmonary_edema_high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="急性低氧性呼吸衰竭 (AHRF, ARDS)" loading="lazy"> </span> </a> </span> </span> （ARDS），另外，部分血性播散或空洞病灶破溃的患者也可出现。</p></div> </div> </section> </div> </section> <section id="v1010739_zh" class="topic__section FHead"> <h2 id="SymptomsAndSigns_v1010740_zh" class="topic__header--section" data-originaltitle="症状和体征"> <span id="v1010740_zh" class="anchor"></span> TB的症状和体征 </h2> <div class="topic__content"> <span id="v68425457_zh" class="anchor"></span><div class="para" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <p><b>原发感染</b> 几乎总是无症状的，但当出现症状时，它们通常是非特异性的，包括低烧和疲劳，但没有明显的咳嗽。</p></div><span id="v1010741_zh" class="anchor"></span><div class="para" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <p><b>急性肺结核</b>，即使是中度和重度感染，可只感觉不适而无其他任何症状。同时，厌食、疲倦和体重减轻等可在感染后数周逐渐出现。主诉中最多见的是咳嗽。起始可能有少量黄绿色痰，随着病情发展，痰量会越来越多。咯血通常见于空洞性肺结核患者（部分由于合并真菌感染）。</p></div><span id="v38408792_zh" class="anchor"></span><div class="para"> <p>低烧是常见的，但也可没有。反复盗汗是一种典型的症状，但在结核病中既不常见也不特异。肺实质破坏，气胸和结核性胸膜炎患者可出现呼吸困难。</p></div><span id="v1010742_zh" class="anchor"></span><div class="para"> <p>因为迟发性超敏反应受损，HIV合并感染时，临床表现通常不典型；患者更有可能出现肺外或播散性疾病的症状。</p></div><span id="v11555450_zh" class="anchor"></span><div class="para"> <p>根据感染的器官不同， <a href="./{41EBCC40-5B7B-404D-B6F0-50D8151C4612}.html" data-toggle="tooltip" title="肺外结核（TB）感染" data-id="1110a485-deec-427d-a74a-de3f6c1aa495" data-itemid="41ebcc40-5b7b-404d-b6f0-50d8151c4612">肺外TB</a><span id="1110a485-deec-427d-a74a-de3f6c1aa495" class="d-none xref"> <span class="tooltip-container"> <a href="./{41EBCC40-5B7B-404D-B6F0-50D8151C4612}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 肺外结核（TB）感染 </span> 肺外结核通常由血行播散引起。有时感染直接从邻近器官延伸而来的。症状因不同感染部位而异，主要有发热、乏力及消瘦。诊断通常依赖痰涂片和培养，快速分子诊断测试越来越受重视。治疗是联合用药至少6个月给。 结核病 (TB) 仅指由 <i>结合分枝杆菌</i>... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/8/4/484-cutaneous-tuberculosis-scrofuloderma-slide-20-springer-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="肺外结核（TB）感染" loading="lazy"> </span> </a> </span> </span>引起各种全身性和局部性表现。</p></div> </div> </section> <section id="v1010743_zh" class="topic__section FHead"> <h2 id="Diagnosis_v1010744_zh" class="topic__header--section" data-originaltitle="诊断"> <span id="v1010744_zh" class="anchor"></span> TB的诊断 </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v11555453_zh" class="anchor"></span><div class="para"> <p>胸部X线检查</p></div></li><li class="topic__listitem"><span id="v1010752_zh" class="anchor"></span><div class="para"> <p>抗酸染色和培养</p></div></li><li class="topic__listitem"><span id="v1010750_zh" class="anchor"></span><div class="para"> <p>结核菌素皮试和干扰素释放试验</p></div></li><li class="topic__listitem"><span id="v1010754_zh" class="anchor"></span><div class="para"> <p>可用时，核酸扩增测试 (NAAT)</p></div></li></ul></div><span id="v1010755_zh" class="anchor"></span><div class="para"> <p>以下任何情况需怀疑肺结核</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v38408796_zh" class="anchor"></span><div class="para"> <p>在评估呼吸道症状（咳嗽持续3周以上、咯血、胸痛、呼吸困难）、不明原因疾病、不明原因发热（FUO）或阳性 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010775_zh" data-toggle="tooltip" title="皮肤菌素实验" data-id="072f3a68-c213-4821-8cf7-7a11b9480d8d" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">结核菌素皮肤试验</a><span id="072f3a68-c213-4821-8cf7-7a11b9480d8d" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010775_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 皮肤菌素实验 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="皮肤菌素实验" loading="lazy"> </span> </a> </span> </span>（TST）时，可进行胸部X线检查。</p></div></li><li class="topic__listitem"><span id="v38408799_zh" class="anchor"></span><div class="para"> <p> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010792_zh" data-toggle="tooltip" title="IGRA（干扰素-γ释放试验）" data-id="81c2e4e0-3e19-4e64-9daf-063f8d5c4f43" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">IGRA</a><span id="81c2e4e0-3e19-4e64-9daf-063f8d5c4f43" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010792_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> IGRA（干扰素-γ释放试验） </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="IGRA（干扰素-γ释放试验）" loading="lazy"> </span> </a> </span> </span> 作为筛选检查或在接触者调查期间完成</p></div></li></ul></div><span id="v38408801_zh" class="anchor"></span><div class="para"> <p> 出现咳嗽持续> 2〜3周，盗汗，消瘦，和/或淋巴结肿大，有结核接触史（如通过接触受感染的家庭成员，朋友或其他联系人;在机构内接触;或前往结核病流行地区）的患者需高度怀疑结核。</p></div><span id="v1010757_zh" class="anchor"></span><div class="para"> <p>检查主要包括胸片、痰涂片和培养。如果在胸部影像学和痰液检查后仍不清楚活动性肺结核的诊断，可以进行TST或IGRA，但这些都是感染检测，而不是活动性疾病。NAAT（例如，基于聚合酶链式反应 [PCR]）是快速的并且可以进行诊断。</p></div><span id="v68425459_zh" class="anchor"></span><div class="para"> <p>与大多数临床试验一样，当结核病感染的先验概率较低时，阳性结核病检测结果在统计学上更有可能是假阳性（另见 <a href="./{F11B88D9-EBB8-40E7-8CBC-789C9D4B84AC}.html" data-toggle="tooltip" title="了解医学检查和检查结果" data-id="c365ff1f-8d83-46ae-9d7b-da48301ca4c1" data-itemid="f11b88d9-ebb8-40e7-8cbc-789c9d4b84ac">了解医学测试和测试结果</a><span id="c365ff1f-8d83-46ae-9d7b-da48301ca4c1" class="d-none xref"> <span class="tooltip-container"> <a href="./{F11B88D9-EBB8-40E7-8CBC-789C9D4B84AC}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 了解医学检查和检查结果 </span> 检查结果可以帮助医生对有症状患者明确诊断（诊断试验），或发现无症状患者的隐匿性疾病（筛查）。如果根据临床表现适当地安排了测试，则任何结果都应有助于排除或排除可能的诊断。 如果检测无法区分疑似疾病患者和非疑似疾病患者，或者检测结果未正确整合到临床环境中，则检测结果可能会干扰临床决策过程。... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>）。</p></div><span id="v11555454_zh" class="anchor"></span><div class="para"> <p>一旦结核诊断明确，患者应 <a href="./{58E097FD-A3ED-437F-85A6-10AC1181C94B}.html#v26306816_zh" data-toggle="tooltip" title="诊断方法" data-id="ddc436a9-5e03-4bd4-bcee-73d5331ba651" data-itemid="58e097fd-a3ed-437f-85a6-10ac1181c94b">排查HIV感染</a><span id="ddc436a9-5e03-4bd4-bcee-73d5331ba651" class="d-none xref"> <span class="tooltip-container"> <a href="./{58E097FD-A3ED-437F-85A6-10AC1181C94B}.html#v26306816_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 诊断方法 </span> 由人免疫缺陷病毒（HIV）的两类相似的反转录病毒（HIV-1和HIV-2）感染引起CD4+T细胞损伤和细胞免疫功能破坏，进而导致发生某些感染和肿瘤的危险性增加。最初的感染可能导致不典型的发热性疾病。之后，由HIV感染所带来的疾病风险取决于免疫缺陷的程度，也即CD4+T淋巴细胞的减低程度。病毒可直接损... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/3/1/3/313_hiv_slide_3_springer_high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="诊断方法" loading="lazy"> </span> </a> </span> </span>，有 <a href="./{1204AFED-6858-4A0D-8F88-42684EC7A72F}.html" data-toggle="tooltip" title="乙型肝炎病毒，急性" data-id="c9f96361-a46e-4bac-9030-f26f1b21d399" data-itemid="1204afed-6858-4a0d-8f88-42684ec7a72f">乙肝</a><span id="c9f96361-a46e-4bac-9030-f26f1b21d399" class="d-none xref"> <span class="tooltip-container"> <a href="./{1204AFED-6858-4A0D-8F88-42684EC7A72F}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 乙型肝炎病毒，急性 </span> 乙型肝炎通常是由非肠道传染的DNA病毒引起的。它引起病毒性肝炎的典型症状，包括厌食，不适，和黄疸。可发生暴发性肝炎和死亡。慢性感染可导致肝硬化和/或肝细胞癌。诊断是通过血清学检测。采用支持治疗。接种疫 苗具有保护作用，暴露后使用乙肝免疫球蛋白可预防或减轻临床疾病。... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>或 <a href="./{D91264F7-BCA6-4A48-99AA-CA7B1C6EFE3A}.html" data-toggle="tooltip" title="急性丙型肝炎" data-id="65fc8106-0fa3-481f-95cd-89765c45c592" data-itemid="d91264f7-bca6-4a48-99aa-ca7b1c6efe3a">丙肝</a><span id="65fc8106-0fa3-481f-95cd-89765c45c592" class="d-none xref"> <span class="tooltip-container"> <a href="./{D91264F7-BCA6-4A48-99AA-CA7B1C6EFE3A}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 急性丙型肝炎 </span> 丙型肝炎通常由非肠道传染的RNA病毒引起的。它有时会引起病毒性肝炎的典型症状，包括食欲不振，倦怠和黄疸，也可以是无症状的。暴发性肝炎和死亡罕见。约75％发展为慢性肝炎，可导致肝硬化，偶尔引起肝细胞癌。通过血清学检测明确诊断。采用抗病毒药物治疗。没有疫苗可用。... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>危险因素的患者也应做相应检测。应进行基线检查（如全血计数、包括肝肾功能在内的基本血液生化检查）。</p></div> <section id="v1010758_zh" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1010744_zh_v1010759_zh" class="topic__header--subsection"> <span id="v1010759_zh" class="anchor"></span> 胸部X线检查 </h3> <div class="topic__content"> <span id="v1010760_zh" class="anchor"></span><div class="para"> <p>成人锁骨上方或后方出现结节性渗出表现（结核特征表现），高度提示活动性结核的可能；它是在前凸位或胸部CT中较明显。</p></div><span id="v38408802_zh" class="anchor"></span><div class="para"> <p>中下肺浸润无特异性，但对症状或接触史提示近期感染的患者（通常是年轻），特别是如果有胸腔积液，需怀疑为原发性结核。</p></div><span id="v38408803_zh" class="anchor"></span><div class="para"> <p> 肺门淋巴结钙化可见于结核原发感染，但是也可见于 <a href="./{0E248B49-3737-4D2C-B118-C59BE70825C5}.html" data-toggle="tooltip" title="组织胞浆菌病" data-id="d78a571e-f961-438d-bc12-7c051660a308" data-itemid="0e248b49-3737-4d2c-b118-c59be70825c5">组织胞浆菌病</a><span id="d78a571e-f961-438d-bc12-7c051660a308" class="d-none xref"> <span class="tooltip-container"> <a href="./{0E248B49-3737-4D2C-B118-C59BE70825C5}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 组织胞浆菌病 </span> 组织胞浆菌病是由 <i>Histoplasma capsulatum</i>荚膜组织胞浆菌引起的肺部和血液感染性疾病，常表现为慢性疾病过程，疾病开始常为无症状性原发性感染。组织胞浆菌病表现为肺炎或慢性非特异性疾病。 临床上通过在痰或组织中检出组织胞浆菌或使用血清和尿液特异抗原检测来诊断本病。如需要治... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/h/i/s/histoplasmosis_orig_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="组织胞浆菌病" loading="lazy"> </span> </a> </span> </span> ，尤其是在该病流行的区域（例如，俄亥俄河谷）。</p></div> <div class="inlinemedia-component " data-ko-rebind="v27304822_zh" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"结核病（胸部 X 光检查）","Credits":"\u003cspan id=\u0022v27304825_zh\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eZEPHYR/科学图片库\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"cb3fcc38-3d3b-4984-8ad6-6370e6d3c7ad","Title":"结核病（胸部 X 光检查）","ShareUrlTitle":"结核病胸部-x-光检查","Description":"\u003cul\u003e\u003cspan id=\u0022v83936391\u0022 class=\u0022anchor\u0022\u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022\u003e \u003cp\u003e肺结核患者胸部 X 光片上的右上叶空洞病变。\u003c/p\u003e\u003c/div\u003e\u003c/ul\u003e","ImageUrl":"./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0\u0026sc_lang=zh","ThumbnailUrl":"./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=zh","MediaType":"image","MediaNameTranslated":"图片","UniqueId":"v27304822_zh","Placement":"inline","IsInCarousel":false,"Edition":0,"ImageWidth":"3969","ImageHeight":"3402","IframeSrc":null,"Target":null}'> </div> </div> </section> <section id="v1010761_zh" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1010744_zh_v1010762_zh" class="topic__header--subsection"> <span id="v1010762_zh" class="anchor"></span> 痰液检查、培养和化验 </h3> <div class="topic__content"> <span id="v1010763_zh" class="anchor"></span><div class="para"> <p> 痰液检测是诊断肺结核的主要手段。长期以来，人们一直在寻求基于非痰液的诊断测试，因为痰液通常难以收集。可以进行呼气和尿检，并且尿检已被证明可用于诊断 HIV 感染者的结核病。如果患者无痰，可以采用高渗盐水雾化诱导。如果诱导感应不成功，可以采用支气管灌洗液。由于诱导痰及支气管镜对医务人员来说有一定的感染风险，这些方法应在最后使用。 同时应采用其他措施（如负压，N95口罩或过滤呼吸器）等以预防医务人员感染。</p></div><span id="v11555456_zh" class="anchor"></span><div class="para"> <p>痰检查的第一步通常是显微镜检查，以检查抗酸杆菌（AFB）。结核杆菌虽是革兰阳性菌，但有时不易着色；样品最好用Ziehl Neelsen或Kinyoun染色用于常规光学显微镜，或用荧光染料染色用于更灵敏的荧光显微镜。涂片镜检可检测约10,000杆菌/毫升的痰，如果菌量较少，如再激活早期或患有HIV合并感染发生时可能不大敏感。</p></div><span id="v11555457_zh" class="anchor"></span><div class="para"> <p>尽管在痰涂片中发现AFB是存在结核病危险因素的结核病的有力推定证据，但在其他情况下，或许更可能是环境分枝杆菌，最终诊断需要阳性分枝杆菌培养或NAAT。</p></div><span id="v38408805_zh" class="anchor"></span><div class="para"> <p>还需要培养以分离细菌进行常规药物敏感性测试和基因分型。然而，分子药物敏感性测试正在越来越多地取代基于培养的方法。培养物可以检测到痰中少至10个杆菌/mL，并且可以使用固体或液体培养基进行。但是，它可能需要长达3个月的培养时间以确定最终的结果。液体培养基较固体培养基具有更高的灵敏度，检测所需时间也更短，通常仅需要2-3周。用于检测MPB64抗原的快速抗原检测可以证实生长在分枝杆菌培养物上的病原体是 <i>M. tuberculosis</i>.</p></div><span id="v11555458_zh" class="anchor"></span><div class="para"> <p> 有两种类型的NAAT可用于结核病诊断：</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v38408809_zh" class="anchor"></span><div class="para"> <p>Xpert MTB/RIF</p></div></li><li class="topic__listitem"><span id="v38408811_zh" class="anchor"></span><div class="para"> <p> 线性探针分析</p></div></li></ul></div><span id="v38408812_zh" class="anchor"></span><div class="para"> <p><b>Xpert MTB/RIF</b>是一种自动快速NAAT，可同时识别痰样本中的<i>结核杆菌</i>DNA，并在2小时内检测利福平（利福平）耐药性。Xpert MTB/RIF NAAT比痰涂片显微镜更敏感，在诊断结核病方面与培养物一样敏感。较新版本的 Xpert MTB/RIF Ultra (Xpert Ultra) 可以检测到两者的抗性突变 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010840_zh" data-toggle="tooltip" title="TB的一线药物" data-id="41a7eaaa-8d4c-4493-95b6-b8c08aad433f" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">一线药物</a><span id="41a7eaaa-8d4c-4493-95b6-b8c08aad433f" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010840_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> TB的一线药物 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="TB的一线药物" loading="lazy"> </span> </a> </span> </span> 和许多 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1011141_zh" data-toggle="tooltip" title="TB的二线药物" data-id="c3786c7f-6a19-4736-88e6-c07508053429" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">二线药物</a><span id="c3786c7f-6a19-4736-88e6-c07508053429" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1011141_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> TB的二线药物 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="TB的二线药物" loading="lazy"> </span> </a> </span> </span>.</p></div><span id="v38408814_zh" class="anchor"></span><div class="para"> <p><b>线性探针分析</b> 可以识别存在 <i>M. tuberculosis</i> 以及利福平和异烟肼耐药。 但灵敏度低于Xpert MTB/RIF。然而，这个检测仅用于痰涂片阳性患者。有几种二线药物的探针可供选择。</p></div><span id="v1010767_zh" class="anchor"></span><div class="para"> <p> 根据现有检测手段，有多种不同的诊断算法。</p></div><span id="v38408816_zh" class="anchor"></span><div class="para"> <p>如果痰液样本的Xpert MTB/RIF检测结果为阳性，则可以诊断为肺结核。在这种情况下，可以根据局部药物敏感性模式开始治疗。</p></div><span id="v38408817_zh" class="anchor"></span><div class="para"> <p> 若NAAT和AFB涂片结果为阴性，或AFB涂片结果为阳性但NAAT结果为阴性，则根据临床判断来决定是否在等待培养结果的同时开始抗TB治疗。</p></div> </div> </section> <section id="v38408818_zh" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1010744_zh_v38408819_zh" class="topic__header--subsection"> <span id="v38408819_zh" class="anchor"></span> 药物敏感性试验 </h3> <div class="topic__content"> <span id="v38408820_zh" class="anchor"></span><div class="para"> <p>药敏试验 应在所有患者的首次分离株中进行，以获得有效的抗结核治疗方案。在患者进行抗结核治疗3个月后痰培养仍为阳性或在痰培养阴性以后又出现阳性者需再次进行药敏试验。结核病可由多种菌株引起，每种菌株具有不同的耐药性模式，特别是在高传播环境中。</p></div><span id="v38408821_zh" class="anchor"></span><div class="para"> <p>如果使用常规细菌学方法，药敏试验的结果可能需要长达8周的时间，但如上所述，几种分子DST可以快速（在数小时内）检测对利福平和其他一线和二线药物的耐药性。</p></div> </div> </section> <section id="v1010770_zh" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1010744_zh_v1010771_zh" class="topic__header--subsection"> <span id="v1010771_zh" class="anchor"></span> 其他样本的检测 </h3> <div class="topic__content"> <span id="v1010772_zh" class="anchor"></span><div class="para"> <p>有浸润者建议采用镜下取组织活检，进行培养、组织学或分子学检测。</p></div><span id="v38408822_zh" class="anchor"></span><div class="para"> <p>少数患者胃洗液培养可为阳性，除婴幼儿在标本不易获取的情况下可采用外，目前已少用。然而，对能配合的幼儿，可使用诱导痰。</p></div><span id="v38408823_zh" class="anchor"></span><div class="para"> <p>理想情况下，其他组织的活检样本应新鲜培养。新鲜标本的培养仍然是检测组织中<i>结核杆菌</i> 的金标准，因为固定可以抑制 PCR，而 PCR 不能区分活的和死的生物。然而，必要时，NAAT可用于固定组织（例如，如果组织学检查意外检测到肉芽肿变化，则用于活检淋巴结）。NAAT的这一用途尚未得到批准，尽管尚未确定阳性和阴性预测值，但它可能非常有用。</p></div> </div> </section> <section id="v1010774_zh" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1010744_zh_v1010775_zh" class="topic__header--subsection"> <span id="v1010775_zh" class="anchor"></span> 皮肤菌素实验 </h3> <div class="topic__content"> <span id="v1010782_zh" class="anchor"></span><div class="para"> <p>结核菌素叉刺试验目前已不推荐使用。</p></div><span id="v38408824_zh" class="anchor"></span><div class="para"> <p>通常使用纯化蛋白衍生物（PPD）进行结核菌素皮肤试验（TST-Mantoux皮内法）。TST测量<i>结核杆菌</i>的免疫反应，在潜伏感染和活动感染中均应为阳性，因此无法区分两者。</p></div><span id="v68425468_zh" class="anchor"></span><div class="para"> <p>在美国，标准剂量的5毫克结核菌素单位（TU）的PPD在0.1毫升的溶液中注射到手掌前臂。 关键是皮内注射，而非皮下注射。注射时出现边界清楚的水泡或风团表明注射位置正确。 注射后48~72小时测量手臂长轴的横向硬化（非红斑）直径。使用笔划定皮肤硬结的边界有助于产生更精确的测量结果，但读取皮肤测试本身是可变的，并且会受到许多错误的影响，包括终端数字偏好，即倾向于记录5、10、15和20毫米的结果。在研究研究中，使用卡尺或直尺进行测量时，如果测量数字不能立即被读者看到，则读数偏差较小。</p></div><span id="v68425469_zh" class="anchor"></span><div class="para"> <p>鉴于难以划定和准确测量硬结，不建议将临床意义附加到微小的差异上。例如，9 毫米读数可能不应被解释为与 11 毫米读数不同（即，将 11 毫米读数视为潜在感染，而将 9 毫米读数视为未感染）。在家庭接触者中，以及在其他认为近期传播是肯定的环境中，TST结果平均硬化约为17 mm。在临床上，记住最近感染的人最有可能再次激活是有用的，如果他们有免疫能力，他们通常会有强烈的免疫反应，表现为大量的 TST 或干扰素 γ 释放试验。 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010792_zh" data-toggle="tooltip" title="IGRA（干扰素-γ释放试验）" data-id="62becd10-3f41-4d85-ab93-15c7b24a68ff" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">伊格拉</a><span id="62becd10-3f41-4d85-ab93-15c7b24a68ff" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010792_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> IGRA（干扰素-γ释放试验） </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="IGRA（干扰素-γ释放试验）" loading="lazy"> </span> </a> </span> </span>） 结果。</p></div> <a id="v68425138_zh"></a> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--pearlsandpitfalls "> <div class="inlinebox__wrapper" id="v68425140_zh"> <div class="inlinebox__content"> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v68425140_zh"></span> <div class="TableHalfPage" id="v83848827"> <h3 class="title"> 优点与缺陷 </h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v83848836" class="anchor"></span><div class="para"> <p>在结核菌素皮肤试验中，测量的是硬结的直径，而不是红斑。</p></div></li></ul></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div> <div> </div> </div> </div> <!-- Type: PearlsAndPitfalls --> </div><span id="v68425472_zh" class="anchor"></span><div class="para"> <p>TST 反应往往会随着时间的推移而减少，通常在存活的 <i>结核分枝杆菌</i> 能够重新激活的情况下会持续更长久。尽管晚期再激活被充分记录，但大多数潜伏感染的再激活发生在最初感染的一年至18个月内。当考虑免疫抑制时，在感染可能发生多年后治疗潜伏性结核病可能是可取的，但可能重新激活的残余感染可能不再存在。由于没有进行后续测试，在没有治疗或无反应（对任何皮肤测试都没有反应）的情况下发生的皮肤测试逆转通常会被错过。自发治愈是可能的原因。在高传播环境中，疾病通常由 <i>最近的</i> 而不是 <i>偏僻的</i> 感染，尽管两者都可能发生。</p></div><span id="v68425474_zh" class="anchor"></span><div class="para"> <p>重复使用 TST 可以使免疫系统回忆起以前随着时间的推移而减弱的超敏反应，即所谓的增强。例如，在疫情调查中，无法识别的助推可能会导致对接触者进行不必要的治疗。为避免在需要进行连续检测的环境中将加强免疫误解为近期感染，建议进行两步基线检测。这个想法是在1到4周内重新测试TST结果为阴性的人，看看他们是否回忆起以前的超敏反应。如果不是，则该结果为真阴性。然而，假设在第一次测试后1至4周再次测试的TST结果为阳性，表明预先存在潜在感染，并且根据临床标准对患者进行治疗或不进行治疗。反复进行IGRA检测时，由于没有注射抗原，因此增强不是问题。</p></div><span id="v38408825_zh" class="anchor"></span><div class="para"> <p><b>TST阳性反应的推荐阈值</b>取决于临床情况：</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1010785_zh" class="anchor"></span><div class="para"> <p><b>5mm：</b>有高度危险发展为活动性结核的患者，如胸片提示陈旧结核、艾滋病、药物所致免疫缺陷（例如，TNF-αlpha抑制剂、与泼尼松15 mg/日持续<span class='symbol'>></span>1月当量的皮质类固醇）或有与结核患者密切接触史者。</p></div></li><li class="topic__listitem"><span id="v1010787_zh" class="anchor"></span><div class="para"> <p><b>10mm：</b>有中度危险发展为活动性结核的患者，如静脉吸毒者，来自于结核流行区的移民，高危险人群中的居住者（监狱\收容所），矽肺、肾功能不全、糖尿病、头颈部肿瘤患者以及行胃切除术和空肠回肠旁路术者。</p></div></li><li class="topic__listitem"><span id="v1010789_zh" class="anchor"></span><div class="para"> <p><b>15mm：</b>无危险因素者。</p></div></li></ul></div><span id="v1010790_zh" class="anchor"></span><div class="para"> <p><b>假阴性 TST 结果</b> 可能发生，最常见于发热、年龄较大、感染 HIV 的患者（尤其是如果 CD4 计数 <span class='symbol'>&lt</span> 200 个细胞/mcL [0.2 x 10<sup>9</sup>/L])、因疾病或使用某些药物（例如，皮质类固醇、某些生物免疫调节剂、某些抗癌药物）而免疫抑制，或病得很重。这些人中的许多人对任何皮肤测试（过敏）都没有反应。假阴性的出现可能是由于抑制性抗体或者由于大量T细胞迁移至病灶而不足以在试验的局部产生反应。</p></div><span id="v38408826_zh" class="anchor"></span><div class="para"> <p>如果患者患有 <a href="./{8CF4C69D-B9A4-4212-9A25-F307B195ECF2}.html" data-toggle="tooltip" title="非结核分枝杆菌感染" data-id="ceb7d92a-ffd9-43c5-b5a1-a2123027bd74" data-itemid="8cf4c69d-b9a4-4212-9a25-f307b195ecf2">非结核分枝杆菌感染</a><span id="ceb7d92a-ffd9-43c5-b5a1-a2123027bd74" class="d-none xref"> <span class="tooltip-container"> <a href="./{8CF4C69D-B9A4-4212-9A25-F307B195ECF2}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 非结核分枝杆菌感染 </span> 有超过 170 种公认的分枝杆菌，主要是环境的。环境暴露于许多这些生物是常见的，但大多数暴露不会导致感染，许多感染不会导致疾病。疾病通常需要局部或全身宿主防御缺陷。患有慢性肺病的人（尤其是 囊性纤维化)、体弱的老年人和免疫功能低下的人面临的风险最高，但其他缺陷不太明显的人可能会出现进展性疾病。定期报... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>或接种了卡介苗，可能会出现<b>假阳性TST结果</b>。然而，卡介苗接种对TST的影响通常在几年后减弱；在此之后，阳性检测很可能是由于结核感染。BCG 疫苗接种后的感染发生在高传播环境中。从高负担地区抵达美国的人经常将卡介苗作为其TST阳性的原因，而不是因诊断为结核病而受到污名化，即使在明确表明存在潜在感染的情况下，也拒绝接受治疗。当局建议应该忽略卡介苗接种状态并假设感染，但这会导致对潜伏性结核感染的过度诊断、不必要的关注和治疗以及潜在的药物副作用。使用 IGRA 诊断 TB 感染，虽然也不是没有解释问题，但在很大程度上解决了 BCG/潜伏 TB 感染的争议。</p></div> </div> </section> <section id="v1010791_zh" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1010744_zh_v1010792_zh" class="topic__header--subsection"> <span id="v1010792_zh" class="anchor"></span> IGRA（干扰素-γ释放试验） </h3> <div class="topic__content"> <span id="v68425476_zh" class="anchor"></span><div class="para"> <p>存在两种具有不同测试平台的商业 IGRA，但许多比较研究表明性能非常相似。IGRA 的选择通常取决于给定临床环境中的可用性。</p></div><span id="v1010793_zh" class="anchor"></span><div class="para"> <p> IGRA是一种基于干扰素释放的血液检测，体外淋巴细胞接触TB特异性抗原后产生gamma干扰素。尽管目前gamma干扰素分泌试验的研究并非均与TST进行对比，但干扰素分泌试验相比TST具有更高的特异度（灵敏度相近）。与TST不同，先前接种卡介苗不会导致IGRA的假阳性检测结果，但重复TST检测本身会导致低水平的IGRA阳性结果。与 TST 一样，IGRA 不能区分活动性结核病和潜伏性结核病，尽管在两种情况下都会发生淋巴细胞超敏反应，因为体外用 TB 抗原刺激淋巴细胞的时间很短，因此认为 IGRAs 更可能反映近期（致敏循环淋巴细胞）而不是远距离（致敏记忆淋巴细胞）结核感染。因此，与 TST 相比，IGRA 被认为与再激活风险的相关性更好。</p></div><span id="v38408827_zh" class="anchor"></span><div class="para"> <p>在有更多资源可用于关注潜伏感染的低结核病负担地区，IGRA 已在很大程度上取代了 TST，因为它们与操作者相关的变异性较小，缺乏 BCG 干扰，缺乏 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1011206_zh" data-toggle="tooltip" title="增强反应" data-id="faf3972c-897d-47d0-b173-c3acae314df3" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">助推</a><span id="faf3972c-897d-47d0-b173-c3acae314df3" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1011206_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 增强反应 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="增强反应" loading="lazy"> </span> </a> </span> </span>，人们不必返回阅读。然而，在像美国这样的低结核病负担地区，越来越少的人有足够的风险来保证进行一次性的更少的连续结核病检测。</p></div><span id="v38408828_zh" class="anchor"></span><div class="para"> <p>由于IGRA成本较高，在资源有限环境下使用受到限制。然而，世界卫生组织强调，治疗高结核病负担中的潜在感染是全球消除结核病的必要组成部分。由于卡介苗对TST的干扰，IGRA对潜在TB的特异性更强。</p></div> </div> </section> </div> </section> <section id="v1010794_zh" class="topic__section FHead"> <h2 id="Prognosis_v1010795_zh" class="topic__header--section" data-originaltitle="预后"> <span id="v1010795_zh" class="anchor"></span> TB的预后 </h2> <div class="topic__content"> <span id="v1010796_zh" class="anchor"></span><div class="para"> <p>对于免疫功能健全的药物敏感型肺结核患者，即使病情严重有大空洞，如果及时实施并完成适当的药物敏感性测试指导治疗，通常是可治愈的。然而，结核病的病死率仍高达10%，多数患者死于其他原因。即使能获得合理的治疗，播散性结核和结核性脑膜炎的病死率高达25%。此外，细菌治疗后残留的组织损伤（尤其是肺部，但任何器官）也会导致严重的发病率。组织损伤通常是由对感染的免疫反应引起的，在 <a href="./{58E097FD-A3ED-437F-85A6-10AC1181C94B}.html#v26307332_zh" data-toggle="tooltip" title="免疫重建炎性综合征（IRIS）" data-id="5fc08c92-1586-4128-913c-f27f862311f7" data-itemid="58e097fd-a3ed-437f-85a6-10ac1181c94b">免疫重建炎症综合征</a><span id="5fc08c92-1586-4128-913c-f27f862311f7" class="d-none xref"> <span class="tooltip-container"> <a href="./{58E097FD-A3ED-437F-85A6-10AC1181C94B}.html#v26307332_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 免疫重建炎性综合征（IRIS） </span> 由人免疫缺陷病毒（HIV）的两类相似的反转录病毒（HIV-1和HIV-2）感染引起CD4+T细胞损伤和细胞免疫功能破坏，进而导致发生某些感染和肿瘤的危险性增加。最初的感染可能导致不典型的发热性疾病。之后，由HIV感染所带来的疾病风险取决于免疫缺陷的程度，也即CD4+T淋巴细胞的减低程度。病毒可直接损... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/3/1/3/313_hiv_slide_3_springer_high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="免疫重建炎性综合征（IRIS）" loading="lazy"> </span> </a> </span> </span> (IRIS)，但在晚期 TB 病例中越来越得到认可，其中 TB 引起的炎症可导致例如慢性呼吸功能不全、上气道狭窄、缩窄性心包炎和骨骼畸形。</p></div><span id="v1010797_zh" class="anchor"></span><div class="para"> <p>尽管免疫诱导的组织损伤是一个主要问题，但缺乏免疫反应是一个更大的问题。在免疫功能低下的患者中，结核病的进展更迅速、更广泛，如果不进行适当和积极的治疗，可能在患者首次就诊后的2个月内死亡，尤其是耐多药结核病（MDR-TB）患者。 然而，通过有效的抗逆转录病毒治疗（和适当的抗结核治疗），HIV感染患者，甚至耐多药结核患者的预后可与免疫功能正常患者相近。由于治疗效果较差，广泛耐药结核病患者的预后较差，但随着新疗法治疗高耐药结核病，这种情况正在迅速改变。</p></div> </div> </section> <section id="v1010798_zh" class="topic__section FHead" itemprop="possibleTreatment" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="Treatment_v1010799_zh" class="topic__header--section" data-originaltitle="治疗"> <span id="v1010799_zh" class="anchor"></span> TB的治疗 </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v38408831_zh" class="anchor"></span><div class="para"> <p>防止传播的措施，有时包括呼吸道隔离</p></div></li><li class="topic__listitem"><span id="v38408833_zh" class="anchor"></span><div class="para"> <p>抗生素治疗</p></div></li></ul></div><span id="v1010800_zh" class="anchor"></span><div class="para"> <p> 多数无并发症的结核患者、所有有并发症（如 <a href="./{58E097FD-A3ED-437F-85A6-10AC1181C94B}.html#v1021396_zh" data-toggle="tooltip" title="免疫系统" data-id="0da77f2e-9da0-48e5-8b0c-cf84aacbeb60" data-itemid="58e097fd-a3ed-437f-85a6-10ac1181c94b">AIDS</a><span id="0da77f2e-9da0-48e5-8b0c-cf84aacbeb60" class="d-none xref"> <span class="tooltip-container"> <a href="./{58E097FD-A3ED-437F-85A6-10AC1181C94B}.html#v1021396_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 免疫系统 </span> 由人免疫缺陷病毒（HIV）的两类相似的反转录病毒（HIV-1和HIV-2）感染引起CD4+T细胞损伤和细胞免疫功能破坏，进而导致发生某些感染和肿瘤的危险性增加。最初的感染可能导致不典型的发热性疾病。之后，由HIV感染所带来的疾病风险取决于免疫缺陷的程度，也即CD4+T淋巴细胞的减低程度。病毒可直接损... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/3/1/3/313_hiv_slide_3_springer_high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="免疫系统" loading="lazy"> </span> </a> </span> </span>， <a href="./{1F2BF905-67B5-4DEF-917F-0EA929C2E382}.html" data-toggle="tooltip" title="肝炎的病因" data-id="063644bb-00aa-4dc4-8675-66eaf5a7715f" data-itemid="1f2bf905-67b5-4def-917f-0ea929c2e382">肝炎</a><span id="063644bb-00aa-4dc4-8675-66eaf5a7715f" class="d-none xref"> <span class="tooltip-container"> <a href="./{1F2BF905-67B5-4DEF-917F-0EA929C2E382}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 肝炎的病因 </span> 肝炎（hepatitis）是一种以广泛或斑片状坏死为特征的肝脏炎症。 肝炎可以是急性的或慢性的（通常定义为炎症持续 > 6个月）。大多数 急性病毒性肝炎可自行缓解，也有一些进展成 慢性肝炎。 肝炎常见病因包括： 特异性肝炎病毒 酒精 <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>， <a href="./{2896CB80-11AC-462A-BDE8-3A98AA056BBC}.html" data-toggle="tooltip" title="糖尿病（DM）" data-id="c82c85bc-f443-4404-b63d-7de7ed87831a" data-itemid="2896cb80-11ac-462a-bde8-3a98aa056bbc">糖尿病</a><span id="c82c85bc-f443-4404-b63d-7de7ed87831a" class="d-none xref"> <span class="tooltip-container"> <a href="./{2896CB80-11AC-462A-BDE8-3A98AA056BBC}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 糖尿病（DM） </span> 糖尿病是由胰岛素分泌受损以及各种不同程度的外周胰岛素抵抗所致的高糖血症。早期症状与高糖血症有关，包括多饮、多尿、多食、视力模糊。后期并发症包括血管病变，周围神经病变、肾病及易发感染。诊断有赖于血糖检测。 治疗是饮食、运动和降低血糖水平的药物，包括胰岛素、口服降糖药和非胰岛素注射药物。... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>等）的结核患者、有药物不良反应的患者以及出现结核耐药的患者均应在结核专科就诊。See also the Official American Thoracic Society, Centers for Disease Control and Prevention, and the Infectious Diseases Society of America's <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/27516382"> 2016 Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis</a>.</p></div><span id="v38408838_zh" class="anchor"></span><div class="para"> <p>根据疾病程度和社会环境，大多数结核病患者可以门诊治疗。关于如何防止传播的说明通常包括</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1010805_zh" class="anchor"></span><div class="para"> <p>建议他们多待在家里</p></div></li><li class="topic__listitem"><span id="v1010807_zh" class="anchor"></span><div class="para"> <p> 回避访客（已接触的家人可无需回避）</p></div></li><li class="topic__listitem"><span id="v1010809_zh" class="anchor"></span><div class="para"> <p>用纸巾盖住咳嗽</p></div></li></ul></div><span id="v1010810_zh" class="anchor"></span><div class="para"> <p>用于结核病患者的外科口罩可有效限制传播，但可能会造成污名化，通常不建议合作患者使用，例如需要在医院或诊所进行预处理的患者除外。长期以来的专家建议是在患者开始治疗后至少2周内保持传播控制预防措施（如咳嗽、发烧和疲劳减轻所示）。然而，有强有力的证据表明，有效的治疗可以更快地阻止传播，通过对生物体的亚致死效应在开始的几小时或几天内，这在痰涂片或培养导致痰转化之前很长时间（通常需要 2 个月）。即使在大多数耐药病例中（有效治疗时），这一发现似乎也是正确的。然而，准确预测治疗有效的可能性需要患者结核病分离株的药敏试验 (DST) 数据，理想情况下还有足够的时间来判断良好的临床反应。此外，药物必须符合 DST 曲线，必须可靠地摄入，并达到治疗性血液水平。因此，尽管有效的药物可能会在数小时内停止传播，但可能需要对正在接受治疗的患者进行几天的观察，以确保获得良好的临床反应。对于高度耐药结核病，传播的后果更大，对治疗的反应可能更慢，因此在取消传播控制预防措施之前要更加谨慎。</p></div> <section id="v1010811_zh" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1010799_zh_v1010812_zh" class="topic__header--subsection"> <span id="v1010812_zh" class="anchor"></span> 住院治疗 </h3> <div class="topic__content"> <span id="v1010813_zh" class="anchor"></span><div class="para"> <p>活动性肺结核住院治疗的主要适应症是</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1010816_zh" class="anchor"></span><div class="para"> <p>伴有其他严重疾病</p></div></li><li class="topic__listitem"><span id="v1010818_zh" class="anchor"></span><div class="para"> <p>需进一步诊断者</p></div></li><li class="topic__listitem"><span id="v1010820_zh" class="anchor"></span><div class="para"> <p> 社会问题（如无家可归者）</p></div></li><li class="topic__listitem"><span id="v1010822_zh" class="anchor"></span><div class="para"> <p>需呼吸道隔离者，如居住在人口密集地区者（如无法接受有效治疗则尤其需要关注）。</p></div></li></ul></div><span id="v1010823_zh" class="anchor"></span><div class="para"> <p>由于抗药性结核病的后果非常严重，因此至少在确定治疗的临床反应之前，需要住院并进行呼吸道隔离以开始治疗。理想情况下，所有住院患者应在负压室中，每小时换气6至12次。进入房间的医护人员应佩戴已适当安装且符合国家职业安全与健康协会认证（N-95或更高）的呼吸器（而非外科口罩）。由于传染给其他住院患者非风险较高，即使接受有效治疗的患者在痰涂片呈阴性之前变得无感染性，解除呼吸隔离通常需要在2天内进行3次痰涂片阴性，包括至少一次清晨阴性标本。在根据症状或体征进行评估的患者中，两个阴性的痰 NAAT 可用于排除 TB 以用于隔离目的，但不能用于已知 TB 的患者，因为 <i>结核杆菌</i> 在治疗使患者不再具有感染性之后很久，NAAT 可能会检测到 DNA。然而，无论痰涂片状况如何，将患者直接从隔离室送回家通常是很有意义的，因为家庭成员（以前曾接触过病毒）的风险可能低于因疾病使他们更容易受到伤害的住院患者。</p></div><span id="v68425482_zh" class="anchor"></span><div class="para"> <p>一个常见的问题是患者因结核病需要住院多长时间。鉴于大多数结核病患者，无论痰涂片状态如何，都可以在家中完全门诊进行诊断和治疗，因此在出院前不应该住院，也不应该根据痰涂片或培养状态出院。如前所述，开始有效治疗会迅速减少传播。在美国，结核病患者通常首先在医院急诊科就诊，入院接受诊断，然后开始治疗，同时将病例通知卫生部门并安排接触者调查和监督治疗。由于这种入院和呼吸隔离的顺序经常发生，因此存在一种错误印象，即需要住院和呼吸隔离，直到根据痰液检测认为一个人不具有传染性。这个要求是不正确的，临床医生应该关注有临床责任的早期出院。</p></div> <a id="v11555460_zh"></a> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--pearlsandpitfalls "> <div class="inlinebox__wrapper" id="v11555462_zh"> <div class="inlinebox__content"> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v11555462_zh"></span> <div class="SidebarHalfPage" id="v83848837"> <h3 class="title">经验与提示</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v83848846" class="anchor"></span><div class="para"> <p>在医院和诊所里，结核病的传播风险最高的是结核诊断不明确以及结核耐药不明确但又未接受有效治疗者，而不是那些已知结核并接受有效治疗者。</p></div></li></ul></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div> <div> </div> </div> </div> <!-- Type: PearlsAndPitfalls --> </div> </div> </section> <section id="v1010824_zh" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1010799_zh_v1010825_zh" class="topic__header--subsection"> <span id="v1010825_zh" class="anchor"></span> 公共卫生防治 </h3> <div class="topic__content"> <span id="v1010827_zh" class="anchor"></span><div class="para"> <p>为了防止耐药结核的进一步扩散和发展，即使患者在私人医生处就诊，也需对患者实行治疗监控。在美国大多数州，结核病护理（包括皮肤测试、胸部x光片和药物）通过公共卫生诊所免费提供，以减少治疗障碍。</p></div><span id="v1010828_zh" class="anchor"></span><div class="para"> <p><b>直接观察治疗</b>（DOT）越来越成为最佳患者病例管理的一部分；DOT涉及由公共卫生人员（最好不是家庭成员）监督每一剂药物的摄入。DOT 将完成整个疗程的可能性从 61% 提高到 86%。增强的DOT，其中提供了诸如交通券、儿童保育、外展人员和餐食等激励和促进因素，将可能性提高到91%。</p></div><span id="v38408840_zh" class="anchor"></span><div class="para"> <p> DOT特别重要</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1010831_zh" class="anchor"></span><div class="para"> <p>儿童和青少年</p></div></li><li class="topic__listitem"><span id="v1010833_zh" class="anchor"></span><div class="para"> <p>艾滋病、精神病和吸毒者</p></div></li><li class="topic__listitem"><span id="v1010835_zh" class="anchor"></span><div class="para"> <p>治疗失败，复发及耐药者</p></div></li></ul></div><span id="v1010836_zh" class="anchor"></span><div class="para"> <p>对于部分患者来说， <b>选择性自我管理治疗</b> （SAT）是被接受治疗的患者的一种选择；理想情况下，使用固定剂量的联合药物制剂来避免可能导致耐药性的单一治疗。同时，也可采用药物监测技术辅助SAT。</p></div><span id="v1010837_zh" class="anchor"></span><div class="para"> <p> 公共卫生部门通常上门做以下事情：</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v38408843_zh" class="anchor"></span><div class="para"> <p> 明确患者治疗中的困难，（如，赤贫、居无定所、儿保为题、酗酒、精神疾病）。</p></div></li><li class="topic__listitem"><span id="v38408845_zh" class="anchor"></span><div class="para"> <p>检查其他活动性结核患者</p></div></li><li class="topic__listitem"><span id="v38408847_zh" class="anchor"></span><div class="para"> <p>评估密切接触者</p></div></li></ul></div><span id="v38408848_zh" class="anchor"></span><div class="para"> <p><b>密切接触者</b> 是指长时间共享同一呼吸空间的人，通常是家庭居民，但通常包括工作、学校和娱乐场所的人。构成风险的确切持续时间和接触程度各不相同，因为结核患者的传染性差异很大。有多个家庭成员发病或皮肤检测阳性的患者具有高度的传染性，即使是相对偶然的接触者（例如，他们乘坐的公交车上的乘客），也应进行皮肤检测和 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1011186_zh" data-toggle="tooltip" title="结核病筛查" data-id="20524519-e22b-42a3-bbf5-838bc8b5a61c" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">评估潜在感染</a><span id="20524519-e22b-42a3-bbf5-838bc8b5a61c" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1011186_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 结核病筛查 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt=" 结核病筛查" loading="lazy"> </span> </a> </span> </span>，并在需要时进行 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1011213_zh" data-toggle="tooltip" title="LTBI的治疗" data-id="1c085cd8-1bfc-49a8-8308-95ce9e5645e3" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">预防性治疗</a><span id="1c085cd8-1bfc-49a8-8308-95ce9e5645e3" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1011213_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> LTBI的治疗 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="LTBI的治疗" loading="lazy"> </span> </a> </span> </span>。没有感染任何家庭接触者的患者感染偶然接触者的可能性较小。</p></div> </div> </section> <section id="v1010839_zh" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1010799_zh_v1010840_zh" class="topic__header--subsection"> <span id="v1010840_zh" class="anchor"></span> TB的一线药物 </h3> <div class="topic__content"> <span id="v1010842_zh" class="anchor"></span><div class="para"> <p>一线抗结核药物有异烟肼（INH）、利福平（RIF）、吡嗪酰胺（PZA）和乙胺丁醇（EMB），这些药物应联合治疗，用于处治患者 。有几种不同的 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1011166_zh" data-toggle="tooltip" title="治疗方案" data-id="67525d4f-2745-471c-9c99-b40ab3a76783" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">TB治疗方案</a><span id="67525d4f-2745-471c-9c99-b40ab3a76783" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1011166_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 治疗方案 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="治疗方案" loading="lazy"> </span> </a> </span> </span>，选择基于许多因素。 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010855_zh" data-toggle="tooltip" title="一线抗结核药物*" data-id="fbce7e6d-e691-4680-a2b6-248fc330aeb5" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">一线药物剂量</a><span id="fbce7e6d-e691-4680-a2b6-248fc330aeb5" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010855_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 一线抗结核药物* </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="./Content/Images/Redesign/table/icon_table_red.png?mh=160&mw=160" class="tooltip-Preview" alt="一线抗结核药物*" loading="lazy"> </span> </a> </span> </span> 可以在不同的时间间隔进行。</p></div><span id="v1011120_zh" class="anchor"></span><div class="para"> <p><b>异烟肼（INH）</b>口服，每天一次，具有良好的组织渗透性（包括脑脊液），并且具有高度杀菌性。是目前抗结核治疗中最有效、最便宜的一种药物。然而，数十年非正规使用（尤其是东亚地区）导致耐药株大量增加。在美国已有10％的结核菌株是耐异烟肼型。</p></div><span id="v1435190_zh" class="anchor"></span><div class="para"> <p>异烟肼的不良反应包括皮疹，发热，贫血和粒细胞缺乏症少见。INH导致高达20％患者出现无症状的，一过性的转氨酶升高；约1/1000的患者出现临床肝炎症状（通常是可逆的）。临床肝炎多发生于<span class='symbol'> ></span>35岁的患者、酗酒者、产后妇女和慢性肝病患者。除非患者有肝病的危险因素，否则不建议每月进行肝脏检查。不明原因的乏力、厌食、恶心、呕吐或黄疸患者可能有肝毒性；暂停治疗并进行肝脏检查。出现临床症状并且有转氨酶显著升高（或无临床症状，但转氨酶升高 <span class='symbol'>></span> 5倍正常值）可定义具有肝毒性，INH需停用。</p></div><span id="v38408856_zh" class="anchor"></span><div class="para"> <p>如轻度转氨酶升高和症状恢复后，患者可以尝试使用半量2至3天。如果此剂量耐受（通常在大约一半的患者），可使用全剂量，并且密切注意症状复发和检测肝功能情况。如果患者正在接受INH，RIF和PZA，所有药物必须停止，每种药物分别单独进行尝试。INH或PZA，而不是RIF，更容易引起肝损害。</p></div><span id="v38408857_zh" class="anchor"></span><div class="para"> <p>周围神经病变可由INH诱导的吡哆醇（维生素B6）缺乏引起，最可能发生在孕妇或哺乳期妇女、营养不良患者、糖尿病或HIV感染患者、酒精使用障碍患者、癌症或尿毒症患者以及老年患者。维生素B6 25-50mg每天可预防这种并发症，儿童和健康的年轻人通常不需使用。</p></div><span id="v38408858_zh" class="anchor"></span><div class="para"> <p>INH延缓苯妥英钠肝脏代谢，需要减少苯妥英钠剂量。它还可以引起对双硫仑的剧烈反应，双硫仑是一种偶尔用于酒精使用障碍的药物。孕妇也可用该药。</p></div><span id="v1011124_zh" class="anchor"></span><div class="para"> <p><b>利福平（RIF），</b>口服具有杀菌作用，吸收良好，能很好地渗透到细胞和脑脊液中，作用迅速。另外，它还可以清除巨噬细胞和干酪样病灶中处于静止期的结核菌以防复发。因此应全程用药。</p></div><span id="v38408859_zh" class="anchor"></span><div class="para"> <p> 利福平的不良反应包括胆汁淤积性黄疸（罕见）、发热、血小板减少和肾功能衰竭。 RIF的肝毒性比INH低。使用利福平时需考虑药物相互作用。 它能加速抗凝剂、口服避孕药、皮质类固醇、洋地黄毒苷、口服降糖药、美沙酮等多种药物的代谢。利福霉素与许多抗逆转录病毒药物的相互作用特别复杂;联合应用咨询专家。 孕期使用RIF是安全的。</p></div><span id="v1435206_zh" class="anchor"></span><div class="para"> <p>特殊情况下可使用以下的利福霉素：</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1011131_zh" class="anchor"></span><div class="para"> <p><b>利福布丁</b>使用抗反转录病毒治疗者可服用利福布丁，以减轻利福平引起的药物相互作用。其作用类似于RIF，但它较少影响其他药物代谢。但有报道利福布丁与克拉霉素或氟康唑合用后可引起葡萄膜炎。</p></div></li><li class="topic__listitem"><span id="v1011133_zh" class="anchor"></span><div class="para"> <p><b>利福喷丁</b>用于单剂量/周方案和新的4个月治疗方案，但不用于儿童或HIV患者（因为治疗失败率不可接受）或 <a href="./{41EBCC40-5B7B-404D-B6F0-50D8151C4612}.html" data-toggle="tooltip" title="肺外结核（TB）感染" data-id="84b5ad35-fcbd-4feb-87af-f95f4bc0b920" data-itemid="41ebcc40-5b7b-404d-b6f0-50d8151c4612">肺外结核</a><span id="84b5ad35-fcbd-4feb-87af-f95f4bc0b920" class="d-none xref"> <span class="tooltip-container"> <a href="./{41EBCC40-5B7B-404D-B6F0-50D8151C4612}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 肺外结核（TB）感染 </span> 肺外结核通常由血行播散引起。有时感染直接从邻近器官延伸而来的。症状因不同感染部位而异，主要有发热、乏力及消瘦。诊断通常依赖痰涂片和培养，快速分子诊断测试越来越受重视。治疗是联合用药至少6个月给。 结核病 (TB) 仅指由 <i>结合分枝杆菌</i>... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/8/4/484-cutaneous-tuberculosis-scrofuloderma-slide-20-springer-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="肺外结核（TB）感染" loading="lazy"> </span> </a> </span> </span>患者。它也可以与异烟肼合用，以12粒/次周的DOT方案预防结核。但不推荐用于儿童<></p></div></li></ul></div><span id="v68425488_zh" class="anchor"></span><div class="para"> <p>2020年，RIF样品中发现亚硝胺杂质， <span class="genericDrug" data-showrollover="false">利福喷丁</span>.在长期动物研究中，其中一些杂质被认为是可能的致癌物，其毒性主要与累积接触有关。然而，对于结核病的治疗，如果患者可以接受，疾病控制和预防中心 (CDC) 倾向于继续使用 RIF，因为暴露是有时间限制的，并且不服用 RIF 的风险可能超过亚硝胺的任何潜在风险杂质。</p></div><span id="v1011135_zh" class="anchor"></span><div class="para"> <p><b>吡嗪酰胺（PZA）</b>是口服杀菌剂。早期服用2个月可减少利福平耐药的产生，并可将治疗疗程缩减至6个月。</p></div><span id="v1435210_zh" class="anchor"></span><div class="para"> <p>PZA的主要副作用是胃肠道不适和肝炎。另外，它还可引起高尿酸血症，少数患者还会出现痛风。吡嗪酰胺孕期也经常使用，但安全性尚不肯定。</p></div><span id="v1011137_zh" class="anchor"></span><div class="para"> <p><b>乙胺丁醇（EMB）</b>是耐受性最好的一线口服药。 副作用主要有视神经炎，通常剂量超过25mg/kg或患者本身肾功能不全时才可能出现。最初表现为不能分辨蓝色和绿色，后期可能出现视力下降，而且一旦出现后将不可逆转。因此服用乙胺丁醇的患者需在用药前并在用后定期检测视力和色觉。服用EMB超过2个月或剂量高于<span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"b9ae3000-0eeb-45ea-aa72-3cda78f44d1e","Title":"%E4%B8%80%E7%BA%BF%E6%8A%97%E7%BB%93%E6%A0%B8%E8%8D%AF%E7%89%A9%2A","ShareUrlTitle":"一线抗结核药物","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"%E8%A1%A8%E6%A0%BC","UniqueId":"v1010853_zh","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3E%E8%A1%A8%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"%E8%A1%A8%E6%A0%BC","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>中所列剂量的患者应每月进行视力和色觉测试。对于沟通障碍的患者，应慎用。同样，除非对其他药物耐药或不能耐受的，一般也不建议不能进行视力检查的儿童患者使用本药。一旦出现视力损伤后，需换用其他药物。 乙胺丁醇在孕期可以安全使用。与其他一线药物相比，对EMB的耐药性并不常见。</p></div> <span id="v1010845_zh"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v1010855_zh"> <div class="inlinebox__header">表格 </div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"b9ae3000-0eeb-45ea-aa72-3cda78f44d1e","Title":"%E4%B8%80%E7%BA%BF%E6%8A%97%E7%BB%93%E6%A0%B8%E8%8D%AF%E7%89%A9%2A","ShareUrlTitle":"一线抗结核药物","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"%E8%A1%A8%E6%A0%BC","UniqueId":"v1010853_zh","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"%E4%B8%80%E7%BA%BF%E6%8A%97%E7%BB%93%E6%A0%B8%E8%8D%AF%E7%89%A9%2A","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"%E8%A1%A8%E6%A0%BC","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="b9ae3000-0eeb-45ea-aa72-3cda78f44d1e"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'b9ae3000-0eeb-45ea-aa72-3cda78f44d1e' }, async: true, success: function (data) { $('#b9ae3000-0eeb-45ea-aa72-3cda78f44d1e').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> </div> </section> <section id="v1011140_zh" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1010799_zh_v1011141_zh" class="topic__header--subsection"> <span id="v1011141_zh" class="anchor"></span> TB的二线药物 </h3> <div class="topic__content"> <span id="v1011143_zh" class="anchor"></span><div class="para"> <p>除一线药物外的其他抗结核药，常在耐药结核患者或不能耐受一线药物的患者中使用。直到2016年，最重要的两类药物是氨基糖苷类药物和密切相关的多肽药物——卷曲霉素（仅可注射）和氟喹诺酮类药物。</p></div><span id="v1011144_zh" class="anchor"></span><div class="para"> <p><b>链霉素，</b> 第一种也是曾经最常用的注射剂，现在已很少使用，并且越来越难以获得，因为它被更新的注射剂和口服二线药物所取代。它非常有效和杀菌。在美国，对该药耐药的病例较少但是全球范围内对该药耐药较为常见。脑脊液穿透力较差，也不建议鞘内注射。</p></div><span id="v1435212_zh" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">链霉素</span>不良反应主要包括肾小管损伤、前庭损伤以及耳毒性，与剂量相关。剂量是15 mg/kg肌内注射。成人最大剂量为1g；<span class='symbol'>≥</span>60岁患者可减为0.75g (10 mg/kg) .为减少剂量相关的副作用，建议每周5天给药最多2个月。必要时，后2个月再用每周给药2次。 肾功能不全患者可增大给药间隔，如12~15mg/kg，每周2~3次。患者需定期检测平衡觉、听力以及血清肌酐水平。</p></div><span id="v38408860_zh" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">链霉素</span>的副作用包括皮疹、发热、粒细胞缺乏症和血清病。口腔周围的潮红和刺痛通常和注射有关，但很快消退。<span class="genericDrug" data-showrollover="false">链霉素</span>对孕妇禁用，因为它可能损伤胎儿的前庭神经和具有耳毒性。</p></div><span id="v1011146_zh" class="anchor"></span><div class="para"> <p><b>卡那霉素</b>和<b>阿米卡星</b>可能仍然有效，即使<span class="genericDrug" data-showrollover="false">链霉素</span>已经产生耐药性。肾毒性和神经毒性与<span class="genericDrug" data-showrollover="false">链霉素</span>相同。<span class="genericDrug" data-showrollover="false">卡那霉素</span> 已被广泛用于耐多药结核病的注射剂，但在越来越少见的需要注射剂的情况下，阿米卡星正在迅速取代它。</p></div><span id="v1435214_zh" class="anchor"></span><div class="para"> <p><b>卷曲霉素</b>是一种非氨基糖苷类注射用抗生素。它的杀菌效果、用药剂量和不良反应都与链霉素类似，而且对耐药结核十分有效。 它是治疗MDR-TB的一种重要药物，因为对链霉素耐药的菌株往往对<span class="genericDrug" data-showrollover="false">卷曲霉素</span>敏感。而且卷曲霉素比其他氨基糖苷类药物的耐受性更好，当病情需要时可延长用药时间。与所有注射剂一样，它给药很痛苦，而且耐受性不如现在通常首选的新的口服抗药性疗法。</p></div><span id="v1011150_zh" class="anchor"></span><div class="para"> <p>一些 <b>氟喹诺酮类</b> （左氧氟沙星、莫西沙星）是继异烟肼、利福平之后最有效、最安全的抗结核药物；然而，直到引入新的 4 个月方案，其中包含 <span class="genericDrug" data-showrollover="false">莫西沙星</span>, 氟喹诺酮类药物不是治疗对<span class="genericDrug" data-showrollover="false">异烟肼</span>和<span class="genericDrug" data-showrollover="false">利福平</span>敏感结核病的一线药物。当与<span class="genericDrug" data-showrollover="false">利福平</span>或<span class="genericDrug" data-showrollover="false">利福喷丁</span>一起使用时，<span class="genericDrug" data-showrollover="false">莫西沙星</span>似乎与<span class="genericDrug" data-showrollover="false">异烟肼</span>一样有效。</p></div><span id="v1011153_zh" class="anchor"></span><div class="para"> <p><b>其他二线药物</b>还有乙硫异烟胺、环丝氨酸以及对氨基水杨酸等。与其他抗结核药物相比，这些药物的疗效更低，毒性更大，但在所有口服疗法问世之前，这些药物都是必不可少的（<a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v11555485_zh" data-toggle="tooltip" title="耐药性" data-id="ec29b862-afcb-4d5c-bd91-7e68ade5612e" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">见下文</a><span id="ec29b862-afcb-4d5c-bd91-7e68ade5612e" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v11555485_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 耐药性 </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="耐药性" loading="lazy"> </span> </a> </span> </span>）。</p></div><span id="v11555477_zh" class="anchor"></span><div class="para"> <p><b>较新的抗结核药物</b> 包括贝达喹啉、delamanid、pretomanid 和 sutezolid。这些药物是为高度耐药的结核病或不能耐受其他二线药物的患者保留的，但越来越多地用于所有口服抗药性方案。</p></div> </div> </section> <section id="v1011157_zh" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1010799_zh_v1011158_zh" class="topic__header--subsection"> <span id="v1011158_zh" class="anchor"></span> 耐药性 </h3> <div class="topic__content"> <span id="v1011160_zh" class="anchor"></span><div class="para"> <p>耐药性是一个主要问题。它是通过自发的基因突变发展起来的。不完整、不稳定或单一药物治疗和不良依从性导致了这些耐药菌。一旦耐药菌株发展和增殖，它可能通过随后的突变获得对其他药物的抗性。通过这种方式，有机体可以逐步对多种抗生素产生耐药性，这一过程可以迅速发生，即使分枝杆菌之间的质粒转移不起作用。</p></div><span id="v68425507_zh" class="anchor"></span><div class="para"> <p>这些药物是为高度耐药的结核病或不能耐受其他二线药物的患者保留的，但越来越多地用于所有口服抗药性方案。在全球范围内，只有三分之一的耐多药结核病患者可以获得有效治疗。在耐药性检测不充分或不可用的地区，许多对一线治疗没有反应的患者可能患有未被识别的耐多药结核病，并会传染给其他人，包括再次感染易感药物结核病患者。结核病和利福平耐药性的快速分子检测已被证明可以减少DR-TB的传播。</p></div><span id="v68425508_zh" class="anchor"></span><div class="para"> <p>耐药性类别是根据生物体对抗生素的耐药性来定义的。2021 年 1 月，WHO 修订了广泛耐药结核病的定义，正式定义了广泛耐药结核病前期（<a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v68425542_zh" data-toggle="tooltip" title="治疗参考文献" data-id="5a01c50c-b737-4151-b986-24034f670f26" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">4</a><span id="5a01c50c-b737-4151-b986-24034f670f26" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v68425542_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 治疗参考文献 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="治疗参考文献" loading="lazy"> </span> </a> </span> </span>）。2022 年 1 月在美国，CDC 推荐了混合定义，允许使用 WHO 定义或在美国适用的替代方案：</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v68425512_zh" class="anchor"></span><div class="para"> <p><b>耐多药结核病（MDR-TB）：</b> 对异烟肼和利福平这两种最有效的一线药物耐药，对其他药物有或无耐药性</p></div></li><li class="topic__listitem"><span id="v68425514_zh" class="anchor"></span><div class="para"> <p><b>广泛耐药结核病前：</b> 对异烟肼和利福平以及任何氟喹诺酮类药物耐药； CDC 替代定义：对异烟肼、利福平和二线注射剂（阿米卡星、卷曲霉素和卡那霉素）的耐药性</p></div></li><li class="topic__listitem"><span id="v68425516_zh" class="anchor"></span><div class="para"> <p><b>广泛耐药结核病（XDR-TB）：</b> 对异烟肼、利福平、任何氟喹诺酮类药物和至少一种额外的 A 组药物（A 组药物是左氧氟沙星、莫西沙星、贝达喹啉和利奈唑胺）耐药。它们是用于耐药结核病和耐药结核病的最有效的二线药物。需要更长的治疗方案。）； CDC 替代定义：对异烟肼、利福平、任何氟喹诺酮类药物以及贝达喹啉或利奈唑胺（或两者）的耐药性</p></div></li></ul></div><span id="v68425517_zh" class="anchor"></span><div class="para"> <p>耐多药结核病的诊断以及随后使用二线药物的需求在治疗的长度、成本和成功率方面具有重要意义。然而，新的、更短的、全口服耐药结核病治疗方案降低了治疗的难度，并使这些问题不再是临床成功与失败之间的分界线。</p></div><span id="v68425518_zh" class="anchor"></span><div class="para"> <p>已经报告了许多耐多药结核病暴发，全球负担仍然很高，部分原因是诊断和治疗的局限性； 2020 年，约 71% 的经细菌学证实的病例可以进行利福平耐药性检测（识别耐多药结核病的替代方法），比 2019 年报告的 61% 有所改善。2020 年，世界卫生组织报告了全球 157,903 例新的耐多药结核病病例，但这仅占估计病例总数的 38%。 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v68425542_zh" data-toggle="tooltip" title="治疗参考文献" data-id="6354d6c3-732a-4bb8-b093-5d66cf955a93" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">3</a><span id="6354d6c3-732a-4bb8-b093-5d66cf955a93" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v68425542_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 治疗参考文献 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="治疗参考文献" loading="lazy"> </span> </a> </span> </span>）。世卫组织估计，每年患 MDR/RR-TB 的人中只有大约三分之一的人参加了治疗（<a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v68425542_zh" data-toggle="tooltip" title="治疗参考文献" data-id="b3cd27aa-f0ae-4cde-b1cf-725fbc87b363" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">3</a><span id="b3cd27aa-f0ae-4cde-b1cf-725fbc87b363" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v68425542_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 治疗参考文献 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="治疗参考文献" loading="lazy"> </span> </a> </span> </span>）。</p></div><span id="v11555485_zh" class="anchor"></span><div class="para"> <p>新型抗结核药物贝达喹啉、德拉马尼、前托马尼和氟喹诺酮莫西沙星是口服药物，对耐药菌株具有高度活性，治疗时间比其他方案短。它们迅速阻止传播，完成率和治愈率更高，因此可能有助于控制耐药结核病的流行。然而，成功将继续取决于强有力的全球承诺，以提供获得分子诊断和有效治疗以及全面治疗监督的途径。2020 年，65 个国家正在使用较短的口服耐药结核病治疗方案。</p></div><span id="v68425521_zh" class="anchor"></span><div class="para"> <p>据估计，在高达 49% 的病例中，耐药结核病患者及其治疗的成本是灾难性的。</p></div> </div> </section> <section id="v1011165_zh" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1010799_zh_v1011166_zh" class="topic__header--subsection"> <span id="v1011166_zh" class="anchor"></span> 治疗方案 </h3> <div class="topic__content"> <span id="v1011167_zh" class="anchor"></span><div class="para"> <p>在引入新的4个月方案之前，所有新的、以前未经治疗的结核病患者的治疗包括以下内容：</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1011170_zh" class="anchor"></span><div class="para"> <p>2个月的强化期</p></div></li><li class="topic__listitem"><span id="v1011172_zh" class="anchor"></span><div class="para"> <p>4～7个月的巩固期</p></div></li></ul></div><span id="v1011173_zh" class="anchor"></span><div class="para"> <p><b>初始强化阶段治疗</b>使用4种抗生素（剂量见 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010855_zh" data-toggle="tooltip" title="一线抗结核药物*" data-id="9b0b9718-5f64-4968-81c9-dc349f7824c4" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">表</a><span id="9b0b9718-5f64-4968-81c9-dc349f7824c4" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010855_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 一线抗结核药物* </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="./Content/Images/Redesign/table/icon_table_red.png?mh=160&mw=160" class="tooltip-Preview" alt="一线抗结核药物*" loading="lazy"> </span> </a> </span> </span>）：</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v38408864_zh" class="anchor"></span><div class="para"> <p> 异烟肼（INH）</p></div></li><li class="topic__listitem"><span id="v38408866_zh" class="anchor"></span><div class="para"> <p> 利福平（RIF）</p></div></li><li class="topic__listitem"><span id="v38408868_zh" class="anchor"></span><div class="para"> <p> 吡嗪酰胺（PZA）</p></div></li><li class="topic__listitem"><span id="v38408870_zh" class="anchor"></span><div class="para"> <p>乙胺丁醇 (EMB)</p></div></li></ul></div><span id="v38408872_zh" class="anchor"></span><div class="para"> <p>这些药物可以在整个2个月阶段每天给药，或每天给药2周，然后每周给药2次或3次，持续6周。由于结核杆菌的生长缓慢和残余抗生素后效应的作用（在抗生素低于最小抑制浓度后细菌生长仍延迟很久），间歇给药（通常用较高剂量）的效果通常是令人满意的。 但是，MDR-TB或HIV合并感染患者建议每日治疗。涉及少于每日剂量的方案必须作为直接观察治疗（DOT）进行，因为每个剂量变得更重要。</p></div><span id="v1011175_zh" class="anchor"></span><div class="para"> <p>2个月的强化期后，一般视分离株中耐药情况而定是否停用吡嗪酰胺和乙胺丁醇。</p></div><span id="v1011176_zh" class="anchor"></span><div class="para"> <p><b>巩固期治疗</b> 取决于</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v38408875_zh" class="anchor"></span><div class="para"> <p> 初始分离株的药敏试验结果（如有）</p></div></li><li class="topic__listitem"><span id="v38408877_zh" class="anchor"></span><div class="para"> <p> 初始胸部X线上是否存在空洞病变</p></div></li><li class="topic__listitem"><span id="v38408879_zh" class="anchor"></span><div class="para"> <p>2个月时的培养和涂片结果</p></div></li></ul></div><span id="v38408880_zh" class="anchor"></span><div class="para"> <p>如果治疗2个月后，痰培养结果仍然为阳性，则需要更长的疗程。</p></div><span id="v38408881_zh" class="anchor"></span><div class="para"> <p> 如果培养和涂片均为阴性，无论胸部X光如何；或培养或涂片为阳性但X线显示无空洞，则继续服用INH和RIF4个月（共6个月）。</p></div><span id="v38408882_zh" class="anchor"></span><div class="para"> <p> 若X射线显示空洞，培养物或涂片呈阳性，则INH和RIF继续服用7个月（总共9个月）。</p></div><span id="v38408883_zh" class="anchor"></span><div class="para"> <p>在任何一个方案中，若培养示没有耐药产生，需停用乙胺丁醇。巩固期可选每日一次给药，若患者未合并HIV感染，亦可每周2次。2个月时培养和涂片阴性、胸部x光片无空洞且HIV阴性的患者可每周接受一次INH加利福喷丁治疗。</p></div><span id="v38408884_zh" class="anchor"></span><div class="para"> <p>如果治疗2月后，培养仍阳性，应做进一步的测试，以确定病因。需彻底评估有无耐多药结核发生（常见原因）。 临床医生也应该检查其他常见原因（如依从性低，广泛空洞，耐药，药物吸收不良）。</p></div><span id="v1011177_zh" class="anchor"></span><div class="para"> <p>无论是强化期还是巩固期，应确保患者服用了所需的总剂量（每周剂量X周次）。因为一旦有遗漏，就必须延长疗程。</p></div><span id="v68425523_zh" class="anchor"></span><div class="para"> <p>一个 <b>新的 4 个月疗程</b> 在 2021 年发表的一项临床试验中进行了描述，该试验报告了 4 个月的结核病治疗方案，包括利福喷丁 1200 毫克口服每天一次和莫西沙星 400 毫克口服每天一次。 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v68425542_zh" data-toggle="tooltip" title="治疗参考文献" data-id="eb29e7e5-fbba-456e-8675-e398a96c7182" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">1</a><span id="eb29e7e5-fbba-456e-8675-e398a96c7182" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v68425542_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 治疗参考文献 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="治疗参考文献" loading="lazy"> </span> </a> </span> </span>, <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v68425542_zh" data-toggle="tooltip" title="治疗参考文献" data-id="a26d7db3-065b-4eb9-ac26-d0684c12fced" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">2</a><span id="a26d7db3-065b-4eb9-ac26-d0684c12fced" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v68425542_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 治疗参考文献 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="治疗参考文献" loading="lazy"> </span> </a> </span> </span>) 不劣于利福平、异烟肼、吡嗪酰胺和乙胺丁醇的标准 6 个月方案。4 个月和 6 个月方案之间的严重不良反应没有差异。</p></div><span id="v68425526_zh" class="anchor"></span><div class="para"> <p>使用较短的利福喷汀-莫西沙星方案之前的注意事项包括：</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v68425529_zh" class="anchor"></span><div class="para"> <p>测试应显示对氟喹诺酮类药物、异烟肼和利福平的敏感性。</p></div></li><li class="topic__listitem"><span id="v68425531_zh" class="anchor"></span><div class="para"> <p>高脂肪食物会增加肠道对利福喷丁的吸收。</p></div></li><li class="topic__listitem"><span id="v68425533_zh" class="anchor"></span><div class="para"> <p>这 <span class="genericDrug" data-showrollover="false">利福喷丁</span>–<span class="genericDrug" data-showrollover="false">莫西沙星</span> 短期内，该方案可能比标准的 6 个月方案更昂贵。</p></div></li></ul></div><span id="v68425536_zh" class="anchor"></span><div class="para"> <p>由于 4 个月方案的成本，许多公共卫生计划可能会继续对大多数病例使用标准的 6 个月方案，并为坚持 6 个月方案的简单病例保留 4 个月方案选项方案是有问题的（例如，当患者必须在 6 个月完成之前旅行时）。</p></div><span id="v1011178_zh" class="anchor"></span><div class="para"> <p><b>耐药结核病（DR-TB）的管理</b> 直到最近才随着耐药性的模式而变化，由于长时间注射和严重的不良反应，对患者来说时间长（18 到 24 个月）和艰巨，并且给药成本高，尤其是在需要长时间住院时。与药物敏感性结核病相比，耐药结核病更需要治疗中心的专家进行管理，并配备足够的支持系统。然而，最近使用新药对耐药结核病进行全口服治疗的试验结果正在改变治疗耐药结核病的成功率、耐受性和成本。由贝达喹啉、pretomanid 和利奈唑胺组成的三药方案（称为 BPaL 方案）在一项针对 109 名广泛耐药结核病 (XDR-TB) 以及治疗不耐受或无反应患者的非对照临床试验中取得了良好的结果耐多药结核病。在这项试验中，90%的患者的预后良好，而XDR-TB患者的预后在历史上低于50%，并且当存在合并症时往往更差。 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v68425542_zh" data-toggle="tooltip" title="治疗参考文献" data-id="07e47b42-e605-4c04-9d87-7b1becbb5afe" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">6</a><span id="07e47b42-e605-4c04-9d87-7b1becbb5afe" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v68425542_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 治疗参考文献 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="治疗参考文献" loading="lazy"> </span> </a> </span> </span>）。药物毒性 <span class="genericDrug" data-showrollover="false">利奈唑胺</span> 是该试验的主要限制，但随后的试验正在测试较低剂量的 <span class="genericDrug" data-showrollover="false">利奈唑胺</span> 以及针对高度耐药结核病的全口服方案的其他变体。针对高度耐药结核病的全口服、更短、耐受性更好的方案的发展是全球结核病控制的一个里程碑，但各国仍需要做出重大承诺来诊断和有效治疗此类病例并防止其传播。</p></div> </div> </section> <section id="v1011180_zh" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1010799_zh_v1011181_zh" class="topic__header--subsection"> <span id="v1011181_zh" class="anchor"></span> 其他治疗 </h3> <div class="topic__content"> <span id="v1011182_zh" class="anchor"></span><div class="para"> <p>顽固性结核空洞或肺部坏死有时需<b>手术切除治疗</b> 。有些多重耐药结核、症状长期存在者，当药物无法进入病灶时，可选择手术切除部分肺组织。手术指征还包括无法控制的咯血和支气管狭窄。</p></div><span id="v68425540_zh" class="anchor"></span><div class="para"> <p>手术在高负担地区并不广泛。但随着越来越多的人获得快速的耐药性分子检测和更短、耐受性更好的耐药性治疗，需要手术治疗的肺部破坏慢性耐药患者的数量可能最终会减少。同时，获得熟练的肺结核外科医师往往意味着晚期严重肺损伤患者治疗成功与失败的区别。即使采用细菌疗法，手术对心肺功能的长期不良影响仍需进一步研究。</p></div><span id="v1011183_zh" class="anchor"></span><div class="para"> <p>以炎症为主要病因或患急性呼吸窘迫综合征（ARDS）、脑膜炎及心包炎的患者可使用<b>激素</b>。成人和体重<span class='symbol'>></span>25kg者青少年，可使用地塞米松12mg静滴，6小时1次；体重<span class='symbol'>&lt</span>25kg者改为8mg。疗程均为2～3周。在接受有效抗结核治疗的患者中，激素的使用并不增加患者的风险。</p></div> </div> </section> <section id="v68425541_zh" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1010799_zh_v68425542_zh" class="topic__header--subsection"> <span id="v68425542_zh" class="anchor"></span> 治疗参考文献 </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v68425545_zh" class="anchor"></span><div class="para"> <p>1.<a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282329/">Dorman SE, Nahid P, Kurbatova EV, et al</a>: Four-month rifapentine regimens with or without moxifloxacin for tuberculosis.<i>N Engl J Med</i> 384(18):1705–1718, 2021.doi: 10.1056/NEJMoa2033400</p></div></li><li class="topic__listitem"><span id="v68425548_zh" class="anchor"></span><div class="para"> <p>2.<a rel="nofollow" target="_blank" href="https://www.cdc.gov/mmwr/volumes/71/wr/mm7108a1.htm?s_cid=mm7108a1_w">Carr W, Kurbatova E, Starks A, et al</a>: Interim guidance: 4-Month rifapentine-moxifloxacin regimen for the treatment of drug-susceptible pulmonary tuberculosis—United States, 2022.<i>MMWR Morb Mortal Wkly Rep</i> 71(8):285–289, 2022.doi: 10.15585/mmwr.mm7108a1</p></div></li><li class="topic__listitem"><span id="v68425551_zh" class="anchor"></span><div class="para"> <p>3.<a rel="nofollow" target="_blank" href="https://www.who.int/publications/i/item/9789240037021">World Health Organization (WHO)</a>: Global Tuberculosis Report 2021.Accessed on 4/29/2022.</p></div></li><li class="topic__listitem"><span id="v68425554_zh" class="anchor"></span><div class="para"> <p>4.<a rel="nofollow" target="_blank" href="https://www.who.int/news/item/27-01-2021-who-announces-updated-definitions-of-extensively-drug-resistant-tuberculosis">WHO</a>: WHO announces updated definitions of extensively drug-resistant tuberculosis.Accessed 4/29/2022.</p></div></li><li class="topic__listitem"><span id="v68425557_zh" class="anchor"></span><div class="para"> <p>5.<a rel="nofollow" target="_blank" href="https://www.cdc.gov/tb/publications/letters/2022/surv-def-xdr.html">Centers for Disease Control and Prevention (CDC)</a>: Surveillance definitions for extensively drug resistant (XDR) and pre-XDR tuberculosis.Accessed 4/29/2022.</p></div></li><li class="topic__listitem"><span id="v68425560_zh" class="anchor"></span><div class="para"> <p>6.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/32130813/">Conradie F, Diacon AH, Ngubane N, et al</a>: Treatment of highly drug-resistant pulmonary tuberculosis.<i>N Engl J Med</i> 382(10):893–902, 2022.doi: 10.1056/NEJMoa1901814</p></div></li></ul></div> </div> </section> </div> </section> <section id="v1011185_zh" class="topic__section FHead" itemprop="associatedAnatomy" itemscope="" itemtype="http://schema.org/AnatomicalStructure"> <h2 id="Other_v1011186_zh" class="topic__header--section"> <span id="v1011186_zh" class="anchor"></span> 结核病筛查 </h2> <div class="topic__content"> <span id="v1011188_zh" class="anchor"></span><div class="para"> <p>筛查潜伏性结核感染（LTBI）是通过 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010775_zh" data-toggle="tooltip" title="皮肤菌素实验" data-id="05169d77-a9eb-4f03-a8cd-83ef8c4ba55f" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">结核菌素皮肤试验 (TST)</a><span id="05169d77-a9eb-4f03-a8cd-83ef8c4ba55f" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010775_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 皮肤菌素实验 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="皮肤菌素实验" loading="lazy"> </span> </a> </span> </span>或者 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010792_zh" data-toggle="tooltip" title="IGRA（干扰素-γ释放试验）" data-id="7316abb5-87bb-4bbb-bedc-ad2cc40d3828" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">干扰素-γ释放试验（IGRA）</a><span id="7316abb5-87bb-4bbb-bedc-ad2cc40d3828" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010792_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> IGRA（干扰素-γ释放试验） </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="IGRA（干扰素-γ释放试验）" loading="lazy"> </span> </a> </span> </span>。筛查指征包括：</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1011191_zh" class="anchor"></span><div class="para"> <p>密切接触过活动性肺结核者。</p></div></li><li class="topic__listitem"><span id="v1011193_zh" class="anchor"></span><div class="para"> <p>胸片可显示陈旧性结核病灶。</p></div></li><li class="topic__listitem"><span id="v1011195_zh" class="anchor"></span><div class="para"> <p>暴露于结核病的风险因素（例如，5年内从高风险地区移民的人、贫困患者、静脉注射吸毒者、特定的医疗从业者，如呼吸治疗师和与高风险人群工作的从业者）</p></div></li><li class="topic__listitem"><span id="v1011197_zh" class="anchor"></span><div class="para"> <p> 进展为活动性结核的高危因素主要包括HIV感染或其他导致免疫力下降因素、胃切除术、空回肠造瘘、矽肺、肾衰竭、糖尿病、头颈部肿瘤或高龄（<span class='symbol'>></span>70岁）等。</p></div></li><li class="topic__listitem"><span id="v1011199_zh" class="anchor"></span><div class="para"> <p>皮质类固醇、肿瘤坏死因子（TNF）抑制剂或癌症化疗的治疗性免疫抑制</p></div></li></ul></div><span id="v1011200_zh" class="anchor"></span><div class="para"> <p>在美国，大多数没有特定结核病危险因素的儿童和其他人不应该接受检测，以尽量减少假阳性结果的数量。</p></div><span id="v1011201_zh" class="anchor"></span><div class="para"> <p>TST或IGRA结果阳性（见 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010775_zh" data-toggle="tooltip" title="皮肤菌素实验" data-id="87e255d4-d88e-4b53-97d5-2ed5db50065e" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">皮肤测试</a><span id="87e255d4-d88e-4b53-97d5-2ed5db50065e" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010775_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 皮肤菌素实验 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="皮肤菌素实验" loading="lazy"> </span> </a> </span> </span>标准）表明潜伏性结核感染（LTBI）。需分析其他危险因素包括流行病学资料，并拍胸片进行排除：那些有x光异常提示TB的患者需要 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010744_zh" data-toggle="tooltip" title="诊断" data-id="444a9226-6531-478f-9ad3-39531623d8b9" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">如上所述对活动性结核病的评估</a><span id="444a9226-6531-478f-9ad3-39531623d8b9" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010744_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 诊断 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="诊断" loading="lazy"> </span> </a> </span> </span>, 包括显微镜和培养痰检查。</p></div><span id="v38408887_zh" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://www.cdc.gov/tb/topic/testing/whobetested.htm">LTBI检测的更新指南</a>可从CDC获得。</p></div> <section id="v1011205_zh" class="topic__section GHead"> <span></span> <h3 id="Other_v1011186_zh_v1011206_zh" class="topic__header--subsection"> <span id="v1011206_zh" class="anchor"></span> 增强反应 </h3> <div class="topic__content"> <span id="v1011207_zh" class="anchor"></span><div class="para"> <p>部分人曾接触过TB患者或接种过卡介苗或感染了非结核分枝杆菌在进行TST或IGRA时可能呈现阴性结果。然而，TST所用的试剂本身即是一个免疫增强剂，因而在接受TST之后的一周或者数年以后再次进行检测，则可能转为阳性。因此，在定期接受检测的人（如医护人员）中，第二次常规检测将呈阳性，给人一种虚假的感觉<i>最近的</i> 感染（因此要求进行进一步的检测和治疗）。如果需要反复进行LTBI测试，则应在第一次测试后1至4周进行第二次TST（在对侧前臂上），以确定强化反应（因为在该短暂间隔内感染导致的转化极不可能）。其后的检测可以按常规进行。</p></div><span id="v1011208_zh" class="anchor"></span><div class="para"> <p>IGRA采用的是外周血体外实验，因而不会有增强反应。同时，IGRA也不受患者卡介苗接种的影响，而且患者即使感染环境中除外<i>M. kansasii</i>, <i>M. szulgai</i>,和<i>M. marinum</i>，堪萨斯分枝杆菌，苏尔加分枝杆菌（苏尔加分枝杆菌）以及海分枝杆菌（海分枝杆菌）的分枝杆菌，其结果也均呈阴性。</p></div> </div> </section> <section id="v1011212_zh" class="topic__section GHead"> <span></span> <h3 id="Other_v1011186_zh_v1011213_zh" class="topic__header--subsection"> <span id="v1011213_zh" class="anchor"></span> LTBI的治疗 </h3> <div class="topic__content"> <span id="v1011214_zh" class="anchor"></span><div class="para"> <p> 潜伏期结核感染接受治疗的主要目的包括</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1011217_zh" class="anchor"></span><div class="para"> <p>两年内TST由阴性转为阳性者</p></div></li><li class="topic__listitem"><span id="v1011219_zh" class="anchor"></span><div class="para"> <p>出现与成旧性结核相一致的胸片表现，并排除活动性结核者</p></div></li></ul></div><span id="v1228324_zh" class="anchor"></span><div class="para"> <p>下列患者也应接受预防</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1011222_zh" class="anchor"></span><div class="para"> <p>如果感染，则有患者易从高风险发展为活动性结核病（如HIV感染者、药物诱导免疫抑制者）</p></div></li><li class="topic__listitem"><span id="v1011224_zh" class="anchor"></span><div class="para"> <p><span class='symbol'>&lt</span>5岁的儿童无论菌素实验有没有转阳，只要密切接触过痰涂片为阳性者其他人群如TST或IGRA呈阳性，也可以接受预防治疗。</p></div></li></ul></div><span id="v1011225_zh" class="anchor"></span><div class="para"> <p>其他TST或IGRA结果偶然阳性但没有这些危险因素的人通常需接受LTBI治疗，但医生应平衡药物毒性的个体风险和治疗的益处。</p></div><span id="v1011226_zh" class="anchor"></span><div class="para"> <p>治疗通常包括异烟肼（INH），除非怀疑有耐药性（例如，暴露于已知的INH耐药病例）。成人每天1次，300mg/次，疗程为9个月；儿童10mg/kg，服用9个月。对INH耐药或不耐受患者的替代方案是利福平（RIF）600 mg，每天一次，持续4个月。INH加利福喷丁每周服用一次，持续3个月也是有效的。</p></div><span id="v68425565_zh" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://www.cdc.gov/tb/topic/treatment/ltbi.htm">LTBI治疗的更新指南</a>可从CDC获得。</p></div><span id="v1011227_zh" class="anchor"></span><div class="para"> <p> LTBI治疗的主要局限性是</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v38408891_zh" class="anchor"></span><div class="para"> <p>肝毒性</p></div></li><li class="topic__listitem"><span id="v38408893_zh" class="anchor"></span><div class="para"> <p> 依从性差</p></div></li></ul></div><span id="v38408894_zh" class="anchor"></span><div class="para"> <p>异烟肼用于治疗LTBI临床肝损的发生率可达1/1000；不过停药后通常会恢复。接受LTBI治疗的患者如果出现任何新症状，尤其是不明原因的疲劳、食欲不振或恶心，应指示他们停止服用该药。利福平引起的肝损比异烟肼少，但药物间的相互作用比较多见。</p></div><span id="v38408895_zh" class="anchor"></span><div class="para"> <p>只有约50％患者完成推荐9个月的INH治疗。4个月的RIF方案依从性更好。临床医生应当督促患者定期随访以便监测不良反应并保证患者的依从性。</p></div> </div> </section> </div> </section> <section id="v1011229_zh" class="topic__section FHead"> <h2 id="Prevention_v1011230_zh" class="topic__header--section" data-originaltitle="预防"> <span id="v1011230_zh" class="anchor"></span> TB的预防 </h2> <div class="topic__content"> <span id="v1011232_zh" class="anchor"></span><div class="para"> <p> 包括 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010799_zh" data-toggle="tooltip" title="治疗" data-id="587f39f1-bf1d-4e50-b325-af09ed119685" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">常规的预防措施</a><span id="587f39f1-bf1d-4e50-b325-af09ed119685" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1010799_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 治疗 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="治疗" loading="lazy"> </span> </a> </span> </span>（如，居家，避免访客，咳嗽时用纸巾捂嘴等）。</p></div> <section id="v1011234_zh" class="topic__section GHead"> <span></span> <h3 id="Prevention_v1011230_zh_v1011235_zh" class="topic__header--subsection"> <span id="v1011235_zh" class="anchor"></span> 疫苗接种 </h3> <div class="topic__content"> <span id="v1011239_zh" class="anchor"></span><div class="para"> <p><b>BCG疫苗</b>是减毒灭活 <i>M. bovis </i>结核分枝杆菌，目前全球有<span class='symbol'>></span>80％的儿童已注射，尤其是结核高发国家。但其有效力仅达50％。 卡介苗可减少儿童肺外结核的发病率也可能可以预防结核感染。因此，推荐在结核高发国家使用。卡介苗免疫在美国并没有推广使用，除非是儿童不可避免地接触无法有效治疗的传染性结核病病例（即 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1011158_zh" data-toggle="tooltip" title="耐药性" data-id="4f18ccd3-b047-4b6e-be76-6461611d0ccd" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">广泛耐药前</a><span id="4f18ccd3-b047-4b6e-be76-6461611d0ccd" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1011158_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 耐药性 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="耐药性" loading="lazy"> </span> </a> </span> </span>或 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1011158_zh" data-toggle="tooltip" title="耐药性" data-id="32fa3ced-446e-4805-8163-e75aec35d20e" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">广泛耐药结核病</a><span id="32fa3ced-446e-4805-8163-e75aec35d20e" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1011158_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 耐药性 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="耐药性" loading="lazy"> </span> </a> </span> </span>），以及可能以前未感染的医护人员定期接触 <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1011158_zh" data-toggle="tooltip" title="耐药性" data-id="a00b2960-0882-4c4a-bcbd-afb19f3d337c" data-itemid="1768e837-2640-4ba1-82b4-00fecd3bc5a7">耐多药结核病</a><span id="a00b2960-0882-4c4a-bcbd-afb19f3d337c" class="d-none xref"> <span class="tooltip-container"> <a href="./{1768E837-2640-4BA1-82B4-00FECD3BC5A7}.html#v1011158_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 耐药性 </span> 结核病是一种慢性进行性分枝杆菌感染，通常在最初感染后有无症状潜伏期。肺结核最常见于肺部。表现为咳嗽、咳痰、发热、消瘦及乏力。最常见的诊断方法是痰涂片和培养，如果可以，还可以通过核酸扩增检测。抗结核治疗需联合用药至少4个月。 （另请参阅 围产期结核病... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="耐药性" loading="lazy"> </span> </a> </span> </span>或广泛耐药结核。</p></div><span id="v11555487_zh" class="anchor"></span><div class="para"> <p>尽管BCG接种经常使TST成阳性，但其反应通常比自然感染结核菌所引起的更小，它通常消退更迅速。卡介苗接种所致的TST阳性反应很少<span class='symbol'>></span>15mm，注射后的15年后很少<span class='symbol'> ></span>10 mm。由于儿童感染结核分枝杆菌具有严重的并发症，美国CDC建议注射卡介苗后的儿童TST阳性时，均考虑为结核感染并治疗。IGRAs不受BCG接种的影响，因此最适宜用于接种卡介苗后需要明确TST反应是由于接种引起还是感染 <i>M. tuberculosis</i>结核分枝杆菌者.</p></div> </div> </section> </div> </section> <section id="v1011242_zh" class="topic__section FHead" itemprop="associatedAnatomy" itemscope="" itemtype="http://schema.org/AnatomicalStructure"> <h2 id="Other_v1011243_zh" class="topic__header--section"> <span id="v1011243_zh" class="anchor"></span> 特殊人群 </h2> <div class="topic__content"> <section id="v1011244_zh" class="topic__section GHead"> <span></span> <h3 id="Other_v1011243_zh_v1011245_zh" class="topic__header--subsection"> <span id="v1011245_zh" class="anchor"></span> 儿童 </h3> <div class="topic__content"> <span id="v1011249_zh" class="anchor"></span><div class="para"> <p>感染结核病的儿童比成人更容易发展为活动性结核，其中常见的表现为肺外疾病。淋巴结炎（瘰）是最常见的肺外的表现，但结核病也可能影响椎骨（<a href="./{41EBCC40-5B7B-404D-B6F0-50D8151C4612}.html#v11555572_zh" data-toggle="tooltip" title="骨关节结核" data-id="f37ce585-ebbe-4e3f-9ad8-777bf4dd4b5d" data-itemid="41ebcc40-5b7b-404d-b6f0-50d8151c4612">波特病</a><span id="f37ce585-ebbe-4e3f-9ad8-777bf4dd4b5d" class="d-none xref"> <span class="tooltip-container"> <a href="./{41EBCC40-5B7B-404D-B6F0-50D8151C4612}.html#v11555572_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 骨关节结核 </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/8/4/484-cutaneous-tuberculosis-scrofuloderma-slide-20-springer-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="骨关节结核" loading="lazy"> </span> </a> </span> </span>）或中枢神经系统和脑膜。</p></div><span id="v38408898_zh" class="anchor"></span><div class="para"> <p>儿童活动性结核病的临床表现各不相同，使其诊断比较困难。大多数孩子除咳嗽外无其他症状。</p></div><span id="v11555490_zh" class="anchor"></span><div class="para"> <p> 获取培养样本通常需要以下条件之一：</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v38408901_zh" class="anchor"></span><div class="para"> <p> 胃液误吸</p></div></li><li class="topic__listitem"><span id="v38408903_zh" class="anchor"></span><div class="para"> <p>诱导痰</p></div></li><li class="topic__listitem"><span id="v38408905_zh" class="anchor"></span><div class="para"> <p>更具侵入性的操作，如支气管肺泡灌洗</p></div></li></ul></div><span id="v38408906_zh" class="anchor"></span><div class="para"> <p>胸部X线最常见的标志是肺门淋巴结肿大，但节段性肺不张也可出现。即使治疗开始后淋巴结肿大仍可能进展，并可能导致肺叶不张，通常在治疗后逐渐好转。空洞较成人患者少见，大多数儿童携带较少病原体，传染性较低。</p></div><span id="v38408907_zh" class="anchor"></span><div class="para"> <p>治疗策略与成人相似，只是药物必须严格根据孩子的体重来给药（见表<span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"b9ae3000-0eeb-45ea-aa72-3cda78f44d1e","Title":"%E4%B8%80%E7%BA%BF%E6%8A%97%E7%BB%93%E6%A0%B8%E8%8D%AF%E7%89%A9%2A","ShareUrlTitle":"一线抗结核药物","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"%E8%A1%A8%E6%A0%BC","UniqueId":"v1010853_zh","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3E%E4%B8%80%E7%BA%BF%E6%8A%97%E7%BB%93%E6%A0%B8%E8%8D%AF%E7%89%A9%E7%9A%84%E5%89%82%E9%87%8F%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"%E8%A1%A8%E6%A0%BC","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>）。</p></div> </div> </section> <section id="v1011251_zh" class="topic__section GHead"> <span></span> <h3 id="Other_v1011243_zh_v1011252_zh" class="topic__header--subsection"> <span id="v1011252_zh" class="anchor"></span> 老年人群 </h3> <div class="topic__content"> <span id="v1011254_zh" class="anchor"></span><div class="para"> <p>活动性结核可累及任何器官，尤其是肺、颅内、肾、长骨、椎骨和淋巴结。可没有任何临床表现，容易漏诊，延误治疗。老年人常因伴随其他疾病，更易延误诊断。</p></div><span id="v38408909_zh" class="anchor"></span><div class="para"> <p>无论他们的年龄如何，以前TST阴性的养老院居民由于最近的传播而有患病风险，这可能导致心尖、中叶或下叶肺炎以及胸腔积液。肺部炎症可能不被诊断为结核，一旦未及时诊治，可能会导致感染的进一步扩散至其他人群。</p></div><span id="v38408910_zh" class="anchor"></span><div class="para"> <p>在美国，粟粒性结核和结核性脑膜炎以往认为在儿童发病率最高，但实际上，老年人是最多见的。</p></div><span id="v1011255_zh" class="anchor"></span><div class="para"> <p>风险和预防性治疗的获益应在老人治疗前得到仔细评估。<span class='symbol'>></span>65岁的患者中，异烟肼的肝损发生率达4～5％（<span class='symbol'>&lt</span>65岁患者的发生率<span class='symbol'>&lt</span>1%）。因此，只有而且老年人的皮肤菌素实验从原来的阴性转为<span class='symbol'>≥</span>15mm时，才建议进行预防性治疗。除非有禁忌，密切接触过活动性结核患者或有其他高危因素时，即使菌素实验或IGRA为阴性也需进行预防治疗。</p></div> </div> </section> <section id="v1011256_zh" class="topic__section GHead"> <span></span> <h3 id="Other_v1011243_zh_v1011257_zh" class="topic__header--subsection"> <span id="v1011257_zh" class="anchor"></span> HIV感染者 </h3> <div class="topic__content"> <span id="v1011260_zh" class="anchor"></span><div class="para"> <p>免疫力低下患者对免疫无应答，故结核菌素实验通常反应很弱。部分研究显示，IGRA的敏感性较结核菌素要高，虽然这一优势还没确定。</p></div><span id="v1437012_zh" class="anchor"></span><div class="para"> <p>在未经治疗的 <a href="./{58E097FD-A3ED-437F-85A6-10AC1181C94B}.html" data-toggle="tooltip" title="人类免疫缺陷病毒感染" data-id="16c2f9a2-07fc-45b3-be80-b2fd0a109c16" data-itemid="58e097fd-a3ed-437f-85a6-10ac1181c94b">HIV感染</a><span id="16c2f9a2-07fc-45b3-be80-b2fd0a109c16" class="d-none xref"> <span class="tooltip-container"> <a href="./{58E097FD-A3ED-437F-85A6-10AC1181C94B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 人类免疫缺陷病毒感染 </span> 由人免疫缺陷病毒（HIV）的两类相似的反转录病毒（HIV-1和HIV-2）感染引起CD4+T细胞损伤和细胞免疫功能破坏，进而导致发生某些感染和肿瘤的危险性增加。最初的感染可能导致不典型的发热性疾病。之后，由HIV感染所带来的疾病风险取决于免疫缺陷的程度，也即CD4+T淋巴细胞的减低程度。病毒可直接损... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/3/1/3/313_hiv_slide_3_springer_high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="人类免疫缺陷病毒感染" loading="lazy"> </span> </a> </span> </span>者和潜伏结核感染者（LTBI）中，活动性结核病的发病率约为10%/年，而在没有免疫缺陷的人中，其发病率在一生中大致相同。在20世纪90年代初，一半未经治疗或感染了耐多药毒株的结核病和艾滋病患者死亡，中位生存期仅为60天。现在，由于早期的结核病诊断和抗逆转录病毒治疗，在检测和治疗更好的国家，结果稍好一些，但艾滋病毒患者的结核病仍然是一个严重的问题。在药物和结核病和艾滋病毒感染检测有限的国家，同时感染艾滋病毒和耐多药结核病或广泛耐药结核病的患者死亡率仍然很高。</p></div><span id="v1011261_zh" class="anchor"></span><div class="para"> <p>HIV感染者原发感染期间结核传播通常更加广泛。因此，肺外结核比例较大。结核瘤（肺结核引起的肺部或中枢神经系统肿块）更常见，破坏性更强。HIV感染降低了炎症反应和肺部空洞的形成。其结果是，胸部X射线可能会显示一个非特异性肺炎，甚至是正常的。</p></div><span id="v38408912_zh" class="anchor"></span><div class="para"> <p>涂片阴性的结核病在HIV合并感染中较为普遍。由于涂片阴性的结核病常见，HIV-TB合并感染通常认为传染性略低。</p></div><span id="v1011262_zh" class="anchor"></span><div class="para"> <p>艾滋病早期结核也可发病，成为进入AIDS期的表现；血行播散型结核相对较重。患者的CD4＋T淋巴细胞数<span class='symbol'>≥</span>200/mcL (0.2 × 10<sup>9</sup>/L)时结核病多由结核分枝杆菌引起。相对地，CD4＋T淋巴细胞数<span class='symbol'>&lt</span>50/mcL (0.05 × 10<sup>9</sup>/L) 时多应考虑 M. avium鸟分枝杆菌复合体（<i>Mycobacterium avium</i> complex， <a href="./{8CF4C69D-B9A4-4212-9A25-F307B195ECF2}.html" data-toggle="tooltip" title="非结核分枝杆菌感染" data-id="0d916ea0-b94f-41d0-9798-a9eb03c3b3d6" data-itemid="8cf4c69d-b9a4-4212-9a25-f307b195ecf2">MAC</a><span id="0d916ea0-b94f-41d0-9798-a9eb03c3b3d6" class="d-none xref"> <span class="tooltip-container"> <a href="./{8CF4C69D-B9A4-4212-9A25-F307B195ECF2}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 非结核分枝杆菌感染 </span> 有超过 170 种公认的分枝杆菌，主要是环境的。环境暴露于许多这些生物是常见的，但大多数暴露不会导致感染，许多感染不会导致疾病。疾病通常需要局部或全身宿主防御缺陷。患有慢性肺病的人（尤其是 囊性纤维化)、体弱的老年人和免疫功能低下的人面临的风险最高，但其他缺陷不太明显的人可能会出现进展性疾病。定期报... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>）引起。MAC感染不具有传染性，在HIV感染患者中，主要影响血液和骨髓，而不是肺部。</p></div><span id="v1011265_zh" class="anchor"></span><div class="para"> <p>在出现结核病之前未被诊断的HIV感染患者应在开始抗逆转录病毒治疗之前接受2周的抗分枝杆菌治疗，以降低发生 <a href="./{58E097FD-A3ED-437F-85A6-10AC1181C94B}.html#v26307332_zh" data-toggle="tooltip" title="免疫重建炎性综合征（IRIS）" data-id="a34d9c77-3a1c-4dd8-9a18-745f45e40ec0" data-itemid="58e097fd-a3ed-437f-85a6-10ac1181c94b">免疫重建炎症综合征</a><span id="a34d9c77-3a1c-4dd8-9a18-745f45e40ec0" class="d-none xref"> <span class="tooltip-container"> <a href="./{58E097FD-A3ED-437F-85A6-10AC1181C94B}.html#v26307332_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 免疫重建炎性综合征（IRIS） </span> 由人免疫缺陷病毒（HIV）的两类相似的反转录病毒（HIV-1和HIV-2）感染引起CD4+T细胞损伤和细胞免疫功能破坏，进而导致发生某些感染和肿瘤的危险性增加。最初的感染可能导致不典型的发热性疾病。之后，由HIV感染所带来的疾病风险取决于免疫缺陷的程度，也即CD4+T淋巴细胞的减低程度。病毒可直接损... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/3/1/3/313_hiv_slide_3_springer_high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="免疫重建炎性综合征（IRIS）" loading="lazy"> </span> </a> </span> </span>（IRIS）的风险。当体外试验显示药物敏感性时，HIV感染患者的结核病通常对常规治疗方案反应良好。然而，对于耐多药结核菌株，结果并没有那么好，因为这些药物毒性更大，疗效更低。痰培养转为阴性后，易感结核病的治疗应持续6至9个月，但如果3次单独的预处理痰涂片呈阴性，则可缩短至6个月，这表明有机体负担较低。若治疗2个月后，培养仍为阳性，疗程需治疗9个月。</p></div><span id="v38408915_zh" class="anchor"></span><div class="para"> <p>HIV感染者的结核菌素反应<span class='symbol'>≥</span>5毫米（或IGRA阳性）应接受药物预防。</p></div><span id="v38408916_zh" class="anchor"></span><div class="para"> <p>目前 <a rel="nofollow" target="_blank" href="http://www.cdc.gov/tb/publications/guidelines/Treatment.htm">CDC TB treatment guidelines</a> 应该查阅CDC TB治疗指南。</p></div> </div> </section> </div> </section> <section id="v11555492_zh" class="topic__section topic__section--keypoints FHead"> <h2 id="KeyPoints_v11555493_zh" class="topic__header--section"> <span id="v11555493_zh" class="anchor"></span> 关键点 <span class="topic__keypoints--icon"></span> </h2> <div class="topic__content--keypoints"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v11555496_zh" class="anchor"></span><div class="para"> <p> 结核可引起原发感染，通常无症状，然后是潜伏感染，少数患者可进入活动性疾病期。</p></div></li><li class="topic__listitem"><span id="v11555498_zh" class="anchor"></span><div class="para"> <p>世界人口的大约四分之一感染结核病，其中1500万活动性结核患者。</p></div></li><li class="topic__listitem"><span id="v11555500_zh" class="anchor"></span><div class="para"> <p>免疫功能受损患者，尤其是HIV感染患者更容易出现活动性结核。</p></div></li><li class="topic__listitem"><span id="v11555502_zh" class="anchor"></span><div class="para"> <p>根据症状，风险因素，结核菌素测试和gamma干扰素释放试验明确可疑患者;依靠痰检（镜检和培养）和/或核酸扩增试验确认。</p></div></li><li class="topic__listitem"><span id="v11555504_zh" class="anchor"></span><div class="para"> <p>多药联用治疗数月。</p></div></li><li class="topic__listitem"><span id="v11555506_zh" class="anchor"></span><div class="para"> <p>耐药性是一个主要问题，因为依从性差，使用不恰当的药物治疗方案，药敏试验开展不足而逐渐增加。</p></div></li></ul></div> </div> </section> <section id="v13952583_zh" class="topic__section FHead"> <h2 id="Further_v13952593_zh" class="topic__header--section"> <span id="v13952593_zh" class="anchor"></span> 更多信息 </h2> <div class="topic__content"> <span id="v68425572_zh" class="anchor"></span><div class="para"> <p> 以下英语资源可能会有用。 请注意，本手册对这些资源的内容不承担任何责任。 </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v68425574_zh" class="anchor"></span><div class="para"> <p>Official American Thoracic Society, Centers for Disease Control and Prevention, and the Infectious Diseases Society of America: <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/27516382"> Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis</a> (2016)</p></div></li><li class="topic__listitem"><span id="v68425577_zh" class="anchor"></span><div class="para"> <p>Centers for Disease Control and Prevention (CDC): <a rel="nofollow" target="_blank" href="https://www.cdc.gov/tb/topic/testing/whobetested.htm">Updated guidelines for testing of latent TB infection</a></p></div></li><li class="topic__listitem"><span id="v13952596_zh" class="anchor"></span><div class="para"> <p>CDC: <a rel="nofollow" target="_blank" href="http://www.cdc.gov/tb/topic/treatment/ltbi.htm">Treatment Regimens for Latent TB Infection (LTBI)</a></p></div></li><li class="topic__listitem"><span id="v13953514_zh" class="anchor"></span><div class="para"> <p>CDC: <a rel="nofollow" target="_blank" href="http://www.cdc.gov/tb/publications/guidelines/Treatment.htm">TB Treatment Guidelines</a></p></div></li></ul></div> </div> </section>
 
 <section class="topic__section">
 <div class="topicswitch topic__patient-education topic__patient-education--bottom hide-on-print" data-icd9="010;011;012;013;014;015;016;017;018;771.2;137">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 看法 进行患者培训
 </div>
 </div>
 </div>
 </section>
</div>
<script type="text/javascript">
 $(document).ready(function () {
 $(document).on('click', '.topicswitch', function (e) {
 e.preventDefault();
 $.ajax({
 url: '/Custom/Edition/GetSwitchUrl',
 type: "GET",
 dataType: "json",
 data: {
 icd9: '010;011;012;013;014;015;016;017;018;771.2;137',
 title: '（TB） 结核',
 itemGuid: '1768e837-2640-4ba1-82b4-00fecd3bc5a7'
 }
 }).done(function (data) {
 
 // redirect
 location.href = data.href;
 }).fail(function (jqxhr, textStatus, errorThrown) {
 console.error(errorThrown);
 });
 });
 });
</script>
 </article>
 <div class="copyright-print">
 <div class="copyright-print--logo">
<img src="./Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71">
 </div>
 <div class="copyright-print--text">
 版权所有 © 2023 Merck & Co., Inc., Rahway, NJ, USA 及其附属公司。保留所有权利。
 </div>
 </div>
 <section class="bottomnav__wrapper hide-on-print" style="display:none">
 
<div class="bottomnav no-print collapsed">
 <div class="bottomnav__gotolink bottomnav__gotolink--previous">
 <a href="./{3F43DD03-DE03-44A9-A46A-C2170C9598F0}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__icon bottomnav__icon--previous"></div>
 <div class="bottomnav__linktext">微孢子虫病</div>
 </div>
 </a>
 </div>
 
 <div class="bottomnav__gotolink bottomnav__gotolink--next">
 <a href="./{41EBCC40-5B7B-404D-B6F0-50D8151C4612}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__linktext">肺外结核（TB）感染</div>
 <div class="bottomnav__icon bottomnav__icon--next"></div>
 </div>
 </a>
 </div>
</div>
 </section>
</div>
<span id="showpopup"></span>
<span id="showchildpopup"></span>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1301">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
<div class="marketingblock-quiz hide-on-print">
<div class="marketingblock-quiz-img">
<img alt="quiz link" src="./Content/Images/Redesign/quizzes_lightbulb_red.png" loading="lazy" width="64" height="52">
</div>
<div class="marketingblock-quiz-desc">
<h4>Test your knowledge</h4>
<a href="./{976709AA-1FDC-4953-8B32-2A9E9973AC21}.html">Take a Quiz! </a></div>
</div> </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1550">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
 <div class="box__content--mobile">
 <img loading="lazy" alt="" id="84c7ba05-e718-4fca-9cd6-db2fa237f9fd_mobile" usemap="#84c7ba05-e718-4fca-9cd6-db2fa237f9fd_mobile" width="0" height="0">
 <map name="84c7ba05-e718-4fca-9cd6-db2fa237f9fd_mobile">
 <area shape="RECT" coords="177,320,263,364" href="https://play.google.com/store/apps/details?id=com.msd.professionalChinese&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
<area shape="RECT" coords="88,318,179,365" href="https://apps.apple.com/app/mo-sha-dong-zhen-liao-zhong/id1187944606" target="_blank" alt="iOS">
<area shape="RECT" coords="0,300,132,363" href="https://apps.appinchina.com.cn/details/com.msd.professionalChinese" target="_blank" alt="APPS in CHINA">
 </map>
 </div>
 <div class="box__content--tablet">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/zh_msd_mobile_pro_429.gif" alt="" id="84c7ba05-e718-4fca-9cd6-db2fa237f9fd_tablet" usemap="#84c7ba05-e718-4fca-9cd6-db2fa237f9fd_tablet" width="429" height="598">
 <map name="84c7ba05-e718-4fca-9cd6-db2fa237f9fd_tablet">
 <area shape="RECT" coords="288,509,426,595" href="https://play.google.com/store/apps/details?id=com.msd.professionalChinese&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
<area shape="RECT" coords="147,509,287,596" href="https://apps.apple.com/app/mo-sha-dong-zhen-liao-zhong/id1187944606" target="_blank" alt="iOS">
<area shape="RECT" coords="0,509,146,594" https://apps.appinchina.com.cn/details/com.msd.professionalchinese"="" target="_blank" alt="APPS in CHINA">
 </map>
 </div>
 <div class="box__content--desktop">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/zh_msd_mobile_pro_262.gif" alt="" id="84c7ba05-e718-4fca-9cd6-db2fa237f9fd_desktop" usemap="#84c7ba05-e718-4fca-9cd6-db2fa237f9fd_desktop" width="262" height="365">
 <map name="84c7ba05-e718-4fca-9cd6-db2fa237f9fd_desktop">
 <area shape="RECT" coords="177,320,263,364" href="https://play.google.com/store/apps/details?id=com.msd.professionalChinese&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
<area shape="RECT" coords="88,318,179,365" href="https://apps.apple.com/app/mo-sha-dong-zhen-liao-zhong/id1187944606" target="_blank" alt="iOS">
<area shape="RECT" coords="0,300,132,363" href="https://apps.appinchina.com.cn/details/com.msd.professionalChinese" target="_blank" alt="APPS in CHINA">
 </map>
 </div>
 </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<a id="autoload" role="button" tabindex="-1"></a>
 <div class="autoload-placeholder hide-on-print" name="下一个:"></div>
 <a class="next-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
</div>
 </section>
 
 </main>
 
 <div class="l-layer l-layer--topscroll">
 <div class="topscroll topscroll--hidden">
 <div class="topscroll__container">
 <div class="topscroll__button">
 <div class="topscroll__content">
 <i class="topscroll__arrow"></i>
 顶部
 </div>
 </div>
 </div>
 <div class="topscroll__bar"></div>
</div>
 </div>
 </div>
 
 <div class="flyout hide-on-print" tabindex="0">
 <nav class="flyout__menu" role="application" aria-label="菜单">
 </nav>
 </div>
 <div class="print">
 <div id="print__content">
 </div>
 </div>
 <div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
 <script type="text/javascript">
 //global value for translating the 'Read More' value
 var MMReadMore = "阅读更多";
 var MMMaxTeaseCount = 250;
 </script>
 
 
<div class="sticky-footer hide-on-print">
 <ul>
 <li class="sticky-footer--topic">
 <button aria-label="话题" class="sticky-footer-topicmenu" aria-expanded="false">
 <span class="footer-bar__icon topic-ico"></span>
 </button>
 <div class="footer-expand-cont footer-parent-cont topicList">
 <button aria-label="关闭" class="footer-expand-cont__close"></button>
 <div class="footer-topicList-wrapper">
 <div class="in-this-topic-sidebar">
 <div class="box__header">
 <span>在该主题中</span>
 <span class="in-this-topic-togggle-btn" aria-label="在该主题中" aria-expanded="false"></span>
 </div>
 </div>
 </div>
 </div>
 </li>
 <li class="sticky-footer--version-switcher nontopicpage">
 <a data-id="HE" href="/home" target="_self" aria-label="版本切换">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--version-switcher topicpage">
 <a class="topicswitch" href="#" target="_self" aria-label="版本切换">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--vetFilter"></li>
 <li>
 <a href="./{3E29C424-F2D9-4E90-9F91-65F55E8C00D7}.html" target="_self" aria-label="资源">
 <span class="footer-bar__icon resources-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--social">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Common.AriaLabels.SocialMediaShare"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="打印"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="邮件"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </li>
 <li class="sticky-footer--moreCont">
 <button aria-label="更多的" class="sticky-footer--more" aria-expanded="false">
 <span class="footer-bar__icon more-ico"></span>
 </button>
 <div class="footer-expand-cont more-footer-container">
 <ul>
 <li>
 <a href="./{41EBCC40-5B7B-404D-B6F0-50D8151C4612}.html" target="_self" aria-label="首页">
 <span class="footer-bar__icon home-ico"></span>
 </a>
 </li>
 <li>
 <a href="./{FF41B506-E267-4A7F-8357-F8C0474115E2}.html" target="_self" aria-label="信息">
 <span class="footer-bar__icon info-ico"></span>
 </a>
 </li>
 <li>
 <button aria-label="Common.AriaLabels.Settings" aria-expanded="false">
 <span class="footer-bar__icon settings-ico"></span>
 </button>
 <div class="footer-sub-cont settings-footer-cont"></div>
 </li>
 <li class="language-footer">
 <button aria-label="
选择语言" aria-expanded="false">
 <span class="footer-bar__icon language-ico"></span>
 </button>
 <div class="footer-sub-cont language-footer-cont"></div>
 </li>
 </ul>
 </div>
 </li>
 </ul>
</div>
 
 
 
<!--[if (gte IE 9)|!(IE)]><!-->
<script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("./bundles/redesign/libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 MManual.utils.loadScripts(MManual.deferredScripts);
 }
 $(document).ready(downloadJSAtOnload);
</script>
<!--<![endif]-->
<!--[if lt IE 9]>
 
 <script src="/Content/Scripts/Lib/mediaelement-and-player.min.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script src="/Content/Scripts/Lib/zoomerang.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("/bundles/redesign/ie8libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 for (var i = 0; i < MManual.deferredScripts.length; i++) {
 var element = document.createElement("script");
 element.src = MManual.deferredScripts[i];
 element.classList.add("optanon-category-C0002");
 document.body.appendChild(element);
 }
 }
 $(document).ready(downloadJSAtOnload);
 </script>
<![endif]-->
 <!-- Current instance name : cn2-p-sc-cd01
 Current application version : 4.1.2.2-13178e13ca
 -->
 <!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsEndjsv4.1.2.2-13178e13ca.js?v=NWrOPHpqntlKhYlvryw8nEPZpRaWQrScEY3i127KnfI1"></script>
<!--<![endif]-->
<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="1768E83726404BA182B400FECD3BC5A7">
</div><div id="hiddentblcontents" style="display:none"><div id='hidden_v1010853_zh'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1010855_zh"></span> <div class="TableFullPage" id="v1010853_zh"> <h3 class="title">一线抗结核药物*</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228030_zh" class="anchor"></span><div class="para"> <p>药物</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228033_zh" class="anchor"></span><div class="para"> <p>成人/儿童</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228036_zh" class="anchor"></span><div class="para"> <p>每日用药†</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228039_zh" class="anchor"></span><div class="para"> <p>每星期一次</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228042_zh" class="anchor"></span><div class="para"> <p>一周2次</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228045_zh" class="anchor"></span><div class="para"> <p>一周3次</p></div></p></th></tr></thead> <tbody><tr class="odd"><td rowspan="2"><span id="v1010873_zh" class="anchor"></span><div class="para"> <p>异烟肼</p></div></td><td><span id="v1010875_zh" class="anchor"></span><div class="para"> <p>成人（最大剂量）</p></div></td><td><span id="v1010877_zh" class="anchor"></span><div class="para"> <p>5mg/kg（300mg）</p></div></td><td><span id="v1010879_zh" class="anchor"></span><div class="para"> <p>15mg/kg（900mg）</p></div></td><td><span id="v1010881_zh" class="anchor"></span><div class="para"> <p>15mg/kg（900mg）</p></div></td><td><span id="v1010883_zh" class="anchor"></span><div class="para"> <p>15mg/kg（900mg）</p></div></td></tr><tr class="even"><td><span id="v1010888_zh" class="anchor"></span><div class="para"> <p>儿童（最大剂量）</p></div></td><td><span id="v1010890_zh" class="anchor"></span><div class="para"> <p>10～20 mg/kg（300 mg）</p></div></td><td><span id="v1010892_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010894_zh" class="anchor"></span><div class="para"> <p>20～40 mg/kg（900 mg）</p></div></td><td><span id="v1010896_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="odd"><td rowspan="2"><span id="v1010899_zh" class="anchor"></span><div class="para"> <p>利福平</p></div></td><td><span id="v1010901_zh" class="anchor"></span><div class="para"> <p>成人（最大剂量）</p></div></td><td><span id="v1010903_zh" class="anchor"></span><div class="para"> <p>10mg/kg（600mg）</p></div></td><td><span id="v1010905_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010907_zh" class="anchor"></span><div class="para"> <p>10mg/kg（600mg）</p></div></td><td><span id="v1010909_zh" class="anchor"></span><div class="para"> <p>10mg/kg（600mg）</p></div></td></tr><tr class="even"><td><span id="v1010914_zh" class="anchor"></span><div class="para"> <p>儿童（最大剂量）</p></div></td><td><span id="v1010916_zh" class="anchor"></span><div class="para"> <p>10～20mg/kg（600mg）</p></div></td><td><span id="v1010918_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010920_zh" class="anchor"></span><div class="para"> <p>10～20mg/kg（600mg）</p></div></td><td><span id="v1010922_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="odd"><td rowspan="2"><span id="v1010925_zh" class="anchor"></span><div class="para"> <p>利福布丁</p></div></td><td><span id="v1010927_zh" class="anchor"></span><div class="para"> <p>成人（最大剂量）</p></div></td><td><span id="v1010929_zh" class="anchor"></span><div class="para"> <p>5mg/kg（300mg）</p></div></td><td><span id="v1010931_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010933_zh" class="anchor"></span><div class="para"> <p>5mg/kg（300mg）</p></div></td><td><span id="v1010935_zh" class="anchor"></span><div class="para"> <p>5mg/kg（300mg）</p></div></td></tr><tr class="even"><td><span id="v1010940_zh" class="anchor"></span><div class="para"> <p>儿童</p></div></td><td><span id="v1010942_zh" class="anchor"></span><div class="para"> <p>10～20 mg/kg（300 mg）</p></div></td><td><span id="v1010944_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010946_zh" class="anchor"></span><div class="para"> <p>10～20 mg/kg（300 mg）</p></div></td><td><span id="v1010948_zh" class="anchor"></span><div class="para"> <p>10～20mg/kg（600mg）</p></div></td></tr><tr class="odd"><td rowspan="2"><span id="v1010951_zh" class="anchor"></span><div class="para"> <p>利福喷丁‡</p></div></td><td><span id="v1010953_zh" class="anchor"></span><div class="para"> <p>成人</p></div></td><td><span id="v1010955_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010957_zh" class="anchor"></span><div class="para"> <p>10mg/kg（600mg）</p></div></td><td><span id="v1010959_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010961_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="even"><td><span id="v1010966_zh" class="anchor"></span><div class="para"> <p>儿童</p></div></td><td><span id="v1010968_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010970_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010972_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010974_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="odd"><td rowspan="5"><span id="v1010977_zh" class="anchor"></span><div class="para"> <p>吡嗪酰胺</p></div></td><td><span id="v1010979_zh" class="anchor"></span><div class="para"> <p>成人（整片剂）</p></div></td><td><span id="v1010981_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1010983_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1010985_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1010987_zh" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v1010992_zh" class="anchor"></span><div class="para"> <p>40～55kg</p></div></td><td><span id="v1010994_zh" class="anchor"></span><div class="para"> <p>1g</p></div></td><td><span id="v1010996_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010998_zh" class="anchor"></span><div class="para"> <p>2g</p></div></td><td><span id="v1011000_zh" class="anchor"></span><div class="para"> <p>1.5g</p></div></td></tr><tr class="odd"><td><span id="v1011005_zh" class="anchor"></span><div class="para"> <p>56～75kg</p></div></td><td><span id="v1011007_zh" class="anchor"></span><div class="para"> <p>1.5g</p></div></td><td><span id="v1011009_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011011_zh" class="anchor"></span><div class="para"> <p>3g</p></div></td><td><span id="v1011013_zh" class="anchor"></span><div class="para"> <p>2.5g</p></div></td></tr><tr class="even"><td><span id="v1011018_zh" class="anchor"></span><div class="para"> <p><span class='symbol'>≥</span>76kg§</p></div></td><td><span id="v1011020_zh" class="anchor"></span><div class="para"> <p>2g</p></div></td><td><span id="v1011022_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011024_zh" class="anchor"></span><div class="para"> <p>4g</p></div></td><td><span id="v1011026_zh" class="anchor"></span><div class="para"> <p>3g</p></div></td></tr><tr class="odd"><td><span id="v1011031_zh" class="anchor"></span><div class="para"> <p>儿童（最大剂量）</p></div></td><td><span id="v1011033_zh" class="anchor"></span><div class="para"> <p>15～30mg/kg（2g）</p></div></td><td><span id="v1011035_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011037_zh" class="anchor"></span><div class="para"> <p>50mg/kg（2g）</p></div></td><td><span id="v1011039_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="even"><td rowspan="5"><span id="v1011042_zh" class="anchor"></span><div class="para"> <p>乙胺丁醇</p></div></td><td><span id="v1011044_zh" class="anchor"></span><div class="para"> <p>成人（整片剂）</p></div></td><td><span id="v1011046_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1011048_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1011050_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1011052_zh" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="odd"><td><span id="v1011057_zh" class="anchor"></span><div class="para"> <p>40～55kg</p></div></td><td><span id="v1011059_zh" class="anchor"></span><div class="para"> <p>800mg</p></div></td><td><span id="v1011061_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011063_zh" class="anchor"></span><div class="para"> <p>2000mg</p></div></td><td><span id="v1011065_zh" class="anchor"></span><div class="para"> <p>1200 mg</p></div></td></tr><tr class="even"><td><span id="v1011070_zh" class="anchor"></span><div class="para"> <p>56～75kg</p></div></td><td><span id="v1011072_zh" class="anchor"></span><div class="para"> <p>1200 mg</p></div></td><td><span id="v1011074_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011076_zh" class="anchor"></span><div class="para"> <p>2800mg</p></div></td><td><span id="v1011078_zh" class="anchor"></span><div class="para"> <p>2000mg</p></div></td></tr><tr class="odd"><td><span id="v1011082_zh" class="anchor"></span><div class="para"> <p><span class='symbol'>≥</span>76kg§</p></div></td><td><span id="v1011084_zh" class="anchor"></span><div class="para"> <p>1600mg</p></div></td><td><span id="v1011086_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011088_zh" class="anchor"></span><div class="para"> <p>4000mg</p></div></td><td><span id="v1011090_zh" class="anchor"></span><div class="para"> <p>2400mg</p></div></td></tr><tr class="even"><td><span id="v1011095_zh" class="anchor"></span><div class="para"> <p>儿童（最大剂量）</p></div></td><td><span id="v1011097_zh" class="anchor"></span><div class="para"> <p>15～20mg/kg（1g）</p></div></td><td><span id="v1011099_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011101_zh" class="anchor"></span><div class="para"> <p>50mg/kg（2.5g）</p></div></td><td><span id="v1011103_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="odd"><td rowspan="2"><span id="v1010873_zh" class="anchor"></span><div class="para"> <p>莫西沙星</p></div></td><td><span id="v1010875_zh" class="anchor"></span><div class="para"> <p>≥ 12 岁</p></div></td><td><span id="v1010877_zh" class="anchor"></span><div class="para"> <p>400 mg</p></div></td><td><span id="v1010879_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010881_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010883_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr></tbody> <tfoot><tr><td colspan="6"><span id="v1011107_zh" class="anchor"></span><div class="para"> <p>*特殊剂量和方案见文字讨论。</p></div></td></tr><tr><td colspan="6"><span id="v1011110_zh" class="anchor"></span><div class="para"> <p>†每天被认为是 5 或 7 天/周。所有剂量 <span class='symbol'></span> 7 天/周必须作为直接观察治疗给予。</p></div></td></tr><tr><td colspan="6"><span id="v1011113_zh" class="anchor"></span><div class="para"> <p>‡仅用于巩固期。</p></div></td></tr><tr><td colspan="6"><span id="v1011116_zh" class="anchor"></span><div class="para"> <p>§最大剂量。</p></div></td></tr><tr><td colspan="6"><span id="v1011119_zh" class="anchor"></span><div class="para"> <p>N/A=不适用</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v1010853_zh'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1010855_zh"></span> <div class="TableFullPage" id="v1010853_zh"> <h3 class="title">一线抗结核药物*</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228030_zh" class="anchor"></span><div class="para"> <p>药物</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228033_zh" class="anchor"></span><div class="para"> <p>成人/儿童</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228036_zh" class="anchor"></span><div class="para"> <p>每日用药†</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228039_zh" class="anchor"></span><div class="para"> <p>每星期一次</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228042_zh" class="anchor"></span><div class="para"> <p>一周2次</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228045_zh" class="anchor"></span><div class="para"> <p>一周3次</p></div></p></th></tr></thead> <tbody><tr class="odd"><td rowspan="2"><span id="v1010873_zh" class="anchor"></span><div class="para"> <p>异烟肼</p></div></td><td><span id="v1010875_zh" class="anchor"></span><div class="para"> <p>成人（最大剂量）</p></div></td><td><span id="v1010877_zh" class="anchor"></span><div class="para"> <p>5mg/kg（300mg）</p></div></td><td><span id="v1010879_zh" class="anchor"></span><div class="para"> <p>15mg/kg（900mg）</p></div></td><td><span id="v1010881_zh" class="anchor"></span><div class="para"> <p>15mg/kg（900mg）</p></div></td><td><span id="v1010883_zh" class="anchor"></span><div class="para"> <p>15mg/kg（900mg）</p></div></td></tr><tr class="even"><td><span id="v1010888_zh" class="anchor"></span><div class="para"> <p>儿童（最大剂量）</p></div></td><td><span id="v1010890_zh" class="anchor"></span><div class="para"> <p>10～20 mg/kg（300 mg）</p></div></td><td><span id="v1010892_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010894_zh" class="anchor"></span><div class="para"> <p>20～40 mg/kg（900 mg）</p></div></td><td><span id="v1010896_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="odd"><td rowspan="2"><span id="v1010899_zh" class="anchor"></span><div class="para"> <p>利福平</p></div></td><td><span id="v1010901_zh" class="anchor"></span><div class="para"> <p>成人（最大剂量）</p></div></td><td><span id="v1010903_zh" class="anchor"></span><div class="para"> <p>10mg/kg（600mg）</p></div></td><td><span id="v1010905_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010907_zh" class="anchor"></span><div class="para"> <p>10mg/kg（600mg）</p></div></td><td><span id="v1010909_zh" class="anchor"></span><div class="para"> <p>10mg/kg（600mg）</p></div></td></tr><tr class="even"><td><span id="v1010914_zh" class="anchor"></span><div class="para"> <p>儿童（最大剂量）</p></div></td><td><span id="v1010916_zh" class="anchor"></span><div class="para"> <p>10～20mg/kg（600mg）</p></div></td><td><span id="v1010918_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010920_zh" class="anchor"></span><div class="para"> <p>10～20mg/kg（600mg）</p></div></td><td><span id="v1010922_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="odd"><td rowspan="2"><span id="v1010925_zh" class="anchor"></span><div class="para"> <p>利福布丁</p></div></td><td><span id="v1010927_zh" class="anchor"></span><div class="para"> <p>成人（最大剂量）</p></div></td><td><span id="v1010929_zh" class="anchor"></span><div class="para"> <p>5mg/kg（300mg）</p></div></td><td><span id="v1010931_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010933_zh" class="anchor"></span><div class="para"> <p>5mg/kg（300mg）</p></div></td><td><span id="v1010935_zh" class="anchor"></span><div class="para"> <p>5mg/kg（300mg）</p></div></td></tr><tr class="even"><td><span id="v1010940_zh" class="anchor"></span><div class="para"> <p>儿童</p></div></td><td><span id="v1010942_zh" class="anchor"></span><div class="para"> <p>10～20 mg/kg（300 mg）</p></div></td><td><span id="v1010944_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010946_zh" class="anchor"></span><div class="para"> <p>10～20 mg/kg（300 mg）</p></div></td><td><span id="v1010948_zh" class="anchor"></span><div class="para"> <p>10～20mg/kg（600mg）</p></div></td></tr><tr class="odd"><td rowspan="2"><span id="v1010951_zh" class="anchor"></span><div class="para"> <p>利福喷丁‡</p></div></td><td><span id="v1010953_zh" class="anchor"></span><div class="para"> <p>成人</p></div></td><td><span id="v1010955_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010957_zh" class="anchor"></span><div class="para"> <p>10mg/kg（600mg）</p></div></td><td><span id="v1010959_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010961_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="even"><td><span id="v1010966_zh" class="anchor"></span><div class="para"> <p>儿童</p></div></td><td><span id="v1010968_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010970_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010972_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010974_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="odd"><td rowspan="5"><span id="v1010977_zh" class="anchor"></span><div class="para"> <p>吡嗪酰胺</p></div></td><td><span id="v1010979_zh" class="anchor"></span><div class="para"> <p>成人（整片剂）</p></div></td><td><span id="v1010981_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1010983_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1010985_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1010987_zh" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v1010992_zh" class="anchor"></span><div class="para"> <p>40～55kg</p></div></td><td><span id="v1010994_zh" class="anchor"></span><div class="para"> <p>1g</p></div></td><td><span id="v1010996_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010998_zh" class="anchor"></span><div class="para"> <p>2g</p></div></td><td><span id="v1011000_zh" class="anchor"></span><div class="para"> <p>1.5g</p></div></td></tr><tr class="odd"><td><span id="v1011005_zh" class="anchor"></span><div class="para"> <p>56～75kg</p></div></td><td><span id="v1011007_zh" class="anchor"></span><div class="para"> <p>1.5g</p></div></td><td><span id="v1011009_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011011_zh" class="anchor"></span><div class="para"> <p>3g</p></div></td><td><span id="v1011013_zh" class="anchor"></span><div class="para"> <p>2.5g</p></div></td></tr><tr class="even"><td><span id="v1011018_zh" class="anchor"></span><div class="para"> <p><span class='symbol'>≥</span>76kg§</p></div></td><td><span id="v1011020_zh" class="anchor"></span><div class="para"> <p>2g</p></div></td><td><span id="v1011022_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011024_zh" class="anchor"></span><div class="para"> <p>4g</p></div></td><td><span id="v1011026_zh" class="anchor"></span><div class="para"> <p>3g</p></div></td></tr><tr class="odd"><td><span id="v1011031_zh" class="anchor"></span><div class="para"> <p>儿童（最大剂量）</p></div></td><td><span id="v1011033_zh" class="anchor"></span><div class="para"> <p>15～30mg/kg（2g）</p></div></td><td><span id="v1011035_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011037_zh" class="anchor"></span><div class="para"> <p>50mg/kg（2g）</p></div></td><td><span id="v1011039_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="even"><td rowspan="5"><span id="v1011042_zh" class="anchor"></span><div class="para"> <p>乙胺丁醇</p></div></td><td><span id="v1011044_zh" class="anchor"></span><div class="para"> <p>成人（整片剂）</p></div></td><td><span id="v1011046_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1011048_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1011050_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1011052_zh" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="odd"><td><span id="v1011057_zh" class="anchor"></span><div class="para"> <p>40～55kg</p></div></td><td><span id="v1011059_zh" class="anchor"></span><div class="para"> <p>800mg</p></div></td><td><span id="v1011061_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011063_zh" class="anchor"></span><div class="para"> <p>2000mg</p></div></td><td><span id="v1011065_zh" class="anchor"></span><div class="para"> <p>1200 mg</p></div></td></tr><tr class="even"><td><span id="v1011070_zh" class="anchor"></span><div class="para"> <p>56～75kg</p></div></td><td><span id="v1011072_zh" class="anchor"></span><div class="para"> <p>1200 mg</p></div></td><td><span id="v1011074_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011076_zh" class="anchor"></span><div class="para"> <p>2800mg</p></div></td><td><span id="v1011078_zh" class="anchor"></span><div class="para"> <p>2000mg</p></div></td></tr><tr class="odd"><td><span id="v1011082_zh" class="anchor"></span><div class="para"> <p><span class='symbol'>≥</span>76kg§</p></div></td><td><span id="v1011084_zh" class="anchor"></span><div class="para"> <p>1600mg</p></div></td><td><span id="v1011086_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011088_zh" class="anchor"></span><div class="para"> <p>4000mg</p></div></td><td><span id="v1011090_zh" class="anchor"></span><div class="para"> <p>2400mg</p></div></td></tr><tr class="even"><td><span id="v1011095_zh" class="anchor"></span><div class="para"> <p>儿童（最大剂量）</p></div></td><td><span id="v1011097_zh" class="anchor"></span><div class="para"> <p>15～20mg/kg（1g）</p></div></td><td><span id="v1011099_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011101_zh" class="anchor"></span><div class="para"> <p>50mg/kg（2.5g）</p></div></td><td><span id="v1011103_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="odd"><td rowspan="2"><span id="v1010873_zh" class="anchor"></span><div class="para"> <p>莫西沙星</p></div></td><td><span id="v1010875_zh" class="anchor"></span><div class="para"> <p>≥ 12 岁</p></div></td><td><span id="v1010877_zh" class="anchor"></span><div class="para"> <p>400 mg</p></div></td><td><span id="v1010879_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010881_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010883_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr></tbody> <tfoot><tr><td colspan="6"><span id="v1011107_zh" class="anchor"></span><div class="para"> <p>*特殊剂量和方案见文字讨论。</p></div></td></tr><tr><td colspan="6"><span id="v1011110_zh" class="anchor"></span><div class="para"> <p>†每天被认为是 5 或 7 天/周。所有剂量 <span class='symbol'></span> 7 天/周必须作为直接观察治疗给予。</p></div></td></tr><tr><td colspan="6"><span id="v1011113_zh" class="anchor"></span><div class="para"> <p>‡仅用于巩固期。</p></div></td></tr><tr><td colspan="6"><span id="v1011116_zh" class="anchor"></span><div class="para"> <p>§最大剂量。</p></div></td></tr><tr><td colspan="6"><span id="v1011119_zh" class="anchor"></span><div class="para"> <p>N/A=不适用</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v1010853_zh'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1010855_zh"></span> <div class="TableFullPage" id="v1010853_zh"> <h3 class="title">一线抗结核药物*</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228030_zh" class="anchor"></span><div class="para"> <p>药物</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228033_zh" class="anchor"></span><div class="para"> <p>成人/儿童</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228036_zh" class="anchor"></span><div class="para"> <p>每日用药†</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228039_zh" class="anchor"></span><div class="para"> <p>每星期一次</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228042_zh" class="anchor"></span><div class="para"> <p>一周2次</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1228045_zh" class="anchor"></span><div class="para"> <p>一周3次</p></div></p></th></tr></thead> <tbody><tr class="odd"><td rowspan="2"><span id="v1010873_zh" class="anchor"></span><div class="para"> <p>异烟肼</p></div></td><td><span id="v1010875_zh" class="anchor"></span><div class="para"> <p>成人（最大剂量）</p></div></td><td><span id="v1010877_zh" class="anchor"></span><div class="para"> <p>5mg/kg（300mg）</p></div></td><td><span id="v1010879_zh" class="anchor"></span><div class="para"> <p>15mg/kg（900mg）</p></div></td><td><span id="v1010881_zh" class="anchor"></span><div class="para"> <p>15mg/kg（900mg）</p></div></td><td><span id="v1010883_zh" class="anchor"></span><div class="para"> <p>15mg/kg（900mg）</p></div></td></tr><tr class="even"><td><span id="v1010888_zh" class="anchor"></span><div class="para"> <p>儿童（最大剂量）</p></div></td><td><span id="v1010890_zh" class="anchor"></span><div class="para"> <p>10～20 mg/kg（300 mg）</p></div></td><td><span id="v1010892_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010894_zh" class="anchor"></span><div class="para"> <p>20～40 mg/kg（900 mg）</p></div></td><td><span id="v1010896_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="odd"><td rowspan="2"><span id="v1010899_zh" class="anchor"></span><div class="para"> <p>利福平</p></div></td><td><span id="v1010901_zh" class="anchor"></span><div class="para"> <p>成人（最大剂量）</p></div></td><td><span id="v1010903_zh" class="anchor"></span><div class="para"> <p>10mg/kg（600mg）</p></div></td><td><span id="v1010905_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010907_zh" class="anchor"></span><div class="para"> <p>10mg/kg（600mg）</p></div></td><td><span id="v1010909_zh" class="anchor"></span><div class="para"> <p>10mg/kg（600mg）</p></div></td></tr><tr class="even"><td><span id="v1010914_zh" class="anchor"></span><div class="para"> <p>儿童（最大剂量）</p></div></td><td><span id="v1010916_zh" class="anchor"></span><div class="para"> <p>10～20mg/kg（600mg）</p></div></td><td><span id="v1010918_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010920_zh" class="anchor"></span><div class="para"> <p>10～20mg/kg（600mg）</p></div></td><td><span id="v1010922_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="odd"><td rowspan="2"><span id="v1010925_zh" class="anchor"></span><div class="para"> <p>利福布丁</p></div></td><td><span id="v1010927_zh" class="anchor"></span><div class="para"> <p>成人（最大剂量）</p></div></td><td><span id="v1010929_zh" class="anchor"></span><div class="para"> <p>5mg/kg（300mg）</p></div></td><td><span id="v1010931_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010933_zh" class="anchor"></span><div class="para"> <p>5mg/kg（300mg）</p></div></td><td><span id="v1010935_zh" class="anchor"></span><div class="para"> <p>5mg/kg（300mg）</p></div></td></tr><tr class="even"><td><span id="v1010940_zh" class="anchor"></span><div class="para"> <p>儿童</p></div></td><td><span id="v1010942_zh" class="anchor"></span><div class="para"> <p>10～20 mg/kg（300 mg）</p></div></td><td><span id="v1010944_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010946_zh" class="anchor"></span><div class="para"> <p>10～20 mg/kg（300 mg）</p></div></td><td><span id="v1010948_zh" class="anchor"></span><div class="para"> <p>10～20mg/kg（600mg）</p></div></td></tr><tr class="odd"><td rowspan="2"><span id="v1010951_zh" class="anchor"></span><div class="para"> <p>利福喷丁‡</p></div></td><td><span id="v1010953_zh" class="anchor"></span><div class="para"> <p>成人</p></div></td><td><span id="v1010955_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010957_zh" class="anchor"></span><div class="para"> <p>10mg/kg（600mg）</p></div></td><td><span id="v1010959_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010961_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="even"><td><span id="v1010966_zh" class="anchor"></span><div class="para"> <p>儿童</p></div></td><td><span id="v1010968_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010970_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010972_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010974_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="odd"><td rowspan="5"><span id="v1010977_zh" class="anchor"></span><div class="para"> <p>吡嗪酰胺</p></div></td><td><span id="v1010979_zh" class="anchor"></span><div class="para"> <p>成人（整片剂）</p></div></td><td><span id="v1010981_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1010983_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1010985_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1010987_zh" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v1010992_zh" class="anchor"></span><div class="para"> <p>40～55kg</p></div></td><td><span id="v1010994_zh" class="anchor"></span><div class="para"> <p>1g</p></div></td><td><span id="v1010996_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010998_zh" class="anchor"></span><div class="para"> <p>2g</p></div></td><td><span id="v1011000_zh" class="anchor"></span><div class="para"> <p>1.5g</p></div></td></tr><tr class="odd"><td><span id="v1011005_zh" class="anchor"></span><div class="para"> <p>56～75kg</p></div></td><td><span id="v1011007_zh" class="anchor"></span><div class="para"> <p>1.5g</p></div></td><td><span id="v1011009_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011011_zh" class="anchor"></span><div class="para"> <p>3g</p></div></td><td><span id="v1011013_zh" class="anchor"></span><div class="para"> <p>2.5g</p></div></td></tr><tr class="even"><td><span id="v1011018_zh" class="anchor"></span><div class="para"> <p><span class='symbol'>≥</span>76kg§</p></div></td><td><span id="v1011020_zh" class="anchor"></span><div class="para"> <p>2g</p></div></td><td><span id="v1011022_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011024_zh" class="anchor"></span><div class="para"> <p>4g</p></div></td><td><span id="v1011026_zh" class="anchor"></span><div class="para"> <p>3g</p></div></td></tr><tr class="odd"><td><span id="v1011031_zh" class="anchor"></span><div class="para"> <p>儿童（最大剂量）</p></div></td><td><span id="v1011033_zh" class="anchor"></span><div class="para"> <p>15～30mg/kg（2g）</p></div></td><td><span id="v1011035_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011037_zh" class="anchor"></span><div class="para"> <p>50mg/kg（2g）</p></div></td><td><span id="v1011039_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="even"><td rowspan="5"><span id="v1011042_zh" class="anchor"></span><div class="para"> <p>乙胺丁醇</p></div></td><td><span id="v1011044_zh" class="anchor"></span><div class="para"> <p>成人（整片剂）</p></div></td><td><span id="v1011046_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1011048_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1011050_zh" class="anchor"></span><div class="para"> <p></div></td><td><span id="v1011052_zh" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="odd"><td><span id="v1011057_zh" class="anchor"></span><div class="para"> <p>40～55kg</p></div></td><td><span id="v1011059_zh" class="anchor"></span><div class="para"> <p>800mg</p></div></td><td><span id="v1011061_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011063_zh" class="anchor"></span><div class="para"> <p>2000mg</p></div></td><td><span id="v1011065_zh" class="anchor"></span><div class="para"> <p>1200 mg</p></div></td></tr><tr class="even"><td><span id="v1011070_zh" class="anchor"></span><div class="para"> <p>56～75kg</p></div></td><td><span id="v1011072_zh" class="anchor"></span><div class="para"> <p>1200 mg</p></div></td><td><span id="v1011074_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011076_zh" class="anchor"></span><div class="para"> <p>2800mg</p></div></td><td><span id="v1011078_zh" class="anchor"></span><div class="para"> <p>2000mg</p></div></td></tr><tr class="odd"><td><span id="v1011082_zh" class="anchor"></span><div class="para"> <p><span class='symbol'>≥</span>76kg§</p></div></td><td><span id="v1011084_zh" class="anchor"></span><div class="para"> <p>1600mg</p></div></td><td><span id="v1011086_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011088_zh" class="anchor"></span><div class="para"> <p>4000mg</p></div></td><td><span id="v1011090_zh" class="anchor"></span><div class="para"> <p>2400mg</p></div></td></tr><tr class="even"><td><span id="v1011095_zh" class="anchor"></span><div class="para"> <p>儿童（最大剂量）</p></div></td><td><span id="v1011097_zh" class="anchor"></span><div class="para"> <p>15～20mg/kg（1g）</p></div></td><td><span id="v1011099_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1011101_zh" class="anchor"></span><div class="para"> <p>50mg/kg（2.5g）</p></div></td><td><span id="v1011103_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr><tr class="odd"><td rowspan="2"><span id="v1010873_zh" class="anchor"></span><div class="para"> <p>莫西沙星</p></div></td><td><span id="v1010875_zh" class="anchor"></span><div class="para"> <p>≥ 12 岁</p></div></td><td><span id="v1010877_zh" class="anchor"></span><div class="para"> <p>400 mg</p></div></td><td><span id="v1010879_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010881_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td><td><span id="v1010883_zh" class="anchor"></span><div class="para"> <p> N/A </p></div></td></tr></tbody> <tfoot><tr><td colspan="6"><span id="v1011107_zh" class="anchor"></span><div class="para"> <p>*特殊剂量和方案见文字讨论。</p></div></td></tr><tr><td colspan="6"><span id="v1011110_zh" class="anchor"></span><div class="para"> <p>†每天被认为是 5 或 7 天/周。所有剂量 <span class='symbol'></span> 7 天/周必须作为直接观察治疗给予。</p></div></td></tr><tr><td colspan="6"><span id="v1011113_zh" class="anchor"></span><div class="para"> <p>‡仅用于巩固期。</p></div></td></tr><tr><td colspan="6"><span id="v1011116_zh" class="anchor"></span><div class="para"> <p>§最大剂量。</p></div></td></tr><tr><td colspan="6"><span id="v1011119_zh" class="anchor"></span><div class="para"> <p>N/A=不适用</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></body>
<div class="bottomnav__gotolink bottomnav__gotolink--next"></div>  <div class="fixed-footer fixed-width" align="right" id="setbackgrnd"><table class="fixed-width"><tr class="fixed-width"><td id="tdsearch" align="right" class="tdsearch"><input type="text" id="search" onkeyup="search(id)" placeholder="Find on page..." class="form-control search"></td><td id="tdbtn" align="left" class="tdbtn"><button onclick="myFunction()" id="button" class="button"></button></td></tr></table></div>
</html>